data_1pft_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pft _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.452 0.644 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.6 t -104.59 112.41 65.34 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.329 168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.32 -14.71 43.74 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.717 2.278 . . . . 0.0 113.854 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.43 -74.48 0.35 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.514 -174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.1 p -97.07 -6.54 34.93 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.928 -164.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.16 68.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.663 0.744 . . . . 0.0 110.168 -161.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -138.88 105.52 5.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.192 168.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -15.71 63.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.761 -167.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -77.19 104.85 7.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.023 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 27' ' ' CYS . 18.2 mt -109.03 -179.62 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.376 167.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.3 pt -158.86 153.2 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.402 -175.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.457 ' CD1' HG13 ' A' ' 25' ' ' ILE . 6.3 t80 -100.15 159.74 14.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.386 -169.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -140.83 80.03 18.2 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.788 -172.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -60.28 -18.75 54.2 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.546 2.164 . . . . 0.0 113.493 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -75.02 -37.17 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.08 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -102.77 -24.42 13.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.32 36.01 11.41 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.9 tt0 -108.7 165.94 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.011 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.457 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.5 mp -140.82 116.04 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.259 168.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -109.21 170.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.889 -169.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.449 ' HA ' HD21 ' A' ' 16' ' ' LEU . 15.9 t -72.38 151.03 42.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.072 164.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 17' ' ' ILE . . . -99.73 14.23 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.306 171.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -128.0 -69.13 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.892 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.6 p -88.89 -16.02 32.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.601 -171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 -11.04 59.33 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.4 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -66.86 126.88 30.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.14 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 89.1 t -61.08 168.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.199 167.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.449 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 31.6 mm -118.25 -75.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.716 173.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.911 164.045 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 t -80.01 120.16 78.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 156.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -65.96 -14.85 46.42 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 122.768 2.312 . . . . 0.0 113.689 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.15 -50.09 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.597 -163.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -106.92 -11.74 15.63 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.908 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 58.91 47.38 12.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.384 -167.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.0 m -99.99 142.58 31.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.169 159.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 -7.95 59.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.81 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -98.62 125.83 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.951 -166.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.518 HD23 HD13 ' A' ' 34' ' ' ILE . 14.1 mt -135.35 160.81 37.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.413 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 pt -144.07 156.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.492 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -103.67 148.29 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.377 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.81 90.03 33.32 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.866 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.87 -20.39 66.44 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 122.59 2.193 . . . . 0.0 113.598 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.23 -35.75 78.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.088 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.37 17.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.406 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.3 51.73 36.01 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' A' ' 33' ' ' VAL . 1.1 tt0 -143.0 124.71 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.63 134.19 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.145 168.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.8 t -126.79 175.29 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.078 -170.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.514 ' HA ' HD21 ' A' ' 16' ' ' LEU . 20.8 t -84.84 140.72 30.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.983 169.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.15 27.3 3.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.308 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 -69.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.51 172.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -91.74 -16.23 27.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.681 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -10.61 59.61 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.55 136.37 54.41 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.522 -0.839 . . . . 0.0 110.133 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 ' HG3' ' A' ' 24' ' ' GLU . 85.3 t -60.75 167.71 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.235 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.518 HD13 HD23 ' A' ' 16' ' ' LEU . 10.8 mm -118.57 -71.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.809 171.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.026 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 t -99.77 113.81 65.28 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.413 163.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -68.12 -13.22 37.48 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.7 2.267 . . . . 0.0 113.95 168.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.34 -75.62 0.34 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.514 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -90.58 -9.4 47.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.728 -163.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 59.74 64.67 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.929 0.871 . . . . 0.0 110.258 -159.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -135.45 147.21 48.86 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.203 163.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.07 -16.89 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.573 -171.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.67 119.72 22.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.153 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.526 HD21 ' HA ' ' A' ' 27' ' ' CYS . 37.6 mt -130.83 -178.16 4.68 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.331 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 pt -155.5 128.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.449 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.441 ' CE2' ' CG1' ' A' ' 25' ' ' ILE . 4.1 t80 -93.35 138.52 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.342 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.09 86.71 2.6 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.787 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -59.31 -19.8 52.38 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.525 2.15 . . . . 0.0 113.547 -170.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.07 -54.26 19.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.038 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -84.84 -19.46 32.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.458 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.78 21.18 72.28 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -168.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HG2' HG21 ' A' ' 26' ' ' VAL . 21.3 tt0 -75.08 162.8 28.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.132 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.441 ' CG1' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mp -142.45 115.95 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.105 170.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.1 t -111.93 175.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.224 -168.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.526 ' HA ' HD21 ' A' ' 16' ' ' LEU . 16.8 t -103.44 141.91 35.16 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.084 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.84 17.44 19.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.346 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -138.62 -25.84 0.9 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.35 -161.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.5 p -131.07 -16.17 3.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.84 163.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.12 -10.93 67.77 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.518 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.7 137.83 58.27 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.888 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 85.1 t -78.51 159.32 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.858 159.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.477 ' N ' HG11 ' A' ' 33' ' ' VAL . 4.4 mt -114.44 -74.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.717 164.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.967 -168.345 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.8 t -89.17 118.07 68.83 Favored Pre-proline 0 C--O 1.246 0.88 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.181 161.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.51 -11.47 32.27 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.761 2.307 . . . . 0.0 113.832 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.09 -76.78 0.4 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.493 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 p -86.48 -7.8 58.11 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.064 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 56.76 50.02 13.27 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.371 -0.831 . . . . 0.0 110.903 -167.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -101.7 150.82 22.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.275 163.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.96 -16.77 22.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.666 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.92 110.46 18.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.144 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.439 HD12 ' CD1' ' A' ' 34' ' ' ILE . 19.9 mt -120.95 167.07 12.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.362 168.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 pt -144.14 129.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 -169.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.5 ' CD1' HG13 ' A' ' 25' ' ' ILE . 18.2 t80 -74.1 166.78 22.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.37 173.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -149.93 89.28 4.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.734 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.51 -17.92 60.68 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.609 2.206 . . . . 0.0 113.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.37 -36.87 60.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.169 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.1 -20.71 12.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.33 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.05 8.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -168.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HG2' HG21 ' A' ' 26' ' ' VAL . 12.3 tt0 -119.48 167.52 11.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -168.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 35' ' ' GLU . 2.5 mp -135.83 112.27 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.122 166.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 t -105.5 168.91 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.326 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.8 t -73.04 153.51 40.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.123 164.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -106.49 20.77 18.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.345 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 -79.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.581 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.7 p -90.77 -4.68 56.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.631 -157.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.49 86.45 0.07 OUTLIER Glycine 0 CA--C 1.555 2.583 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -158.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -153.11 128.88 10.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 112.503 -1.849 . . . . 0.0 110.204 164.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 93.2 t -79.17 166.74 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.211 167.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.452 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 6.8 mt -126.25 -74.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.172 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HB2' HD11 ' A' ' 25' ' ' ILE . 3.6 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.967 -162.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.51 ' HA ' HD13 ' A' ' 16' ' ' LEU . 10.2 m . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.266 0.555 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.1 t -99.21 105.53 33.04 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.68 173.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -58.93 -13.48 18.81 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.699 2.266 . . . . 0.0 113.944 166.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.72 -61.29 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.567 -171.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.5 -11.3 20.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.764 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 59.56 58.27 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.244 -162.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -113.71 172.05 7.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.208 160.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.18 -10.82 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.785 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -70.27 73.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.044 168.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' A' ' 7' ' ' VAL . 74.4 mt -87.13 176.6 7.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.332 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 pt -144.32 176.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.453 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.516 ' CD1' HG13 ' A' ' 25' ' ' ILE . 14.4 t80 -138.34 142.0 39.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.309 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.37 89.0 34.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -167.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -60.74 -16.52 44.34 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.306 2.004 . . . . 0.0 113.534 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.4 -32.56 37.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.059 -172.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -113.52 -19.9 11.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.403 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.61 54.27 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -168.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' HG21 ' A' ' 26' ' ' VAL . 36.7 tt0 -128.13 125.23 38.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.359 -0.42 . . . . 0.0 109.964 -171.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.516 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.5 mp -97.66 124.41 50.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.097 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.7 t -126.86 177.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.023 -172.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' N ' HG13 ' A' ' 26' ' ' VAL . 15.6 t -87.91 139.94 30.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.249 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.14 25.51 4.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.329 168.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.4 -71.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.409 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.07 -16.24 30.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.605 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -10.76 57.46 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -68.65 129.63 40.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.503 -0.848 . . . . 0.0 110.201 -167.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.9 t -61.16 168.05 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.254 169.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.447 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 14.4 mm -118.01 -71.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.728 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.144 176.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 21.8 m . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -112.74 117.24 46.9 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.212 172.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 -12.55 35.24 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.626 2.217 . . . . 0.0 114.022 168.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.94 -74.48 0.41 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.456 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -89.45 -9.26 50.79 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.961 -167.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.08 51.15 10.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.77 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -134.87 147.36 49.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.547 163.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -87.13 -16.35 35.71 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.55 -160.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.61 109.26 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.082 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 27' ' ' CYS . 8.7 mt -128.51 168.98 14.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.457 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 pt -153.63 150.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.413 -172.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.513 ' CD2' HG13 ' A' ' 25' ' ' ILE . 8.8 t80 -105.65 155.97 18.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.305 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.39 78.31 22.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.773 -172.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -60.3 -19.37 57.55 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.546 2.164 . . . . 0.0 113.562 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.02 -38.72 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.034 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -86.19 -33.45 20.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.436 174.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.46 52.86 4.03 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.14 145.08 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.411 . . . . 0.0 109.952 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.513 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.3 mp -115.15 136.96 50.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.914 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.4 t -130.91 177.61 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.13 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.532 ' HA ' HD21 ' A' ' 16' ' ' LEU . 35.6 t -101.55 138.43 38.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.539 173.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.36 21.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.521 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HG3' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -134.05 -24.74 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.234 -161.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 p -130.26 -16.74 3.5 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.939 161.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -11.01 59.78 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.457 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.57 137.76 56.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.991 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.1 t -60.69 167.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.293 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 16' ' ' LEU . 10.8 mm -120.0 -74.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.627 174.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.058 -171.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m . . . . . 0 CA--C 1.534 0.329 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.9 t -83.28 118.13 70.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.809 157.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.92 -10.02 25.34 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.575 2.183 . . . . 0.0 113.777 169.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.96 -74.7 0.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.37 -170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -85.25 -9.89 57.19 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.568 -166.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 59.57 59.3 2.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.182 -160.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.0 p -99.3 167.68 10.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.206 160.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.17 -6.7 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.805 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -109.27 99.11 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.021 -168.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.457 HD12 ' CD1' ' A' ' 34' ' ' ILE . 45.8 mt -104.77 175.11 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.388 167.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 28' ' ' ALA . 3.3 pt -161.93 132.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.458 -170.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.517 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.7 t80 -89.58 135.7 33.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.382 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -106.35 92.79 7.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.8 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.28 -17.42 60.0 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.566 2.178 . . . . 0.0 113.52 -172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.105 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.25 -21.88 14.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.437 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.11 40.84 6.85 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -168.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -104.69 169.36 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -169.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.517 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -137.78 115.73 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.285 163.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.2 t -115.39 172.76 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.096 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 t -78.25 150.91 33.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.006 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.498 ' HA ' HD13 ' A' ' 17' ' ' ILE . . . -94.03 13.33 23.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.311 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 -79.53 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.559 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.16 -14.81 49.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.545 -159.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.33 -10.21 33.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.287 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' CE2' HG13 ' A' ' 34' ' ' ILE . 70.3 t80 -70.29 119.05 13.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.38 -0.91 . . . . 0.0 110.175 -164.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 93.0 t -73.03 155.29 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.875 161.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.481 HG13 ' CE2' ' A' ' 32' ' ' TYR . 4.3 mt -108.59 -74.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.61 162.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.02 -168.316 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -96.33 113.78 63.1 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.303 165.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -61.84 -19.7 66.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.784 2.323 . . . . 0.0 113.781 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.76 -67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.642 -171.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -94.68 -11.35 29.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.64 -168.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 59.51 57.38 3.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.491 0.663 . . . . 0.0 110.256 -162.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -120.63 156.97 30.57 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.298 161.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.7 -0.44 18.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.698 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -91.47 111.22 22.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.091 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' A' ' 27' ' ' CYS . 26.7 mt -120.12 173.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.464 174.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 pt -151.71 127.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.416 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD1' HG13 ' A' ' 25' ' ' ILE . 10.0 t80 -98.11 137.15 37.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.361 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.53 89.01 6.85 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.742 -173.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -60.88 -14.59 33.31 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.553 2.168 . . . . 0.0 113.527 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -85.68 -34.97 21.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.053 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.3 mtt85 -101.0 -24.11 14.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.393 172.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.28 47.75 8.81 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -122.58 125.77 46.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.005 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CD1' ' A' ' 18' ' ' TYR . 1.9 mp -90.71 138.83 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.396 168.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.0 t -132.67 177.26 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.981 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.5 ' HA ' HD21 ' A' ' 16' ' ' LEU . 21.4 t -96.11 139.13 32.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.011 169.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.21 23.65 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.447 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -120.07 -66.53 1.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.531 171.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.28 -15.19 20.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.697 -168.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.5 -11.32 59.69 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.59 131.76 47.17 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.212 -0.994 . . . . 0.0 109.985 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 94.7 t -61.27 167.93 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.083 164.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.508 ' N ' HG13 ' A' ' 33' ' ' VAL . 31.4 mm -116.71 -76.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.839 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.936 164.253 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t -105.73 116.23 60.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.42 165.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -68.39 -14.74 40.82 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.801 2.334 . . . . 0.0 113.856 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.51 -74.23 0.4 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.534 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -90.97 -9.46 45.96 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.675 -164.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.74 63.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.998 0.904 . . . . 0.0 110.257 -160.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -136.05 145.67 46.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.111 163.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.28 -16.59 19.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.646 -166.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -72.12 129.45 38.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.055 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 34' ' ' ILE . 8.1 mt -139.53 171.32 14.42 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.396 173.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.424 HG23 HD11 ' A' ' 17' ' ' ILE . 4.7 pt -157.62 146.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.475 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 11.1 t80 -97.3 151.35 19.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.259 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.485 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 1.4 t0 -133.28 96.81 16.91 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.29 -18.55 63.13 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.311 2.007 . . . . 0.0 113.506 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -47.78 70.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.09 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -104.84 -19.28 13.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.489 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.78 26.69 49.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -167.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -110.66 122.97 49.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.32 -0.44 . . . . 0.0 109.972 -166.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 mp -89.46 131.4 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.927 164.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.7 t -125.23 172.89 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.091 -171.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.7 t -70.75 147.69 48.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.057 163.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.59 14.69 20.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.353 170.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.01 -74.82 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.447 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.1 p -91.92 -15.68 27.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.645 -160.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.75 -11.99 42.02 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.365 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -63.15 125.35 23.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 113.965 -1.118 . . . . 0.0 109.647 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 92.0 t -60.76 141.44 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.202 169.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.534 HG13 HD11 ' A' ' 16' ' ' LEU . 25.9 mm -90.17 -75.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.791 164.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.908 -168.447 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -80.0 118.92 74.86 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 153.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.43 -12.69 35.57 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.68 2.253 . . . . 0.0 113.862 169.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.86 -75.32 0.38 Allowed 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.556 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.1 -11.39 41.43 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.65 -166.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.31 51.84 6.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.226 -164.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 m -103.61 148.33 26.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.208 158.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.46 -7.31 41.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.753 -169.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.7 144.81 35.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.995 -168.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.531 HD11 HG13 ' A' ' 34' ' ' ILE . 12.7 mt -140.13 171.03 14.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.487 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 28' ' ' ALA . 8.2 pt -159.7 145.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.406 -170.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.8 t80 -97.9 138.99 34.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.398 -167.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.89 95.71 25.52 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.879 176.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -59.33 -15.03 27.32 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.14 1.893 . . . . 0.0 113.611 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.74 -35.12 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.042 -168.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -28.19 15.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.417 169.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.39 44.76 5.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -168.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 33' ' ' VAL . 5.6 tp10 -119.31 160.26 22.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -168.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.509 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.3 mp -120.37 133.05 68.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 162.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -129.15 169.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.056 -167.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HA ' HD21 ' A' ' 16' ' ' LEU . 20.1 t -63.64 149.17 47.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.926 163.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 17' ' ' ILE . . . -94.34 13.61 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.283 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.78 -74.78 0.59 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.66 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -87.11 -16.07 36.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.594 -164.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 -11.39 55.93 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.516 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -67.3 129.83 41.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.055 -170.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.5 t -61.52 167.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.268 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.531 HG13 HD11 ' A' ' 16' ' ' LEU . 15.5 mm -121.8 -79.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.604 170.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.971 173.646 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HB2' HD22 ' A' ' 16' ' ' LEU . 21.8 t -93.48 115.67 65.39 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.063 160.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.29 -19.71 67.83 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.745 2.297 . . . . 0.0 113.751 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.15 -68.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.625 -171.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.51 -12.02 30.61 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.638 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 54.61 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -162.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.2 p -99.04 -172.04 2.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.048 159.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.78 -8.22 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.742 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -112.81 53.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.825 -163.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 27' ' ' CYS . 20.1 mt -60.72 171.43 1.16 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.562 175.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.457 HD12 ' CB ' ' A' ' 28' ' ' ALA . 10.4 pt -160.07 179.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.51 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.5 t80 -131.59 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.417 -169.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.473 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 5.8 t0 -143.73 89.8 7.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.725 -171.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.3 -14.72 25.81 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 C-N-CA 122.54 2.16 . . . . 0.0 113.564 -171.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -88.24 -30.8 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.989 -168.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -96.92 -19.86 18.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.443 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.23 54.85 8.41 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -168.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HG3' HG11 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -136.61 144.39 44.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -167.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.51 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -111.07 112.93 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.892 164.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.1 t -112.39 169.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.165 -166.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.507 ' HA ' HD21 ' A' ' 16' ' ' LEU . 21.9 t -69.73 154.65 41.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.887 164.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.457 ' CB ' HD12 ' A' ' 17' ' ' ILE . . . -104.12 15.9 27.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.302 172.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.3 -66.05 0.91 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.713 -173.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -94.45 -16.58 23.26 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.632 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 -10.53 58.73 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.499 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -66.08 129.96 41.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.475 -0.863 . . . . 0.0 110.166 -167.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG11 ' HG3' ' A' ' 24' ' ' GLU . 87.5 t -61.12 167.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.301 170.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.452 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 14.1 mm -118.99 -75.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.739 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.159 -170.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.3 t -90.09 116.74 67.09 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.004 159.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -61.19 -17.17 50.95 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.732 2.288 . . . . 0.0 113.721 167.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.84 -74.21 0.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.424 -168.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 p -86.17 -9.31 56.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.703 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 59.59 61.74 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.774 0.797 . . . . 0.0 110.285 -160.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.5 p -103.8 -165.06 1.12 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.294 163.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.45 -7.46 1.31 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.816 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -115.53 133.0 56.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.02 -167.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' A' ' 27' ' ' CYS . 19.8 mt -137.67 178.32 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.432 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.1 pt -160.32 139.36 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.413 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.511 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.4 t80 -104.55 136.72 43.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.42 -171.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.21 80.07 71.46 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.822 -169.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -59.26 -18.62 45.92 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 122.46 2.107 . . . . 0.0 113.598 -171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.93 -37.4 84.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.008 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.76 -25.95 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.407 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.14 51.64 4.62 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 1.5 tp10 -130.0 129.13 43.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -167.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.511 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.4 mp -103.31 114.59 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.113 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.2 t -118.15 168.79 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.275 -166.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' HD21 ' A' ' 16' ' ' LEU . 24.0 t -78.06 144.76 36.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.856 167.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.46 20.64 9.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.363 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -75.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.391 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -90.18 -14.85 32.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.648 -159.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.84 -9.82 34.5 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.401 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.48 126.18 29.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 114.539 -0.83 . . . . 0.0 110.126 -164.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 86.1 t -75.87 159.26 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.001 163.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' CD1' HD12 ' A' ' 16' ' ' LEU . 5.5 mt -114.88 -76.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.514 164.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.017 -165.647 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.6 m . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.472 0.653 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.5 t -119.04 110.28 38.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.469 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.92 -4.59 9.07 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.605 2.203 . . . . 0.0 113.85 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.55 -67.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.493 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.9 p -97.56 -11.11 24.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.732 -165.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 59.59 57.7 3.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.305 -165.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.56 160.89 39.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.282 158.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -103.23 -10.97 18.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.791 -166.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -75.71 106.55 7.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.157 -168.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 14' ' ' ALA . 8.5 mt -129.98 171.65 12.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.356 -175.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 pt -159.99 135.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.343 -169.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.512 ' CD1' HG13 ' A' ' 25' ' ' ILE . 27.7 t80 -98.82 149.7 22.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.331 -169.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 30.1 t70 -127.79 95.83 33.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.727 -167.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.73 -18.39 63.98 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.121 1.881 . . . . 0.0 113.543 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.98 -43.23 68.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.014 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.96 -19.31 13.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.487 -174.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.36 44.86 20.79 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -167.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HG2' HG23 ' A' ' 26' ' ' VAL . 41.4 tt0 -120.01 124.51 46.09 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -168.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.512 HG13 ' CD1' ' A' ' 18' ' ' TYR . 1.9 mp -93.9 128.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.86 167.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.0 t -128.88 178.86 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.162 -169.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' HD21 ' A' ' 16' ' ' LEU . 33.8 t -108.67 135.34 50.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.574 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.75 25.68 4.48 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.401 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.69 -36.54 0.56 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -165.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -123.07 -15.65 7.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.845 166.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.73 63.66 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.497 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.59 139.89 56.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.417 -0.891 . . . . 0.0 110.116 -168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 92.4 t -61.03 168.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 167.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.487 HD13 HD12 ' A' ' 16' ' ' LEU . 16.5 mm -121.2 -75.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.462 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.949 168.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.5 t -111.79 111.53 54.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.415 171.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.94 -10.87 30.22 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 113.758 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.33 -73.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.456 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.45 -11.53 34.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.633 -164.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 59.48 57.81 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.254 -162.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.501 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 45.6 m -124.24 162.9 22.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.289 161.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.2 -7.84 15.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.779 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -90.62 119.61 31.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.066 -167.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.52 HD21 ' HA ' ' A' ' 27' ' ' CYS . 10.6 mt -138.04 159.63 41.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.368 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 pt -150.99 146.58 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.433 -169.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.507 ' CD2' HG13 ' A' ' 25' ' ' ILE . 3.5 t80 -98.55 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.42 -168.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.1 90.14 9.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.882 172.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.42 -19.5 51.65 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 122.472 2.114 . . . . 0.0 113.497 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.82 -50.49 72.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.103 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -29.83 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.401 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.55 27.65 14.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -167.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.428 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -92.06 165.31 13.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.341 -0.43 . . . . 0.0 110.0 -168.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.507 HG13 ' CD2' ' A' ' 18' ' ' TYR . 1.9 mp -137.4 114.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.776 166.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.3 t -111.49 177.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.116 -167.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.52 ' HA ' HD21 ' A' ' 16' ' ' LEU . 23.0 t -98.82 135.97 39.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.841 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.56 22.94 6.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.221 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -142.76 -25.08 0.63 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.197 -160.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -133.57 -17.33 2.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.846 163.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.59 58.35 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.476 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.86 138.75 50.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.156 -168.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 64.9 t -61.17 168.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.277 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 16.8 mm -124.61 -74.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.243 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 166.114 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.5 t -110.68 113.25 55.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.507 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -65.49 -16.92 56.11 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.749 2.299 . . . . 0.0 113.76 169.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.55 -72.16 0.39 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.564 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -91.07 -9.15 46.81 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.981 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.82 50.23 12.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.834 -167.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -97.03 -167.05 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.395 164.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.31 -10.12 3.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.844 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.68 116.42 25.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.056 -168.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 34' ' ' ILE . 19.8 mt -136.69 166.55 23.3 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.364 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.5 pt -151.28 133.16 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.476 -171.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 49.2 t80 -80.34 163.01 24.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.322 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.498 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -146.41 100.2 4.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 -167.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -62.28 -18.38 62.19 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.58 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.52 -47.09 77.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.008 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -109.29 -20.17 13.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.415 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.7 52.68 6.33 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -166.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.57 144.5 37.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -166.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.457 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.4 mp -106.26 134.89 46.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.05 169.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.8 t -132.12 178.38 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.079 -167.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' HD22 ' A' ' 16' ' ' LEU . 27.0 t -99.23 139.05 35.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.74 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.66 26.91 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.386 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 -34.66 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 -162.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -126.38 -16.71 5.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.9 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.57 -10.75 70.73 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.666 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -63.06 139.08 58.74 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.599 -0.801 . . . . 0.0 110.025 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 34' ' ' ILE . 84.2 t -61.09 167.24 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.265 170.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.523 HD13 HD12 ' A' ' 16' ' ' LEU . 15.8 mm -121.67 -76.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.567 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.055 177.249 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.7 t -113.64 115.26 46.73 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.004 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.67 -20.35 70.68 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.608 2.205 . . . . 0.0 113.717 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.36 -70.54 0.44 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.49 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -95.16 -9.7 32.7 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.022 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 56.34 48.52 16.92 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.415 -0.803 . . . . 0.0 111.004 -168.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -85.46 -168.4 2.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.414 166.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.61 -13.07 5.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.741 167.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.49 109.56 20.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.12 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 27' ' ' CYS . 15.8 mt -127.9 -177.95 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.387 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 pt -160.4 145.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.414 -169.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.51 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.9 t80 -108.81 119.15 38.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.416 -169.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.98 83.84 0.52 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.795 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -59.93 -19.68 56.31 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.434 2.09 . . . . 0.0 113.596 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.09 -51.99 61.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.999 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -79.12 -30.36 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.407 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.31 40.87 7.68 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -168.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -118.07 159.64 22.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.51 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -129.47 133.13 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.037 163.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 27' ' ' CYS . 4.8 t -131.93 178.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.114 -167.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HA ' HD21 ' A' ' 16' ' ' LEU . 35.9 t -106.15 125.41 50.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.536 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.25 -2.44 31.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.868 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -77.59 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 171.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.5 p -83.2 -17.54 42.46 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.6 -162.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.83 60.52 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.43 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -68.93 139.93 55.09 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.547 -0.826 . . . . 0.0 110.265 -168.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 34' ' ' ILE . 95.7 t -62.17 167.68 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.038 165.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.469 HG13 HD11 ' A' ' 16' ' ' LEU . 16.9 mm -117.82 -74.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.725 171.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 166.707 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 16.9 m . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.7 t -111.57 112.61 53.92 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.175 174.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.25 -16.85 57.06 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.686 2.257 . . . . 0.0 113.735 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.52 -73.56 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.393 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.9 -11.01 40.44 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.645 -166.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 59.37 56.06 3.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.248 -163.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 52.6 p -109.57 -166.21 1.08 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.367 160.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -142.36 -16.96 0.73 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.662 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.39 122.59 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.05 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 27' ' ' CYS . 13.5 mt -137.28 160.43 39.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.466 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.37 132.01 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.369 -168.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.517 ' CD1' HG13 ' A' ' 25' ' ' ILE . 7.4 t80 -88.47 132.7 34.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.379 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 80.76 1.11 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.653 168.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 5.6 Cg_endo -59.16 -20.23 53.48 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 122.558 2.172 . . . . 0.0 113.512 -168.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.03 -53.22 57.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.178 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -86.9 -19.13 29.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.26 30.55 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -168.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.46 162.31 15.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.929 -0.635 . . . . 0.0 109.993 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.1 mp -142.0 115.79 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.202 167.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 t -106.51 177.93 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.232 -170.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HA ' HD21 ' A' ' 16' ' ' LEU . 31.4 t -101.07 125.05 47.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.641 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.53 -4.61 43.64 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.882 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -92.97 -78.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.313 170.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -86.12 -16.6 37.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.612 -161.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 -10.38 54.56 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.455 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -72.61 133.97 44.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.592 -0.804 . . . . 0.0 110.172 -168.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.3 t -61.27 167.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.133 165.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.462 HG13 HD12 ' A' ' 16' ' ' LEU . 33.4 mm -119.18 -76.53 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.644 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.079 168.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -107.72 113.52 61.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.279 170.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.68 -13.72 41.03 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 122.71 2.273 . . . . 0.0 113.721 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.95 -74.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.456 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -91.21 -11.02 39.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.691 -166.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 59.31 54.81 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.223 -163.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.5 p -88.85 176.55 7.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.038 162.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.33 -8.04 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.763 164.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -99.04 116.18 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.988 -167.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 27' ' ' CYS . 16.0 mt -132.62 166.59 21.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.379 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 HD12 ' CB ' ' A' ' 28' ' ' ALA . 10.2 pt -155.15 148.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.399 -167.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.479 ' CD1' HG13 ' A' ' 25' ' ' ILE . 12.9 t80 -107.73 123.17 48.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.312 -170.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.96 98.0 7.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 -171.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.09 -14.18 22.41 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.306 2.004 . . . . 0.0 113.505 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.55 -30.7 21.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.085 -169.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.31 -19.33 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.459 174.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.18 51.2 10.42 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -168.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.442 ' HG2' ' CG2' ' A' ' 26' ' ' VAL . 31.9 tt0 -137.08 125.94 24.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.432 . . . . 0.0 109.9 -167.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.479 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.4 mp -88.83 128.11 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.128 169.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.1 t -130.76 177.12 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.968 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.531 ' HA ' HD21 ' A' ' 16' ' ' LEU . 19.7 t -93.33 124.01 37.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.916 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.416 ' CB ' HD12 ' A' ' 17' ' ' ILE . . . -76.73 7.31 4.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.753 176.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -112.95 -67.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.455 178.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.6 p -91.75 -19.14 22.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.512 -169.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.13 57.81 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.551 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -68.76 126.82 30.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.404 -0.898 . . . . 0.0 110.229 -170.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 65.3 t -61.55 169.36 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.426 175.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.507 HG13 HD12 ' A' ' 16' ' ' LEU . 20.0 mm -124.75 -73.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.185 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.958 166.624 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.476 0.655 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.4 t -113.84 111.04 48.64 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.537 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -67.77 -10.57 29.21 Favored 'Trans proline' 0 N--CA 1.482 0.846 0 C-N-CA 122.751 2.301 . . . . 0.0 113.881 169.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.72 -71.81 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.549 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -93.98 -11.33 31.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.635 -165.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 59.48 58.11 3.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.228 -161.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -110.8 -171.35 1.81 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.231 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.76 -16.44 1.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.717 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -74.85 120.47 20.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.026 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.515 HD21 ' HA ' ' A' ' 27' ' ' CYS . 7.9 mt -135.77 165.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.411 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 pt -150.02 140.37 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.394 -168.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.514 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.0 t80 -101.66 149.48 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.236 -168.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 7.1 t70 -129.3 94.79 32.24 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.736 -167.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -59.89 -20.26 58.86 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.272 1.981 . . . . 0.0 113.571 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.92 -39.04 87.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.112 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -22.62 11.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.52 30.29 30.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.41 164.65 12.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -170.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.6 mp -126.76 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.999 163.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.1 t -132.82 178.5 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.155 -167.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.515 ' HA ' HD21 ' A' ' 16' ' ' LEU . 22.0 t -101.87 136.85 41.0 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.858 175.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.89 29.57 2.67 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.33 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.74 -35.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.613 -165.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.3 p -125.57 -16.49 5.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.823 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.43 -11.11 69.02 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.576 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.04 137.67 58.33 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.639 -0.78 . . . . 0.0 109.976 -173.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.6 t -60.89 167.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.26 168.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 33' ' ' VAL . 20.6 mm -120.78 -69.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.426 173.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.53 0.207 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.066 176.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 27' ' ' CYS . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' HD21 ' A' ' 16' ' ' LEU . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.508 HG13 HD12 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 27' ' ' CYS . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' HD21 ' A' ' 16' ' ' LEU . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.508 HG13 HD12 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 . . . . . 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.9 t -95.63 111.22 54.9 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.338 161.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -69.99 -8.08 22.72 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.6 2.2 . . . . 0.0 113.968 169.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.32 -73.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.514 175.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -92.68 -11.45 34.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.663 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.53 57.15 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.209 -162.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -114.02 172.94 6.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.209 160.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.15 -9.32 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.715 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -96.83 52.64 1.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.977 -162.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.526 HD11 HG13 ' A' ' 34' ' ' ILE . 17.4 mt -69.71 175.97 3.89 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.449 -177.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 pt -157.49 153.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.462 -168.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.512 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.3 t80 -106.8 132.36 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.434 -169.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.3 92.08 6.44 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.703 175.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -59.07 -13.16 17.98 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.388 2.059 . . . . 0.0 113.602 -168.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -47.68 14.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.016 -170.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.413 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -90.05 -24.0 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.419 170.302 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 16.61 50.06 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -177.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.59 164.2 24.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.027 -171.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -130.84 113.0 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.938 165.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.1 t -114.04 177.61 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.147 -169.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.477 ' N ' HG13 ' A' ' 26' ' ' VAL . 15.4 t -90.5 126.17 35.83 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.076 178.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.48 7.05 4.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.774 175.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.23 -67.66 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.514 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.8 p -93.03 -20.13 20.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.48 -167.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.98 60.23 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.639 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -69.52 131.94 45.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.659 -0.771 . . . . 0.0 110.333 -172.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 61.3 t -61.79 170.98 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.368 175.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.526 HG13 HD11 ' A' ' 16' ' ' LEU . 14.0 mm -128.07 -73.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.013 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.022 167.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.0 t -102.61 111.12 64.45 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.369 164.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -68.45 -10.77 29.99 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.741 2.294 . . . . 0.0 113.751 169.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.14 -73.67 0.36 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.482 177.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -93.67 -11.86 30.64 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.596 -163.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 59.25 2.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.579 0.704 . . . . 0.0 110.193 -161.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.455 ' CB ' ' HG3' ' A' ' 29' ' ' LYS . 54.9 m -123.61 148.31 46.53 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.26 161.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.31 27.93 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.602 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.89 118.05 18.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.158 -172.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD21 ' HA ' ' A' ' 27' ' ' CYS . 15.7 mt -141.95 158.04 44.24 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.315 178.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 pt -150.85 158.57 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.415 -167.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -108.68 121.79 45.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.375 -169.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.21 99.75 3.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.748 178.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.61 -15.53 31.55 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.362 2.041 . . . . 0.0 113.469 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -78.21 -30.86 49.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.039 -169.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -111.98 -20.22 12.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.398 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 44.79 7.56 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.46 168.11 9.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.75 128.77 68.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.677 162.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 3.7 t -130.88 176.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.93 -168.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HA ' HD21 ' A' ' 16' ' ' LEU . 17.8 t -94.54 136.78 34.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.01 176.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 20.91 8.1 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.237 178.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' CE ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -143.41 -23.79 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.357 -158.361 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.3 p -135.99 -18.06 1.6 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.838 164.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.15 -11.44 57.14 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.455 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -67.97 137.16 54.92 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.312 -0.944 . . . . 0.0 110.09 -170.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 96.3 t -61.59 167.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.221 175.065 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.533 HG13 HD11 ' A' ' 16' ' ' LEU . 19.4 mm -124.21 -78.27 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.416 172.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.978 174.019 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -102.47 111.44 64.62 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.499 168.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.25 -11.76 33.41 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.706 2.271 . . . . 0.0 113.778 169.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.17 -69.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.619 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.2 p -96.53 -11.45 25.44 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.654 -166.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.62 58.32 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.242 -162.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -114.42 173.78 6.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.283 160.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.86 6.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.611 -169.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.22 126.97 35.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.043 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.474 HD11 HG13 ' A' ' 34' ' ' ILE . 17.6 mt -135.52 161.54 35.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.446 174.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 pt -135.64 140.29 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.367 -167.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -104.29 135.85 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.256 -169.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.65 92.23 49.15 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.794 -168.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -59.47 -20.12 55.15 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.44 2.093 . . . . 0.0 113.61 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 -46.99 61.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.076 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -91.76 -21.79 20.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.406 -178.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 41.79 60.62 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -167.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -128.3 141.34 51.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.404 . . . . 0.0 109.968 -166.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.424 HD11 ' HG3' ' A' ' 35' ' ' GLU . 2.5 mp -108.04 137.67 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.091 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.6 t -134.06 176.95 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.908 -168.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' N ' HG13 ' A' ' 26' ' ' VAL . 18.1 t -92.6 131.09 38.01 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.841 174.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.15 43.24 1.14 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.379 170.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -53.05 0.16 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.464 -178.045 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.8 p -111.03 -18.23 13.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.717 -178.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.99 -10.61 68.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.671 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.17 132.59 53.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.999 -175.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.8 t -61.06 167.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.279 170.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 HD11 ' A' ' 16' ' ' LEU . 21.1 mm -120.24 -77.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.698 173.315 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.424 ' HG3' HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.055 172.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.9 t -103.01 111.73 65.27 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.105 168.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -66.8 -4.26 10.89 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.678 2.252 . . . . 0.0 113.776 170.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.45 -68.53 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.557 -178.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.87 -11.29 29.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.555 -167.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 59.44 57.35 3.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.185 -162.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -101.82 -165.81 1.23 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.279 160.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.08 -16.91 1.23 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.681 175.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.42 122.03 29.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.111 -175.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 27' ' ' CYS . 11.0 mt -137.81 -176.3 4.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.442 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 pt -161.81 138.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 -169.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.7 t80 -105.92 121.08 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.401 -177.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.75 94.56 3.71 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.869 -175.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.92 -15.17 25.85 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 C-N-CA 122.348 2.032 . . . . 0.0 113.449 -170.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.83 -31.69 23.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.988 -170.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -27.15 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.371 171.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.01 3.32 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -163.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.539 ' HG2' HG21 ' A' ' 26' ' ' VAL . 9.3 tt0 -140.78 114.88 9.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.93 -166.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.8 mp -93.36 116.05 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 HG21 ' HG2' ' A' ' 24' ' ' GLU . 5.3 t -121.17 177.66 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.246 -164.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.513 ' HA ' HD21 ' A' ' 16' ' ' LEU . 35.0 t -106.33 131.75 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.457 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.25 39.32 1.02 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 113.661 -1.608 . . . . 0.0 110.455 173.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 -50.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.371 -175.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.0 p -113.12 -17.19 12.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.65 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -11.0 63.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.28 137.02 56.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.406 -0.897 . . . . 0.0 110.037 -170.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 26' ' ' VAL . 90.1 t -79.89 159.85 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.031 161.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 ' N ' HG11 ' A' ' 33' ' ' VAL . 5.3 mt -116.38 -75.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.5 166.093 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.079 -162.842 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.087 0.47 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.2 p -160.63 122.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.298 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 m120 70.15 -155.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.293 -168.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.53 ' HE2' ' HD3' ' A' ' 6' ' ' LYS . 2.0 mmmm -61.09 -43.53 98.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.444 -169.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 68.11 86.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.43 -171.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' HD3' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -166.74 -176.47 3.5 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.2 168.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.0 m 59.53 -163.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.13 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.6 t -104.59 112.41 65.34 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.329 168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.32 -14.71 43.74 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.717 2.278 . . . . 0.0 113.854 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.43 -74.48 0.35 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.514 -174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.1 p -97.07 -6.54 34.93 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.928 -164.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.16 68.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.663 0.744 . . . . 0.0 110.168 -161.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -138.88 105.52 5.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.192 168.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -15.71 63.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.761 -167.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -77.19 104.85 7.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.023 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.449 HD21 ' HA ' ' A' ' 27' ' ' CYS . 18.2 mt -109.03 -179.62 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.376 167.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ALA . 3.3 pt -158.86 153.2 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.402 -175.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.457 ' CD1' HG13 ' A' ' 25' ' ' ILE . 6.3 t80 -100.15 159.74 14.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.386 -169.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -140.83 80.03 18.2 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.788 -172.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -60.28 -18.75 54.2 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.546 2.164 . . . . 0.0 113.493 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -75.02 -37.17 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.08 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -102.77 -24.42 13.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.32 36.01 11.41 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.9 tt0 -108.7 165.94 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.011 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.457 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.5 mp -140.82 116.04 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.259 168.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -109.21 170.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.889 -169.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.449 ' HA ' HD21 ' A' ' 16' ' ' LEU . 15.9 t -72.38 151.03 42.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.072 164.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.431 ' HA ' HD12 ' A' ' 17' ' ' ILE . . . -99.73 14.23 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.306 171.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -128.0 -69.13 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.892 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.6 p -88.89 -16.02 32.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.601 -171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 -11.04 59.33 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.4 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -66.86 126.88 30.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.14 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 89.1 t -61.08 168.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.199 167.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.449 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 31.6 mm -118.25 -75.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.716 173.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -125.07 159.75 30.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.911 164.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -151.51 48.74 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.991 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -158.9 56.9 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.368 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.1 pp -75.93 65.29 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.443 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 tt -171.89 152.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.399 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -162.09 74.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.396 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 mtm -130.34 -55.64 1.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.326 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.23 67.69 1.54 Allowed Glycine 0 CA--C 1.541 1.71 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 171.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.3 -64.55 0.11 Allowed 'Trans proline' 0 N--CA 1.486 1.048 0 C-N-CA 122.256 1.97 . . . . 0.0 113.58 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -157.29 78.14 0.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.959 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -151.33 -40.59 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.432 -168.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -109.72 148.53 31.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.359 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.61 132.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.359 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -131.02 148.34 52.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.374 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -168.23 128.64 1.3 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.358 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.593 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.261 169.843 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mtm . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.149 0.499 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.62 -25.25 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.331 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 p30 61.11 -163.57 0.25 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.655 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -175.75 25.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.301 -168.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -127.87 38.66 3.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.247 -167.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -60.61 114.77 3.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.2 166.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m -95.61 154.28 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.118 -160.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.5 t -80.01 120.16 78.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 156.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -65.96 -14.85 46.42 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 122.768 2.312 . . . . 0.0 113.689 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.15 -50.09 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.597 -163.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -106.92 -11.74 15.63 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.908 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 58.91 47.38 12.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.384 -167.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.0 m -99.99 142.58 31.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.169 159.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 -7.95 59.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.81 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -98.62 125.83 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.951 -166.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.518 HD23 HD13 ' A' ' 34' ' ' ILE . 14.1 mt -135.35 160.81 37.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.413 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 pt -144.07 156.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.492 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -103.67 148.29 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.377 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.81 90.03 33.32 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.866 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.87 -20.39 66.44 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 122.59 2.193 . . . . 0.0 113.598 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.23 -35.75 78.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.088 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.37 17.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.406 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.3 51.73 36.01 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.538 ' HG3' HG11 ' A' ' 33' ' ' VAL . 1.1 tt0 -143.0 124.71 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 mp -91.63 134.19 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.145 168.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.8 t -126.79 175.29 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.078 -170.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.514 ' HA ' HD21 ' A' ' 16' ' ' LEU . 20.8 t -84.84 140.72 30.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.983 169.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.15 27.3 3.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.308 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 -69.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.51 172.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -91.74 -16.23 27.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.681 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -10.61 59.61 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.55 136.37 54.41 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.522 -0.839 . . . . 0.0 110.133 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 ' HG3' ' A' ' 24' ' ' GLU . 85.3 t -60.75 167.71 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.235 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.518 HD13 HD23 ' A' ' 16' ' ' LEU . 10.8 mm -118.57 -71.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.809 171.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.41 149.86 41.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.026 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -122.25 51.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.954 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -143.9 77.2 1.54 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.388 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.8 tt -127.06 130.17 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.323 167.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.512 HG21 ' N ' ' A' ' 40' ' ' ASP . 1.5 tp 76.86 -54.61 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.632 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.512 ' N ' HG21 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -61.05 103.56 0.29 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 -171.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 93.9 mtp -140.3 113.09 8.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.38 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.41 -85.95 0.24 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -53.46 131.03 41.53 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.609 2.206 . . . . 0.0 113.568 -172.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.65 -179.85 6.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.07 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -88.38 -75.49 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.397 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.52 157.12 28.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.407 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.23 19.94 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.304 170.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.64 -72.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.338 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.7 134.52 54.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.402 -169.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.562 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.24 -177.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 m 59.04 -177.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.205 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.35 116.42 2.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.367 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.35 -19.1 8.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.473 170.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -116.76 -76.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.287 -166.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 141.66 34.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.352 -164.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -96.5 -161.94 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.06 166.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 t -99.77 113.81 65.28 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.413 163.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -68.12 -13.22 37.48 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.7 2.267 . . . . 0.0 113.95 168.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.34 -75.62 0.34 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.514 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -90.58 -9.4 47.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.728 -163.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 59.74 64.67 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.929 0.871 . . . . 0.0 110.258 -159.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 49.5 m -135.45 147.21 48.86 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.203 163.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.07 -16.89 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.573 -171.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -78.67 119.72 22.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.153 -175.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.526 HD21 ' HA ' ' A' ' 27' ' ' CYS . 37.6 mt -130.83 -178.16 4.68 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.331 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.0 pt -155.5 128.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.449 -176.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.441 ' CE2' ' CG1' ' A' ' 25' ' ' ILE . 4.1 t80 -93.35 138.52 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.342 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.09 86.71 2.6 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.787 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -59.31 -19.8 52.38 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.525 2.15 . . . . 0.0 113.547 -170.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.07 -54.26 19.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.038 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -84.84 -19.46 32.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.458 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.78 21.18 72.28 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -168.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.51 ' HG2' HG21 ' A' ' 26' ' ' VAL . 21.3 tt0 -75.08 162.8 28.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.132 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.441 ' CG1' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mp -142.45 115.95 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.105 170.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.1 t -111.93 175.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.224 -168.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.526 ' HA ' HD21 ' A' ' 16' ' ' LEU . 16.8 t -103.44 141.91 35.16 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.084 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.84 17.44 19.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.346 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -138.62 -25.84 0.9 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.35 -161.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.5 p -131.07 -16.17 3.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.84 163.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.12 -10.93 67.77 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.518 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.7 137.83 58.27 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.888 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 85.1 t -78.51 159.32 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.858 159.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.477 ' N ' HG11 ' A' ' 33' ' ' VAL . 4.4 mt -114.44 -74.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.717 164.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' ' N ' ' A' ' 36' ' ' GLU . 35.7 tt0 -117.57 163.61 16.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.967 -168.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -141.81 49.29 1.59 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.961 177.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -157.93 157.93 34.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.394 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.6 tp -119.3 139.37 46.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.429 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 pt -60.91 133.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.466 -170.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.49 99.13 0.5 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.363 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.0 tpt -113.43 137.12 51.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 167.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' N ' ' HD2' ' A' ' 43' ' ' PRO . . . 130.61 -52.16 0.84 Allowed Glycine 0 CA--C 1.544 1.883 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 42' ' ' GLY . 6.9 Cg_exo -51.44 -85.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.537 2.158 . . . . 0.0 113.482 -164.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -90.97 100.07 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.984 -162.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER 62.16 108.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.99 164.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -164.9 -80.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.442 163.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.6 177.96 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.361 171.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.11 82.72 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.246 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -174.14 -52.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.406 -168.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.584 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.251 -169.833 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tpp . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.091 0.472 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.32 64.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.377 173.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -165.06 101.71 0.76 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.443 -169.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -153.06 150.53 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.396 170.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -142.22 24.31 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.44 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -121.36 123.38 41.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.305 168.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.2 m -142.43 169.25 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.22 -168.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.8 t -89.17 118.07 68.83 Favored Pre-proline 0 C--O 1.246 0.88 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.181 161.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.51 -11.47 32.27 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.761 2.307 . . . . 0.0 113.832 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.09 -76.78 0.4 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.493 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 p -86.48 -7.8 58.11 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.064 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 56.76 50.02 13.27 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.371 -0.831 . . . . 0.0 110.903 -167.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -101.7 150.82 22.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.275 163.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.96 -16.77 22.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.666 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.92 110.46 18.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.144 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.439 HD12 ' CD1' ' A' ' 34' ' ' ILE . 19.9 mt -120.95 167.07 12.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.362 168.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 pt -144.14 129.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 -169.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.5 ' CD1' HG13 ' A' ' 25' ' ' ILE . 18.2 t80 -74.1 166.78 22.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.37 173.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -149.93 89.28 4.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.734 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.51 -17.92 60.68 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.609 2.206 . . . . 0.0 113.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.37 -36.87 60.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.169 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.1 -20.71 12.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.33 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.05 8.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -168.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HG2' HG21 ' A' ' 26' ' ' VAL . 12.3 tt0 -119.48 167.52 11.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -168.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 35' ' ' GLU . 2.5 mp -135.83 112.27 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.122 166.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 t -105.5 168.91 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.326 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 15.8 t -73.04 153.51 40.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.123 164.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -106.49 20.77 18.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.345 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 -79.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.581 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.7 p -90.77 -4.68 56.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.631 -157.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.49 86.45 0.07 OUTLIER Glycine 0 CA--C 1.555 2.583 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -158.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -153.11 128.88 10.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 112.503 -1.849 . . . . 0.0 110.204 164.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 93.2 t -79.17 166.74 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.211 167.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.452 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 6.8 mt -126.25 -74.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.172 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HB2' HD11 ' A' ' 25' ' ' ILE . 3.6 mm-40 -100.07 133.86 43.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.967 -162.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -110.09 131.78 54.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.079 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.27 155.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.303 168.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 111.86 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.349 168.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.42 145.8 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.441 -168.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.21 -96.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.311 169.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.3 mmt -88.39 140.86 29.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.578 -177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.36 99.65 0.22 Allowed Glycine 0 CA--C 1.541 1.698 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -55.71 110.12 0.51 Allowed 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.283 1.989 . . . . 0.0 113.462 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 -66.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.022 168.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -176.03 38.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.448 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.26 118.2 8.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.406 169.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.35 -49.61 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.338 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -105.37 109.69 21.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.406 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -130.07 -68.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.408 -170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.603 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.268 -169.774 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 121.149 0.5 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -91.79 -59.56 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.385 -170.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -62.45 -98.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.325 -166.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -133.46 79.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.595 -166.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 61.38 -168.1 0.19 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.626 164.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.537 ' HG3' HG12 ' A' ' 7' ' ' VAL . 19.8 ptmt -113.72 -168.94 1.41 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.308 169.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.537 HG12 ' HG3' ' A' ' 6' ' ' LYS . 10.2 m 60.41 -165.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.087 173.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.1 t -99.21 105.53 33.04 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.68 173.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -58.93 -13.48 18.81 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.699 2.266 . . . . 0.0 113.944 166.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.72 -61.29 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.567 -171.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.5 -11.3 20.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.764 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 59.56 58.27 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.244 -162.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -113.71 172.05 7.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.208 160.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.18 -10.82 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.785 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -70.27 73.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.044 168.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' A' ' 7' ' ' VAL . 74.4 mt -87.13 176.6 7.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.332 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 pt -144.32 176.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.453 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.516 ' CD1' HG13 ' A' ' 25' ' ' ILE . 14.4 t80 -138.34 142.0 39.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.309 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.37 89.0 34.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -167.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -60.74 -16.52 44.34 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.306 2.004 . . . . 0.0 113.534 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.4 -32.56 37.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.059 -172.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -113.52 -19.9 11.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.403 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.61 54.27 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -168.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' HG2' HG21 ' A' ' 26' ' ' VAL . 36.7 tt0 -128.13 125.23 38.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.359 -0.42 . . . . 0.0 109.964 -171.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.516 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.5 mp -97.66 124.41 50.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.097 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.7 t -126.86 177.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.023 -172.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' N ' HG13 ' A' ' 26' ' ' VAL . 15.6 t -87.91 139.94 30.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.249 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.14 25.51 4.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.329 168.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.4 -71.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.409 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.07 -16.24 30.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.605 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -10.76 57.46 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -68.65 129.63 40.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.503 -0.848 . . . . 0.0 110.201 -167.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.9 t -61.16 168.05 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.254 169.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.447 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 14.4 mm -118.01 -71.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.728 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -145.9 179.08 7.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.144 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -142.65 77.73 1.59 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.072 168.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.68 44.23 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.42 -172.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mt -138.96 82.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.379 168.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.433 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -61.23 123.87 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.569 -166.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -146.4 41.57 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.207 171.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.535 ' HE1' ' HB2' ' A' ' 44' ' ' GLU . 3.5 ttp -109.46 131.38 55.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.388 -165.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -98.05 -51.26 1.51 Allowed Glycine 0 CA--C 1.541 1.698 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -171.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 42' ' ' GLY . 7.0 Cg_endo -65.27 -0.01 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 C-N-CA 122.268 1.979 . . . . 0.0 113.708 -168.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.535 ' HB2' ' HE1' ' A' ' 41' ' ' MET . 3.1 tp10 -90.89 51.1 1.9 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.89 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 67.87 112.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.349 167.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -163.7 25.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.357 -169.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.37 -39.08 16.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.249 -169.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -80.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.5 -166.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 53.89 -102.02 0.13 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.344 0.658 . . . . 0.0 111.904 170.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.583 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.304 169.396 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 121.188 0.518 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.9 m -73.11 -163.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.315 170.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -92.25 22.8 4.21 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.647 171.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -12.96 6.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.471 170.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 70.7 120.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.408 172.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 141.61 57.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.192 166.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 21.8 m -122.5 -171.2 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.279 -164.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -112.74 117.24 46.9 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.212 172.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 -12.55 35.24 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.626 2.217 . . . . 0.0 114.022 168.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.94 -74.48 0.41 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.456 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -89.45 -9.26 50.79 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.961 -167.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.08 51.15 10.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.77 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.462 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -134.87 147.36 49.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.547 163.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -87.13 -16.35 35.71 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.55 -160.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.61 109.26 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.082 -171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.532 HD21 ' HA ' ' A' ' 27' ' ' CYS . 8.7 mt -128.51 168.98 14.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.457 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 pt -153.63 150.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.413 -172.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.513 ' CD2' HG13 ' A' ' 25' ' ' ILE . 8.8 t80 -105.65 155.97 18.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.305 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.39 78.31 22.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.773 -172.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -60.3 -19.37 57.55 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.546 2.164 . . . . 0.0 113.562 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.02 -38.72 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.034 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -86.19 -33.45 20.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.436 174.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.46 52.86 4.03 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.14 145.08 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.411 . . . . 0.0 109.952 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.513 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.3 mp -115.15 136.96 50.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.914 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.4 t -130.91 177.61 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.13 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.532 ' HA ' HD21 ' A' ' 16' ' ' LEU . 35.6 t -101.55 138.43 38.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.539 173.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.36 21.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.521 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HG3' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -134.05 -24.74 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.234 -161.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 p -130.26 -16.74 3.5 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.939 161.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -11.01 59.78 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.457 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.57 137.76 56.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.991 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.1 t -60.69 167.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.293 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 16' ' ' LEU . 10.8 mm -120.0 -74.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.627 174.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.8 -165.49 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.058 -171.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -116.09 -170.78 1.86 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.972 -172.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.05 98.73 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.537 -165.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.9 tp 55.53 94.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.031 167.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.1 tt -76.26 116.77 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.352 169.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.48 -76.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.378 170.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.1 mtm -175.76 87.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.342 169.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.88 -161.7 12.25 Favored Glycine 0 CA--C 1.543 1.791 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.99 -156.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 122.329 2.019 . . . . 0.0 113.498 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -118.69 -73.25 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.073 168.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -134.82 -179.64 5.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.384 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 65.23 -76.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.242 -167.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.0 -171.81 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.278 165.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -171.39 97.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.251 165.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.54 132.66 37.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.351 -168.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.631 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.284 176.853 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 ptm . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.049 0.452 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -170.67 -29.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.343 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 71.12 -98.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.4 169.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 166.68 13.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.379 -167.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -117.66 72.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.459 -170.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.56 117.15 28.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.259 173.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.22 173.13 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.16 -166.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.9 t -83.28 118.13 70.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.809 157.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.92 -10.02 25.34 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.575 2.183 . . . . 0.0 113.777 169.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.96 -74.7 0.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.37 -170.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -85.25 -9.89 57.19 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.568 -166.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 59.57 59.3 2.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.182 -160.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.0 p -99.3 167.68 10.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.206 160.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.17 -6.7 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.805 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -109.27 99.11 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.021 -168.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.457 HD12 ' CD1' ' A' ' 34' ' ' ILE . 45.8 mt -104.77 175.11 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.388 167.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.498 HD13 ' HA ' ' A' ' 28' ' ' ALA . 3.3 pt -161.93 132.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.458 -170.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.517 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.7 t80 -89.58 135.7 33.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.382 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -106.35 92.79 7.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.8 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -63.28 -17.42 60.0 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.566 2.178 . . . . 0.0 113.52 -172.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.105 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.25 -21.88 14.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.437 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.11 40.84 6.85 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -168.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -104.69 169.36 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -169.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.517 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -137.78 115.73 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.285 163.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.2 t -115.39 172.76 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.096 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.1 t -78.25 150.91 33.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.006 166.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.498 ' HA ' HD13 ' A' ' 17' ' ' ILE . . . -94.03 13.33 23.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.311 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 -79.53 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.559 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.16 -14.81 49.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.545 -159.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.33 -10.21 33.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.287 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' CE2' HG13 ' A' ' 34' ' ' ILE . 70.3 t80 -70.29 119.05 13.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.38 -0.91 . . . . 0.0 110.175 -164.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 93.0 t -73.03 155.29 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.875 161.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.481 HG13 ' CE2' ' A' ' 32' ' ' TYR . 4.3 mt -108.59 -74.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.61 162.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -107.71 122.17 46.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.02 -168.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.52 136.53 35.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.093 172.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 m120 67.36 103.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.355 168.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.9 mt -116.23 47.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.369 168.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.3 mm -113.08 -11.85 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.508 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 70.56 -156.12 0.13 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.451 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 70.9 mtm 65.62 43.18 3.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.264 -169.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.77 90.07 1.51 Allowed Glycine 0 CA--C 1.544 1.862 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.55 -88.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 122.317 2.011 . . . . 0.0 113.493 -168.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.69 -161.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.102 -168.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.4 p90 61.18 16.13 6.95 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.806 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.91 102.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.638 164.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -175.88 160.17 2.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.245 168.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -91.21 77.83 5.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.236 166.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.91 109.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.368 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.514 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.269 -169.276 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 mtt . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 4' ' ' LYS . 10.7 t -103.25 87.01 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.386 174.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.92 129.52 55.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.383 169.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.528 ' HB3' ' HG2' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -131.52 -62.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.394 -169.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 69.39 19.02 7.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.349 -168.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -126.3 150.69 48.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.264 168.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m -153.17 -172.01 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.242 -166.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.9 t -96.33 113.78 63.1 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.303 165.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -61.84 -19.7 66.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.784 2.323 . . . . 0.0 113.781 167.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.76 -67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.642 -171.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -94.68 -11.35 29.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.64 -168.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 59.51 57.38 3.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.491 0.663 . . . . 0.0 110.256 -162.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -120.63 156.97 30.57 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.298 161.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.7 -0.44 18.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.698 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -91.47 111.22 22.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.091 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' A' ' 27' ' ' CYS . 26.7 mt -120.12 173.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.464 174.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.3 pt -151.71 127.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.416 -177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD1' HG13 ' A' ' 25' ' ' ILE . 10.0 t80 -98.11 137.15 37.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.361 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.53 89.01 6.85 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.742 -173.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -60.88 -14.59 33.31 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.553 2.168 . . . . 0.0 113.527 -169.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -85.68 -34.97 21.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.053 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.3 mtt85 -101.0 -24.11 14.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.393 172.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.28 47.75 8.81 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -122.58 125.77 46.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.005 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CD1' ' A' ' 18' ' ' TYR . 1.9 mp -90.71 138.83 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.396 168.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.0 t -132.67 177.26 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.981 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.5 ' HA ' HD21 ' A' ' 16' ' ' LEU . 21.4 t -96.11 139.13 32.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.011 169.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.21 23.65 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.447 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HD2' ' HA ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -120.07 -66.53 1.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.531 171.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.28 -15.19 20.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.697 -168.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.5 -11.32 59.69 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.59 131.76 47.17 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.212 -0.994 . . . . 0.0 109.985 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 94.7 t -61.27 167.93 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.083 164.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.508 ' N ' HG13 ' A' ' 33' ' ' VAL . 31.4 mm -116.71 -76.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.839 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.437 ' HB3' ' ND2' ' A' ' 37' ' ' ASN . 3.0 mp0 -138.95 -171.42 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.936 164.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -144.09 89.74 2.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.134 167.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.478 ' ND2' ' HA2' ' A' ' 42' ' ' GLY . 7.4 p30 -173.54 93.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.392 -174.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.7 pt -105.29 123.99 59.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.189 166.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER 52.73 20.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.405 -169.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -117.11 -163.87 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.423 -168.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.76 -77.75 0.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.503 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . 162.08 -151.14 21.06 Favored Glycine 0 CA--C 1.543 1.816 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.79 169.67 4.29 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.542 2.161 . . . . 0.0 113.514 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -99.02 173.94 6.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.965 168.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.6 m95 66.71 154.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.42 -169.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mmt-85 61.52 79.47 0.25 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.429 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.65 161.02 3.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.289 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.52 -13.31 12.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.321 -170.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.19 79.34 3.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.368 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.24 169.791 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttm . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.87 106.89 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.358 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -156.66 129.68 7.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.338 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.494 ' HD2' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER 58.3 -172.4 0.1 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.603 175.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.34 136.94 25.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.471 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.25 74.79 0.35 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.52 167.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.494 HG12 ' HD2' ' A' ' 4' ' ' LYS . 19.8 m -140.96 -164.09 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.819 169.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.4 t -105.73 116.23 60.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.42 165.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -68.39 -14.74 40.82 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.801 2.334 . . . . 0.0 113.856 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.51 -74.23 0.4 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.534 -175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -90.97 -9.46 45.96 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.675 -164.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.74 63.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.998 0.904 . . . . 0.0 110.257 -160.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -136.05 145.67 46.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.111 163.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.28 -16.59 19.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.646 -166.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -72.12 129.45 38.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.055 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.534 HD11 HG13 ' A' ' 34' ' ' ILE . 8.1 mt -139.53 171.32 14.42 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.396 173.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.424 HG23 HD11 ' A' ' 17' ' ' ILE . 4.7 pt -157.62 146.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.475 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 11.1 t80 -97.3 151.35 19.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.259 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.485 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 1.4 t0 -133.28 96.81 16.91 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.29 -18.55 63.13 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.311 2.007 . . . . 0.0 113.506 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -47.78 70.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.09 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -104.84 -19.28 13.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.489 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' HA3' HG23 ' A' ' 38' ' ' ILE . . . 81.78 26.69 49.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -167.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -110.66 122.97 49.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.32 -0.44 . . . . 0.0 109.972 -166.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.0 mp -89.46 131.4 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.927 164.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.7 t -125.23 172.89 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.091 -171.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 17.7 t -70.75 147.69 48.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.057 163.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.59 14.69 20.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.353 170.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.01 -74.82 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.447 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.1 p -91.92 -15.68 27.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.645 -160.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.75 -11.99 42.02 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.365 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -63.15 125.35 23.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 113.965 -1.118 . . . . 0.0 109.647 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 92.0 t -60.76 141.44 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.202 169.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.534 HG13 HD11 ' A' ' 16' ' ' LEU . 25.9 mm -90.17 -75.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.791 164.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -123.59 -169.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.908 -168.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.81 155.19 39.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.015 166.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -160.8 -174.42 4.41 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.387 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.528 HG23 ' HA3' ' A' ' 23' ' ' GLY . 1.0 OUTLIER 59.74 172.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.709 -177.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 26.4 mt 66.7 88.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.098 -162.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 70.68 72.96 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.054 -162.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.6 ttt -60.59 -45.89 92.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.407 -165.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.11 -140.83 3.61 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -172.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -54.3 -42.28 68.91 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 C-N-CA 122.567 2.178 . . . . 0.0 113.64 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 58.5 176.38 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.558 -168.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -87.31 88.78 7.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.331 -169.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -173.39 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.407 169.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.26 94.05 6.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.235 169.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -100.98 -49.87 3.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.373 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.04 -44.13 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.338 169.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.589 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.246 -169.875 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttp . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.139 0.495 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 p -171.21 91.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.371 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 63.38 -176.04 0.15 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.351 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.82 79.82 1.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.283 168.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 61.59 -165.56 0.22 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.451 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -169.12 43.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.937 -172.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.3 m -157.67 177.52 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.143 -173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 34.0 t -80.0 118.92 74.86 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 153.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.43 -12.69 35.57 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.68 2.253 . . . . 0.0 113.862 169.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.86 -75.32 0.38 Allowed 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.556 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.1 -11.39 41.43 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.65 -166.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.31 51.84 6.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.226 -164.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 m -103.61 148.33 26.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.208 158.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.46 -7.31 41.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.753 -169.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.7 144.81 35.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.995 -168.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.531 HD11 HG13 ' A' ' 34' ' ' ILE . 12.7 mt -140.13 171.03 14.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.487 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 28' ' ' ALA . 8.2 pt -159.7 145.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.406 -170.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.8 t80 -97.9 138.99 34.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.398 -167.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.89 95.71 25.52 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.879 176.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -59.33 -15.03 27.32 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.14 1.893 . . . . 0.0 113.611 -174.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.74 -35.12 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.042 -168.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -28.19 15.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.417 169.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.39 44.76 5.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -168.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HG3' HG11 ' A' ' 33' ' ' VAL . 5.6 tp10 -119.31 160.26 22.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -168.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.509 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.3 mp -120.37 133.05 68.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 162.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -129.15 169.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.056 -167.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HA ' HD21 ' A' ' 16' ' ' LEU . 20.1 t -63.64 149.17 47.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.926 163.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HA ' ' CD1' ' A' ' 17' ' ' ILE . . . -94.34 13.61 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.283 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.78 -74.78 0.59 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.66 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -87.11 -16.07 36.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.594 -164.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 -11.39 55.93 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.516 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -67.3 129.83 41.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.055 -170.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.5 t -61.52 167.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.268 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.531 HG13 HD11 ' A' ' 16' ' ' LEU . 15.5 mm -121.8 -79.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.604 170.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' HG2' ' N ' ' A' ' 36' ' ' GLU . 29.2 tt0 -105.38 170.86 7.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.971 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.515 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -127.68 148.5 50.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.225 -166.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.12 176.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.593 170.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.8 tp -110.25 138.19 39.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.481 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 tp -130.44 -54.57 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.438 -168.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.04 -64.05 1.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.368 -167.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.7 tpp -60.86 159.19 11.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.357 -167.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.57 -84.32 0.18 Allowed Glycine 0 CA--C 1.543 1.842 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 170.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -60.96 139.9 87.28 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.532 2.155 . . . . 0.0 113.559 -169.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -101.89 117.98 35.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.952 166.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -113.39 43.64 1.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.337 -165.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.99 -172.05 3.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.394 170.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 62.03 75.2 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.204 -166.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -79.16 -51.34 9.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.399 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.27 150.59 25.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.337 169.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.611 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.295 178.594 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ptp . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 m 59.52 34.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.211 172.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.453 ' HB3' ' HE3' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -101.99 -22.0 14.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.285 169.316 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' HE3' ' HB3' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -103.02 173.53 6.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.274 168.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -119.23 -58.73 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.347 -168.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.21 95.2 2.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.257 -169.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.1 m -152.41 -169.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.192 -163.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HB2' HD22 ' A' ' 16' ' ' LEU . 21.8 t -93.48 115.67 65.39 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.063 160.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -62.29 -19.71 67.83 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.745 2.297 . . . . 0.0 113.751 167.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.15 -68.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.625 -171.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.51 -12.02 30.61 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.638 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 54.61 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -162.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.2 p -99.04 -172.04 2.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.048 159.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.78 -8.22 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.742 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -112.81 53.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.825 -163.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.507 HD21 ' HA ' ' A' ' 27' ' ' CYS . 20.1 mt -60.72 171.43 1.16 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.562 175.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.457 HD12 ' CB ' ' A' ' 28' ' ' ALA . 10.4 pt -160.07 179.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.51 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.5 t80 -131.59 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.417 -169.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.473 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 5.8 t0 -143.73 89.8 7.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.725 -171.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.3 -14.72 25.81 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 C-N-CA 122.54 2.16 . . . . 0.0 113.564 -171.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -88.24 -30.8 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.989 -168.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -96.92 -19.86 18.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.443 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 38' ' ' ILE . . . 71.23 54.85 8.41 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -168.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' HG3' HG11 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -136.61 144.39 44.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -167.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.51 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -111.07 112.93 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.892 164.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.1 t -112.39 169.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.165 -166.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.507 ' HA ' HD21 ' A' ' 16' ' ' LEU . 21.9 t -69.73 154.65 41.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.887 164.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.457 ' CB ' HD12 ' A' ' 17' ' ' ILE . . . -104.12 15.9 27.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.302 172.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.3 -66.05 0.91 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.713 -173.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -94.45 -16.58 23.26 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.632 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 -10.53 58.73 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.499 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -66.08 129.96 41.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.475 -0.863 . . . . 0.0 110.166 -167.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG11 ' HG3' ' A' ' 24' ' ' GLU . 87.5 t -61.12 167.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.301 170.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.452 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 14.1 mm -118.99 -75.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.739 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.19 102.15 2.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.159 -170.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.94 140.01 57.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.947 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -174.26 119.73 0.25 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.287 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.45 HG23 ' HA2' ' A' ' 23' ' ' GLY . 6.2 tt -175.15 48.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.381 170.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.9 mt -102.93 -51.67 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.435 169.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -173.41 151.39 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.387 169.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 32.2 mtp -67.66 92.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.328 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.55 141.3 8.39 Favored Glycine 0 CA--C 1.543 1.822 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -55.82 -28.56 68.0 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 122.519 2.146 . . . . 0.0 113.601 175.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.5 30.59 19.95 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.686 168.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.57 111.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.468 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.07 -64.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.419 168.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.89 17.7 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.456 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.16 -169.9 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.359 167.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t70 70.42 164.39 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.346 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.585 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.288 -169.465 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtm . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.14 178.74 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.385 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -61.07 173.44 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.333 169.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.454 ' HA ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.38 -77.13 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.465 169.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.68 -74.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.428 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.8 108.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.341 172.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 4' ' ' LYS . 20.8 m -135.76 -177.34 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.129 -166.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 20.3 t -90.09 116.74 67.09 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.004 159.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -61.19 -17.17 50.95 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.732 2.288 . . . . 0.0 113.721 167.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.84 -74.21 0.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.424 -168.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 p -86.17 -9.31 56.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.703 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 59.59 61.74 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.774 0.797 . . . . 0.0 110.285 -160.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 65.5 p -103.8 -165.06 1.12 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.294 163.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.45 -7.46 1.31 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.816 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -115.53 133.0 56.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.02 -167.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.528 HD21 ' HA ' ' A' ' 27' ' ' CYS . 19.8 mt -137.67 178.32 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.432 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.1 pt -160.32 139.36 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.413 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.511 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.4 t80 -104.55 136.72 43.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.42 -171.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.21 80.07 71.46 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.822 -169.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -59.26 -18.62 45.92 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 122.46 2.107 . . . . 0.0 113.598 -171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.93 -37.4 84.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.008 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.76 -25.95 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.407 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.14 51.64 4.62 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 1.5 tp10 -130.0 129.13 43.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -167.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.511 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.4 mp -103.31 114.59 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.113 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.2 t -118.15 168.79 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.275 -166.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HA ' HD21 ' A' ' 16' ' ' LEU . 24.0 t -78.06 144.76 36.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.856 167.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.46 20.64 9.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.363 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -75.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.391 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -90.18 -14.85 32.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.648 -159.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.84 -9.82 34.5 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.401 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.48 126.18 29.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 114.539 -0.83 . . . . 0.0 110.126 -164.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 86.1 t -75.87 159.26 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.001 163.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' CD1' HD12 ' A' ' 16' ' ' LEU . 5.5 mt -114.88 -76.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.514 164.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -110.22 169.0 9.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.017 -165.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.89 146.78 36.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.163 -166.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 60.63 97.48 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.835 168.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.0 mt -147.19 63.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.372 166.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.0 mm -99.41 -79.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.554 -174.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.78 35.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.398 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 55.4 mtt 62.1 85.39 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.419 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' N ' ' HD3' ' A' ' 43' ' ' PRO . . . 88.06 51.95 3.05 Favored Glycine 0 CA--C 1.542 1.766 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 42' ' ' GLY . 2.0 Cg_endo -58.82 -154.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 122.487 2.125 . . . . 0.0 113.499 167.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.79 -174.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.609 -170.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -99.23 42.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.321 -166.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -103.96 18.4 22.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.382 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.74 -165.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.187 -169.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -152.81 -75.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.346 169.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.36 -89.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.409 170.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.56 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.295 169.819 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.055 0.455 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t 62.21 -83.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.394 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p30 60.85 177.2 0.1 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.648 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -130.65 -73.88 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.334 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 62.19 12.23 4.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.445 174.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 118.47 24.19 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.523 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.6 m 59.52 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.25 169.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.5 t -119.04 110.28 38.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.469 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.92 -4.59 9.07 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.605 2.203 . . . . 0.0 113.85 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.55 -67.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.493 -177.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.9 p -97.56 -11.11 24.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.732 -165.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 59.59 57.7 3.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.305 -165.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.56 160.89 39.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.282 158.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -103.23 -10.97 18.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.791 -166.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -75.71 106.55 7.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.157 -168.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 14' ' ' ALA . 8.5 mt -129.98 171.65 12.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.356 -175.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.7 pt -159.99 135.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.343 -169.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.512 ' CD1' HG13 ' A' ' 25' ' ' ILE . 27.7 t80 -98.82 149.7 22.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.331 -169.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 30.1 t70 -127.79 95.83 33.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.727 -167.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.73 -18.39 63.98 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.121 1.881 . . . . 0.0 113.543 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.98 -43.23 68.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.014 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.96 -19.31 13.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.487 -174.08 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.36 44.86 20.79 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -167.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HG2' HG23 ' A' ' 26' ' ' VAL . 41.4 tt0 -120.01 124.51 46.09 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -168.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.512 HG13 ' CD1' ' A' ' 18' ' ' TYR . 1.9 mp -93.9 128.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.86 167.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 6.0 t -128.88 178.86 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.162 -169.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.503 ' HA ' HD21 ' A' ' 16' ' ' LEU . 33.8 t -108.67 135.34 50.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.574 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.75 25.68 4.48 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.401 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -138.69 -36.54 0.56 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -165.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -123.07 -15.65 7.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.845 166.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.73 63.66 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.497 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.59 139.89 56.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.417 -0.891 . . . . 0.0 110.116 -168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 92.4 t -61.03 168.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 167.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.487 HD13 HD12 ' A' ' 16' ' ' LEU . 16.5 mm -121.2 -75.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.462 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.79 -171.18 3.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.949 168.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.19 126.46 3.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.122 169.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -137.7 44.41 2.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.44 -171.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.3 mp -143.08 104.9 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.227 168.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.1 tp 55.83 83.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.011 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -126.67 -24.73 3.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.294 -166.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 7.6 mtp -60.93 -87.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.427 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.38 137.48 12.2 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -169.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.44 -154.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.403 2.069 . . . . 0.0 113.499 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.09 43.11 3.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.063 -170.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.59 -48.95 58.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.399 169.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.49 87.03 7.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.495 170.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.96 -82.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.297 -169.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -80.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.331 -167.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -136.68 94.34 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.419 -169.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.54 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.287 -170.124 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' HG3' ' CG1' ' A' ' 2' ' ' VAL . 4.1 ptt? . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' CG1' ' HG3' ' A' ' 1' ' ' MET . 6.2 m 59.63 33.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.101 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 60.23 97.66 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.851 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.36 166.03 30.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.368 168.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.98 134.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.473 -170.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.63 94.98 2.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.389 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -154.78 -164.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.305 -168.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.5 t -111.79 111.53 54.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.415 171.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.94 -10.87 30.22 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 113.758 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.33 -73.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.456 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.45 -11.53 34.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.633 -164.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 59.48 57.81 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.254 -162.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.501 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 45.6 m -124.24 162.9 22.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.289 161.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.2 -7.84 15.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.779 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -90.62 119.61 31.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.066 -167.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.52 HD21 ' HA ' ' A' ' 27' ' ' CYS . 10.6 mt -138.04 159.63 41.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.368 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.0 pt -150.99 146.58 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.433 -169.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.507 ' CD2' HG13 ' A' ' 25' ' ' ILE . 3.5 t80 -98.55 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.42 -168.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.1 90.14 9.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.882 172.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.42 -19.5 51.65 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 122.472 2.114 . . . . 0.0 113.497 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.82 -50.49 72.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.103 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -29.83 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.401 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.55 27.65 14.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -167.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.428 ' HG2' HG23 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -92.06 165.31 13.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.341 -0.43 . . . . 0.0 110.0 -168.659 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.507 HG13 ' CD2' ' A' ' 18' ' ' TYR . 1.9 mp -137.4 114.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.776 166.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.3 t -111.49 177.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.116 -167.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.52 ' HA ' HD21 ' A' ' 16' ' ' LEU . 23.0 t -98.82 135.97 39.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.841 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.56 22.94 6.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.221 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -142.76 -25.08 0.63 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.197 -160.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -133.57 -17.33 2.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.846 163.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.59 58.35 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.476 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.86 138.75 50.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.156 -168.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 64.9 t -61.17 168.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.277 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' N ' ' CG1' ' A' ' 33' ' ' VAL . 16.8 mm -124.61 -74.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.243 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -143.64 168.26 20.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 166.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.12 -169.77 3.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.094 -166.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.84 80.76 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.465 172.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.5 mt -149.7 65.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.334 167.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.3 pt -99.52 79.34 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.433 -176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.77 70.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.423 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttp 61.71 109.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.384 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.91 92.76 0.09 OUTLIER Glycine 0 CA--C 1.543 1.834 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -57.77 -66.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 122.577 2.185 . . . . 0.0 113.504 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 58.58 20.75 7.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.559 -166.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.54 -37.75 1.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.371 -167.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -107.0 -167.85 1.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.439 -168.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.79 28.66 8.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.324 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 71.16 -74.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.336 -170.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -155.37 -178.58 7.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.351 170.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.516 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.234 169.825 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 mtt . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.107 0.48 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.3 m -111.22 127.76 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.314 -171.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -149.48 -78.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.414 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -129.11 -39.11 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.39 -168.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 70.06 172.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.348 -169.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' CD ' HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER 61.64 98.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.344 -168.088 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.45 -176.66 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.329 -166.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.5 t -110.68 113.25 55.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.507 172.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -65.49 -16.92 56.11 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.749 2.299 . . . . 0.0 113.76 169.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.55 -72.16 0.39 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.564 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -91.07 -9.15 46.81 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.981 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.82 50.23 12.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.834 -167.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -97.03 -167.05 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.395 164.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.31 -10.12 3.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.844 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.68 116.42 25.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.056 -168.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 34' ' ' ILE . 19.8 mt -136.69 166.55 23.3 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.364 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.5 pt -151.28 133.16 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.476 -171.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 49.2 t80 -80.34 163.01 24.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.322 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.498 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -146.41 100.2 4.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 -167.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -62.28 -18.38 62.19 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.58 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.52 -47.09 77.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.008 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -109.29 -20.17 13.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.415 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.7 52.68 6.33 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -166.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.57 144.5 37.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -166.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.457 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.4 mp -106.26 134.89 46.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.05 169.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.8 t -132.12 178.38 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.079 -167.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.521 ' HA ' HD22 ' A' ' 16' ' ' LEU . 27.0 t -99.23 139.05 35.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.74 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.66 26.91 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.386 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 -34.66 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 -162.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -126.38 -16.71 5.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.9 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.57 -10.75 70.73 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.666 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -63.06 139.08 58.74 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.599 -0.801 . . . . 0.0 110.025 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 34' ' ' ILE . 84.2 t -61.09 167.24 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.265 170.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.523 HD13 HD12 ' A' ' 16' ' ' LEU . 15.8 mm -121.67 -76.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.567 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.512 ' HG2' ' N ' ' A' ' 36' ' ' GLU . 2.0 tt0 -125.2 151.41 45.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.055 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 9.6 mt-10 -111.99 165.75 11.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.953 -167.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 t30 69.64 121.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.258 167.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 tt -64.77 111.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.133 166.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.0 tp 58.19 166.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.007 -172.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -129.79 128.88 43.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.383 -171.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 tpt -176.3 -73.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.246 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.57 68.15 0.15 Allowed Glycine 0 CA--C 1.544 1.875 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.76 116.32 3.27 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.688 2.259 . . . . 0.0 113.448 -172.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.89 -82.0 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.662 172.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -154.18 144.71 22.31 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.521 -174.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.506 ' NH1' ' HA ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -75.38 159.22 31.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.342 169.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.63 134.5 37.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.325 -169.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.63 -80.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.38 169.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.07 144.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.35 169.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.58 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.292 169.522 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 121.142 0.496 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.1 m -122.53 144.71 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.329 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.5 m120 64.27 23.86 13.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.34 170.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -125.2 -169.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.408 170.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -80.04 -86.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.406 -167.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HB3' HD13 ' A' ' 16' ' ' LEU . 4.1 tmtp? -178.75 127.87 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.197 -169.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m -92.87 172.35 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.233 -162.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.7 t -113.64 115.26 46.73 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.004 175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.67 -20.35 70.68 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.608 2.205 . . . . 0.0 113.717 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.36 -70.54 0.44 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.49 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -95.16 -9.7 32.7 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.022 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 56.34 48.52 16.92 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.415 -0.803 . . . . 0.0 111.004 -168.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -85.46 -168.4 2.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.414 166.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.61 -13.07 5.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.741 167.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.49 109.56 20.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.12 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 27' ' ' CYS . 15.8 mt -127.9 -177.95 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.387 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.7 pt -160.4 145.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.414 -169.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.51 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.9 t80 -108.81 119.15 38.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.416 -169.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.98 83.84 0.52 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.795 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -59.93 -19.68 56.31 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.434 2.09 . . . . 0.0 113.596 -172.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.09 -51.99 61.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.999 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -79.12 -30.36 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.407 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.472 ' HA2' HD12 ' A' ' 38' ' ' ILE . . . 85.31 40.87 7.68 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -168.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -118.07 159.64 22.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.51 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -129.47 133.13 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.037 163.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 27' ' ' CYS . 4.8 t -131.93 178.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.114 -167.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.522 ' HA ' HD21 ' A' ' 16' ' ' LEU . 35.9 t -106.15 125.41 50.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.536 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.25 -2.44 31.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.868 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -77.59 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 171.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.5 p -83.2 -17.54 42.46 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.6 -162.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.83 60.52 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.43 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -68.93 139.93 55.09 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.547 -0.826 . . . . 0.0 110.265 -168.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 34' ' ' ILE . 95.7 t -62.17 167.68 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.038 165.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.469 HG13 HD11 ' A' ' 16' ' ' LEU . 16.9 mm -117.82 -74.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.725 171.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.44 ' HG3' ' N ' ' A' ' 36' ' ' GLU . 48.1 tp10 -142.2 168.14 20.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 166.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 35' ' ' GLU . 20.6 pm0 -154.22 -174.47 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.092 -168.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 t30 65.73 55.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.404 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.472 HD12 ' HA2' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -91.28 156.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.419 170.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.5 mm 66.19 115.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.409 -170.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.63 148.57 2.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.358 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 35.6 mtm -128.43 128.97 45.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.408 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' N ' ' HD3' ' A' ' 43' ' ' PRO . . . 63.72 50.45 61.38 Favored Glycine 0 CA--C 1.542 1.726 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 171.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER -56.9 76.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 122.391 2.06 . . . . 0.0 113.511 172.452 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -170.92 134.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.032 169.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 20.1 m95 61.3 86.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.266 -167.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -108.56 -80.73 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.366 -166.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.44 -161.42 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.122 -165.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 73.09 -71.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.407 -168.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.4 -171.58 3.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.446 173.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.602 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.368 -176.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtp . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 121.153 0.501 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.59 110.92 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.349 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.89 -152.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.399 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 mttt 65.2 175.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.299 -171.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -79.64 0.09 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.147 -163.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HG3' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER 55.02 179.75 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.555 -168.078 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 16.9 m -135.78 -174.12 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.538 -166.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.7 t -111.57 112.61 53.92 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.175 174.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.25 -16.85 57.06 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.686 2.257 . . . . 0.0 113.735 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.52 -73.56 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.393 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.9 -11.01 40.44 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.645 -166.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 59.37 56.06 3.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.248 -163.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.432 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 52.6 p -109.57 -166.21 1.08 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.367 160.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -142.36 -16.96 0.73 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.662 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -81.39 122.59 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.05 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.535 HD21 ' HA ' ' A' ' 27' ' ' CYS . 13.5 mt -137.28 160.43 39.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.466 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.37 132.01 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.369 -168.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.517 ' CD1' HG13 ' A' ' 25' ' ' ILE . 7.4 t80 -88.47 132.7 34.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.379 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 80.76 1.11 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.653 168.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.414 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 5.6 Cg_endo -59.16 -20.23 53.48 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 122.558 2.172 . . . . 0.0 113.512 -168.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.03 -53.22 57.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.178 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -86.9 -19.13 29.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.466 ' HA2' HG23 ' A' ' 38' ' ' ILE . . . 77.26 30.55 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -168.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -89.46 162.31 15.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.929 -0.635 . . . . 0.0 109.993 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.517 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.1 mp -142.0 115.79 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.202 167.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 t -106.51 177.93 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.232 -170.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.535 ' HA ' HD21 ' A' ' 16' ' ' LEU . 31.4 t -101.07 125.05 47.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.641 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.53 -4.61 43.64 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.882 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -92.97 -78.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.313 170.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -86.12 -16.6 37.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.612 -161.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 -10.38 54.56 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.455 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -72.61 133.97 44.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.592 -0.804 . . . . 0.0 110.172 -168.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.3 t -61.27 167.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.133 165.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.462 HG13 HD12 ' A' ' 16' ' ' LEU . 33.4 mm -119.18 -76.53 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.644 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.87 -177.5 4.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.079 168.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 2.3 pt-20 -146.47 -171.71 3.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.946 -168.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t30 70.92 112.97 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.42 168.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.466 HG23 ' HA2' ' A' ' 23' ' ' GLY . 1.6 tt -151.06 164.55 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.26 167.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.8 tt 59.74 171.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.826 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.17 -99.0 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.318 -166.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -144.48 -161.67 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.435 -164.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.19 -67.57 0.68 Allowed Glycine 0 CA--C 1.544 1.85 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -52.46 102.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.529 2.153 . . . . 0.0 113.598 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -98.28 -25.65 14.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.05 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 18.8 p90 60.54 177.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.67 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -66.45 -34.35 77.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.394 -162.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.92 -164.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.302 -166.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 71.71 -76.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.3 -168.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -132.82 149.39 52.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.347 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.621 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.245 169.616 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttm . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.119 0.485 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.461 HG11 ' HE3' ' A' ' 4' ' ' LYS . 3.4 p -74.61 135.89 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.342 171.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -61.11 100.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.396 -169.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' HE3' HG11 ' A' ' 2' ' ' VAL . 8.8 ptpt -121.05 83.37 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.34 173.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 61.84 84.53 0.13 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.368 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 157.95 40.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.284 166.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 m -104.59 -176.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.247 -164.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.5 t -107.72 113.52 61.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.279 170.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.68 -13.72 41.03 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 122.71 2.273 . . . . 0.0 113.721 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.95 -74.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.456 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -91.21 -11.02 39.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.691 -166.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 59.31 54.81 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.223 -163.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.5 p -88.85 176.55 7.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.038 162.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.33 -8.04 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.763 164.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -99.04 116.18 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.988 -167.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 27' ' ' CYS . 16.0 mt -132.62 166.59 21.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.379 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 HD12 ' CB ' ' A' ' 28' ' ' ALA . 10.2 pt -155.15 148.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.399 -167.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.479 ' CD1' HG13 ' A' ' 25' ' ' ILE . 12.9 t80 -107.73 123.17 48.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.312 -170.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.96 98.0 7.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 -171.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -59.09 -14.18 22.41 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.306 2.004 . . . . 0.0 113.505 -178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.55 -30.7 21.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.085 -169.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.31 -19.33 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.459 174.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.18 51.2 10.42 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -168.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.442 ' HG2' ' CG2' ' A' ' 26' ' ' VAL . 31.9 tt0 -137.08 125.94 24.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.432 . . . . 0.0 109.9 -167.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.479 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.4 mp -88.83 128.11 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.128 169.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.1 t -130.76 177.12 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.968 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.531 ' HA ' HD21 ' A' ' 16' ' ' LEU . 19.7 t -93.33 124.01 37.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.916 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.416 ' CB ' HD12 ' A' ' 17' ' ' ILE . . . -76.73 7.31 4.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.753 176.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -112.95 -67.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.455 178.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.6 p -91.75 -19.14 22.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.512 -169.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.13 57.81 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.551 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -68.76 126.82 30.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.404 -0.898 . . . . 0.0 110.229 -170.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 65.3 t -61.55 169.36 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.426 175.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.507 HG13 HD12 ' A' ' 16' ' ' LEU . 20.0 mm -124.75 -73.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.185 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -136.27 153.59 51.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.958 166.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 24' ' ' GLU . 1.4 tt0 -133.16 -179.23 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.965 -165.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 71.5 87.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.428 167.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 27.7 mt -150.75 141.34 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.309 166.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 pp -153.55 22.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.38 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 68.98 -157.41 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.446 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 7.3 ttp -106.28 153.88 21.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.292 -169.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.07 -98.86 0.22 Allowed Glycine 0 CA--C 1.542 1.778 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 172.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.52 96.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.413 2.076 . . . . 0.0 113.6 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -170.04 40.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.056 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 61.55 101.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.393 -173.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -56.88 10.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.369 -167.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.98 139.23 48.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.272 -167.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.12 -51.99 3.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.334 168.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t0 66.62 -81.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.644 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.285 -169.607 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 ptt? . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 p 60.88 174.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.586 172.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.9 m120 72.06 -68.09 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.458 -168.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -61.17 82.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.411 169.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.0 -54.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.224 175.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp 64.1 -172.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.461 163.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m 59.55 -167.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.248 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.4 t -113.84 111.04 48.64 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.537 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -67.77 -10.57 29.21 Favored 'Trans proline' 0 N--CA 1.482 0.846 0 C-N-CA 122.751 2.301 . . . . 0.0 113.881 169.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.72 -71.81 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.549 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -93.98 -11.33 31.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.635 -165.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 59.48 58.11 3.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.228 -161.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -110.8 -171.35 1.81 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.231 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.76 -16.44 1.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.717 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -74.85 120.47 20.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.026 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.515 HD21 ' HA ' ' A' ' 27' ' ' CYS . 7.9 mt -135.77 165.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.411 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.9 pt -150.02 140.37 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.394 -168.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.514 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.0 t80 -101.66 149.48 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.236 -168.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 7.1 t70 -129.3 94.79 32.24 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.736 -167.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -59.89 -20.26 58.86 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.272 1.981 . . . . 0.0 113.571 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.92 -39.04 87.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.112 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -22.62 11.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.52 30.29 30.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.41 164.65 12.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -170.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.6 mp -126.76 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.999 163.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.1 t -132.82 178.5 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.155 -167.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.515 ' HA ' HD21 ' A' ' 16' ' ' LEU . 22.0 t -101.87 136.85 41.0 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.858 175.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.89 29.57 2.67 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.33 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.74 -35.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.613 -165.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.3 p -125.57 -16.49 5.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.823 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.43 -11.11 69.02 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.576 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.04 137.67 58.33 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.639 -0.78 . . . . 0.0 109.976 -173.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 84.6 t -60.89 167.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.26 168.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.514 ' N ' HG13 ' A' ' 33' ' ' VAL . 20.6 mm -120.78 -69.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.426 173.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.52 140.23 49.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.066 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.92 -161.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.171 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -61.53 141.61 57.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.418 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.501 HG23 HG13 ' A' ' 39' ' ' ILE . 26.7 mt -107.09 120.83 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.367 -167.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.501 HG13 HG23 ' A' ' 38' ' ' ILE . 11.3 mt 61.26 86.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.414 169.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -149.51 -97.49 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.325 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 76.4 mtp 65.23 -79.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.363 -169.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.76 142.68 4.26 Favored Glycine 0 CA--C 1.543 1.793 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 171.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -57.58 -32.78 95.29 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.427 2.085 . . . . 0.0 113.613 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 58.87 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.764 175.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 8.4 m95 68.33 -90.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.286 -165.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.3 -80.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.402 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -168.9 -162.76 0.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.188 168.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -86.2 111.17 20.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.311 168.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -110.85 -81.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.379 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.551 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.203 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttt . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.122 0.487 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 m -61.52 145.03 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.299 -173.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m120 70.18 -59.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.374 -169.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.34 99.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.368 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.85 150.04 34.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.457 -170.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -143.69 46.82 1.47 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.9 171.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.79 -165.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.31 -172.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 27' ' ' CYS . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' HD21 ' A' ' 16' ' ' LEU . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.508 HG13 HD12 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 36' ' ' GLU . 7.8 tp10 -160.33 170.19 21.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 tt0 -138.13 91.85 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.099 -166.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -173.94 105.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.399 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.507 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -121.04 168.42 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.204 164.097 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -82.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.811 -168.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -68.81 77.45 0.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.298 -166.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -152.24 -172.87 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.397 169.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.22 -74.13 0.2 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.2 114.08 1.71 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.501 2.134 . . . . 0.0 113.576 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.86 -160.25 1.03 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.048 -168.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -31.7 51.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.368 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -13.68 18.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.394 -170.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.5 106.31 5.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.321 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -112.0 -29.87 7.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.335 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.63 -162.14 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.414 169.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.542 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.267 -169.588 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttt . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.122 0.487 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 m -61.52 145.03 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.299 -173.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m120 70.18 -59.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.374 -169.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.34 99.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.368 -178.639 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.85 150.04 34.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.457 -170.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -143.69 46.82 1.47 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.9 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.9 m -145.79 -165.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.31 -172.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 27' ' ' CYS . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.53 ' HA ' HD21 ' A' ' 16' ' ' LEU . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.508 HG13 HD12 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 36' ' ' GLU . 7.8 tp10 -160.33 170.19 21.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.514 ' N ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 tt0 -138.13 91.85 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.099 -166.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -173.94 105.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.399 -171.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.507 HG22 ' CZ ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -121.04 168.42 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.204 164.097 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -82.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.811 -168.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -68.81 77.45 0.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.298 -166.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -152.24 -172.87 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.397 169.2 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.22 -74.13 0.2 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -174.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.2 114.08 1.71 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.501 2.134 . . . . 0.0 113.576 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.86 -160.25 1.03 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.048 -168.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -31.7 51.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.368 -169.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -13.68 18.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.394 -170.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.5 106.31 5.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.321 -177.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -112.0 -29.87 7.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.335 169.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.63 -162.14 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.414 169.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.542 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.267 -169.588 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG13 ' HG3' ' A' ' 4' ' ' LYS . 20.6 t 66.55 -85.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.459 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 62.28 99.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.441 -170.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.519 ' HG3' HG13 ' A' ' 2' ' ' VAL . 1.8 mtmm -154.35 32.96 0.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.267 -168.314 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -95.64 33.62 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.541 173.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -82.84 106.41 14.65 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.282 -169.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m -59.84 -161.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.293 166.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.9 t -95.63 111.22 54.9 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.338 161.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -69.99 -8.08 22.72 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.6 2.2 . . . . 0.0 113.968 169.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.32 -73.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.514 175.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -92.68 -11.45 34.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.663 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.53 57.15 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.209 -162.645 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -114.02 172.94 6.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.209 160.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.15 -9.32 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.715 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -96.83 52.64 1.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.977 -162.201 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.526 HD11 HG13 ' A' ' 34' ' ' ILE . 17.4 mt -69.71 175.97 3.89 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.449 -177.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 9.5 pt -157.49 153.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.462 -168.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.512 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.3 t80 -106.8 132.36 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.434 -169.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.3 92.08 6.44 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.703 175.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -59.07 -13.16 17.98 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.388 2.059 . . . . 0.0 113.602 -168.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -47.68 14.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.016 -170.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.413 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -90.05 -24.0 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.419 170.302 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 16.61 50.06 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -177.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.59 164.2 24.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.027 -171.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -130.84 113.0 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.938 165.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.1 t -114.04 177.61 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.147 -169.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.477 ' N ' HG13 ' A' ' 26' ' ' VAL . 15.4 t -90.5 126.17 35.83 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.076 178.03 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.48 7.05 4.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.774 175.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.23 -67.66 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.514 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.8 p -93.03 -20.13 20.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.48 -167.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.98 60.23 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.639 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -69.52 131.94 45.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.659 -0.771 . . . . 0.0 110.333 -172.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 61.3 t -61.79 170.98 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.368 175.012 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.526 HG13 HD11 ' A' ' 16' ' ' LEU . 14.0 mm -128.07 -73.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.013 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.07 174.35 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.022 167.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -130.32 107.89 9.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.113 -167.06 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 p30 61.43 176.24 0.11 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.498 171.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 79.2 mt -145.9 92.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.397 -170.57 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm 66.2 142.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.393 -168.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.55 -17.52 3.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.443 -167.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.3 ttm -95.3 38.72 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.371 -167.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.6 98.25 0.03 OUTLIER Glycine 0 CA--C 1.543 1.837 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 168.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.03 161.27 13.61 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.557 2.172 . . . . 0.0 113.494 170.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.59 106.03 2.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.992 167.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -100.4 98.42 9.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.422 -167.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.99 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.436 167.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -169.87 -162.0 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.28 -165.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 72.62 -60.68 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.475 171.537 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 t0 70.13 79.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.382 -170.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.582 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.243 169.528 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmm? . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.075 0.464 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 p -120.59 81.09 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.327 -170.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.1 m120 64.37 -84.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.364 168.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.3 16.16 9.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.703 -178.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 60.73 105.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.51 166.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.25 177.36 4.71 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.339 -171.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.58 -160.57 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.19 -175.142 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.0 t -102.61 111.12 64.45 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.369 164.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -68.45 -10.77 29.99 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.741 2.294 . . . . 0.0 113.751 169.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.14 -73.67 0.36 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.482 177.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -93.67 -11.86 30.64 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.596 -163.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 59.25 2.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.579 0.704 . . . . 0.0 110.193 -161.374 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.455 ' CB ' ' HG3' ' A' ' 29' ' ' LYS . 54.9 m -123.61 148.31 46.53 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.26 161.171 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.31 27.93 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.602 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -75.89 118.05 18.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.158 -172.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD21 ' HA ' ' A' ' 27' ' ' CYS . 15.7 mt -141.95 158.04 44.24 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.315 178.038 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 pt -150.85 158.57 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.415 -167.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CE2' HD12 ' A' ' 38' ' ' ILE . 2.8 t80 -108.68 121.79 45.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.375 -169.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.21 99.75 3.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.748 178.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.61 -15.53 31.55 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.362 2.041 . . . . 0.0 113.469 179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -78.21 -30.86 49.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.039 -169.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -111.98 -20.22 12.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.398 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 44.79 7.56 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.46 168.11 9.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.75 128.77 68.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.677 162.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 3.7 t -130.88 176.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.93 -168.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.533 ' HA ' HD21 ' A' ' 16' ' ' LEU . 17.8 t -94.54 136.78 34.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.01 176.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 20.91 8.1 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.237 178.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' CE ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -143.41 -23.79 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.357 -158.361 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.3 p -135.99 -18.06 1.6 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.838 164.726 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.15 -11.44 57.14 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.455 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -67.97 137.16 54.92 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.312 -0.944 . . . . 0.0 110.09 -170.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 96.3 t -61.59 167.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.221 175.065 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.533 HG13 HD11 ' A' ' 16' ' ' LEU . 19.4 mm -124.21 -78.27 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.416 172.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.22 -164.05 1.28 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.978 174.019 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -165.68 -170.83 1.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.14 171.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.3 m120 70.84 103.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.428 169.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.519 HD12 ' CE2' ' A' ' 18' ' ' TYR . 3.6 mp -128.23 165.06 28.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.406 176.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.16 115.33 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.391 -168.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.1 -97.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.392 167.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.416 ' HB2' ' HE1' ' A' ' 41' ' ' MET . 3.6 ttm 61.53 18.37 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.566 173.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.19 -157.81 31.6 Favored Glycine 0 CA--C 1.544 1.847 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 170.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.88 171.4 1.07 Allowed 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.509 2.14 . . . . 0.0 113.597 169.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.88 93.31 0.18 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.084 168.049 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -136.57 117.41 14.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.336 169.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -171.08 -74.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.331 170.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.72 104.36 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.277 -170.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -123.7 110.87 15.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.393 170.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.45 -41.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.408 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.617 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.234 169.599 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttm . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.152 0.501 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 m -145.31 108.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.369 172.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -156.5 58.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.368 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.97 149.83 35.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.344 169.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -99.15 33.05 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.365 -167.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -169.26 79.45 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.297 166.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m -146.87 -174.15 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.29 -175.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 t -102.47 111.44 64.62 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.499 168.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.25 -11.76 33.41 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.706 2.271 . . . . 0.0 113.778 169.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.17 -69.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.619 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.2 p -96.53 -11.45 25.44 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.654 -166.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.62 58.32 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.242 -162.255 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -114.42 173.78 6.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.283 160.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.86 6.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.611 -169.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.22 126.97 35.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.043 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 HD11 HG13 ' A' ' 34' ' ' ILE . 17.6 mt -135.52 161.54 35.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.446 174.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 pt -135.64 140.29 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.367 -167.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -104.29 135.85 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.256 -169.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.65 92.23 49.15 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.794 -168.14 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -59.47 -20.12 55.15 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.44 2.093 . . . . 0.0 113.61 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 -46.99 61.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.076 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -91.76 -21.79 20.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.406 -178.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 41.79 60.62 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -167.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -128.3 141.34 51.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.404 . . . . 0.0 109.968 -166.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.424 HD11 ' HG3' ' A' ' 35' ' ' GLU . 2.5 mp -108.04 137.67 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.091 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 4.6 t -134.06 176.95 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.908 -168.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' N ' HG13 ' A' ' 26' ' ' VAL . 18.1 t -92.6 131.09 38.01 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.841 174.138 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.15 43.24 1.14 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.379 170.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -53.05 0.16 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.464 -178.045 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.8 p -111.03 -18.23 13.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.717 -178.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.99 -10.61 68.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.671 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.17 132.59 53.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.999 -175.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.8 t -61.06 167.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.279 170.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.474 HG13 HD11 ' A' ' 16' ' ' LEU . 21.1 mm -120.24 -77.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.698 173.315 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.424 ' HG3' HD11 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -136.33 169.15 18.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.055 172.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.58 148.09 35.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.068 -168.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 60.7 94.54 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.764 176.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.18 114.3 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.477 170.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.479 HG21 ' N ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -171.53 -35.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.473 171.775 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' N ' HG21 ' A' ' 39' ' ' ILE . 1.6 p30 61.25 179.29 0.11 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.584 172.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 61.44 -85.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.434 -169.519 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.17 153.18 25.02 Favored Glycine 0 CA--C 1.541 1.701 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 175.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.81 -156.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 122.354 2.036 . . . . 0.0 113.627 177.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -91.93 137.07 32.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.1 179.394 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -60.89 -75.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.393 168.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 65.57 -80.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.493 170.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -176.06 123.36 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.229 168.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.31 107.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.3 167.23 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -148.02 -72.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.343 168.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.559 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.241 -170.973 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 mtt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.179 0.514 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.81 -44.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.377 -172.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -86.53 -179.37 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.322 167.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.11 139.17 13.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.298 -167.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 70.39 145.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.383 164.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 144.7 55.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.109 164.135 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.3 m -124.53 -176.03 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.333 -163.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.9 t -103.01 111.73 65.27 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.105 168.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -66.8 -4.26 10.89 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.678 2.252 . . . . 0.0 113.776 170.331 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -93.45 -68.53 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.557 -178.107 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.87 -11.29 29.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.555 -167.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 59.44 57.35 3.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.185 -162.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -101.82 -165.81 1.23 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.279 160.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.08 -16.91 1.23 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.681 175.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -86.42 122.03 29.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.111 -175.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 27' ' ' CYS . 11.0 mt -137.81 -176.3 4.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.442 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.3 pt -161.81 138.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 -169.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.7 t80 -105.92 121.08 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.401 -177.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.75 94.56 3.71 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.869 -175.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.92 -15.17 25.85 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 C-N-CA 122.348 2.032 . . . . 0.0 113.449 -170.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.83 -31.69 23.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.988 -170.426 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -27.15 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.371 171.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.01 3.32 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -163.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.539 ' HG2' HG21 ' A' ' 26' ' ' VAL . 9.3 tt0 -140.78 114.88 9.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.93 -166.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.519 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.8 mp -93.36 116.05 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 HG21 ' HG2' ' A' ' 24' ' ' GLU . 5.3 t -121.17 177.66 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.246 -164.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.513 ' HA ' HD21 ' A' ' 16' ' ' LEU . 35.0 t -106.33 131.75 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.457 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.25 39.32 1.02 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 113.661 -1.608 . . . . 0.0 110.455 173.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 -50.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.371 -175.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.0 p -113.12 -17.19 12.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.65 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -11.0 63.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.28 137.02 56.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.406 -0.897 . . . . 0.0 110.037 -170.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 26' ' ' VAL . 90.1 t -79.89 159.85 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.031 161.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 ' N ' HG11 ' A' ' 33' ' ' VAL . 5.3 mt -116.38 -75.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.5 166.093 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -120.46 165.42 14.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.079 -162.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -128.3 134.64 48.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.979 -169.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 60.31 170.41 0.09 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.73 -177.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.508 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 7.4 tt -170.11 46.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.349 -177.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.9 mt 60.86 -88.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.474 169.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -139.85 -156.6 0.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.445 170.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ttt -130.11 113.18 14.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.344 169.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.36 102.58 0.16 Allowed Glycine 0 CA--C 1.542 1.764 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 178.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.65 -156.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.552 2.168 . . . . 0.0 113.6 -175.118 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.37 43.18 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.935 -168.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.44 97.39 0.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.333 169.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.27 79.96 6.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.445 -170.289 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.46 106.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.272 177.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.94 -78.64 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.335 -177.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -99.87 -55.75 2.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.363 -169.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.629 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.215 177.416 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.803 ' O ' HD11 ' A' ' 16' ' ' LEU . 9.0 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.452 0.644 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.6 t -104.59 112.41 65.34 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.329 168.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.32 -14.71 43.74 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.717 2.278 . . . . 0.0 113.854 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.43 -74.48 0.35 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.514 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.1 p -97.07 -6.54 34.93 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.928 -164.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.16 68.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.663 0.744 . . . . 0.0 110.168 -161.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 58.2 m -138.88 105.52 5.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.192 168.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -15.71 63.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.761 -167.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -77.19 104.85 7.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.023 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.803 HD11 ' O ' ' A' ' 7' ' ' VAL . 18.2 mt -109.03 -179.62 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.376 167.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 pt -158.86 153.2 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.402 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.473 ' CD1' HG13 ' A' ' 25' ' ' ILE . 6.3 t80 -100.15 159.74 14.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.386 -169.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -140.83 80.03 18.2 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.788 -172.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -60.28 -18.75 54.2 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.546 2.164 . . . . 0.0 113.493 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -75.02 -37.17 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.08 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -102.77 -24.42 13.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.32 36.01 11.41 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.9 tt0 -108.7 165.94 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.011 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.473 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.5 mp -140.82 116.04 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.259 168.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -109.21 170.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.889 -169.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' N ' HG12 ' A' ' 26' ' ' VAL . 15.9 t -72.38 151.03 42.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.072 164.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.73 14.23 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.306 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -128.0 -69.13 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.892 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.6 p -88.89 -16.02 32.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.601 -171.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 -11.04 59.33 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.4 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -66.86 126.88 30.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.14 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 34' ' ' ILE . 89.1 t -61.08 168.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.199 167.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.531 ' N ' HG12 ' A' ' 33' ' ' VAL . 31.6 mm -118.25 -75.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.716 173.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.911 164.045 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 27.5 t -80.01 120.16 78.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 156.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -65.96 -14.85 46.42 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 122.768 2.312 . . . . 0.0 113.689 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -95.15 -50.09 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.597 -163.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -106.92 -11.74 15.63 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.908 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 58.91 47.38 12.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.384 -167.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.0 m -99.99 142.58 31.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.169 159.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 -7.95 59.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.81 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 16' ' ' LEU . 57.0 mt-10 -98.62 125.83 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.951 -166.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.799 HD13 HG13 ' A' ' 34' ' ' ILE . 14.1 mt -135.35 160.81 37.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.413 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 pt -144.07 156.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.492 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -103.67 148.29 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.377 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.81 90.03 33.32 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.866 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.87 -20.39 66.44 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 122.59 2.193 . . . . 0.0 113.598 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.23 -35.75 78.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.088 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.37 17.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.406 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.3 51.73 36.01 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.599 ' HG3' HG13 ' A' ' 33' ' ' VAL . 1.1 tt0 -143.0 124.71 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.636 HD12 ' H ' ' A' ' 25' ' ' ILE . 2.5 mp -91.63 134.19 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.145 168.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.8 t -126.79 175.29 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.078 -170.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' H ' HG12 ' A' ' 26' ' ' VAL . 20.8 t -84.84 140.72 30.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.983 169.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.15 27.3 3.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.308 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 -69.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.51 172.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -91.74 -16.23 27.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.681 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -10.61 59.61 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.55 136.37 54.41 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.522 -0.839 . . . . 0.0 110.133 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.599 HG13 ' HG3' ' A' ' 24' ' ' GLU . 85.3 t -60.75 167.71 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.235 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.799 HG13 HD13 ' A' ' 16' ' ' LEU . 10.8 mm -118.57 -71.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.809 171.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.026 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.3 m . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.4 t -99.77 113.81 65.28 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.413 163.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 10.3 Cg_exo -68.12 -13.22 37.48 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.7 2.267 . . . . 0.0 113.95 168.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.597 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.34 -75.62 0.34 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.514 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -90.58 -9.4 47.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.728 -163.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 59.74 64.67 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.929 0.871 . . . . 0.0 110.258 -159.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 49.5 m -135.45 147.21 48.86 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.203 163.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.07 -16.89 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.573 -171.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.482 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.7 mt-10 -78.67 119.72 22.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.153 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 17' ' ' ILE . 37.6 mt -130.83 -178.16 4.68 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.331 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.0 pt -155.5 128.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.449 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.441 ' CE2' ' CG1' ' A' ' 25' ' ' ILE . 4.1 t80 -93.35 138.52 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.342 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.09 86.71 2.6 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.787 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 6.6 Cg_endo -59.31 -19.8 52.38 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.525 2.15 . . . . 0.0 113.547 -170.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.07 -54.26 19.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.038 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -84.84 -19.46 32.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.458 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.78 21.18 72.28 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -168.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HG3' HG13 ' A' ' 33' ' ' VAL . 21.3 tt0 -75.08 162.8 28.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.132 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.441 ' CG1' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mp -142.45 115.95 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.105 170.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.923 HG22 HG22 ' A' ' 33' ' ' VAL . 4.1 t -111.93 175.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.224 -168.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' H ' HG12 ' A' ' 26' ' ' VAL . 16.8 t -103.44 141.91 35.16 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.084 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.84 17.44 19.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.346 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -138.62 -25.84 0.9 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.35 -161.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.5 p -131.07 -16.17 3.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.84 163.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.12 -10.93 67.77 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.518 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.7 137.83 58.27 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.888 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.923 HG22 HG22 ' A' ' 26' ' ' VAL . 85.1 t -78.51 159.32 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.858 159.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.403 ' N ' HG12 ' A' ' 33' ' ' VAL . 4.4 mt -114.44 -74.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.717 164.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.967 -168.345 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.718 ' C ' HD11 ' A' ' 16' ' ' LEU . 19.2 m . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 t -89.17 118.07 68.83 Favored Pre-proline 0 C--O 1.246 0.88 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.181 161.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.51 -11.47 32.27 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.761 2.307 . . . . 0.0 113.832 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -89.09 -76.78 0.4 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.493 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 p -86.48 -7.8 58.11 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.064 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 56.76 50.02 13.27 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.371 -0.831 . . . . 0.0 110.903 -167.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -101.7 150.82 22.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.275 163.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.96 -16.77 22.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.666 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.92 110.46 18.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.144 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.718 HD11 ' C ' ' A' ' 7' ' ' VAL . 19.9 mt -120.95 167.07 12.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.362 168.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 pt -144.14 129.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 -169.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.513 ' CD1' HG13 ' A' ' 25' ' ' ILE . 18.2 t80 -74.1 166.78 22.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.37 173.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -149.93 89.28 4.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.734 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.51 -17.92 60.68 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.609 2.206 . . . . 0.0 113.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.37 -36.87 60.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.169 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.1 -20.71 12.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.33 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.05 8.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -168.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.3 tt0 -119.48 167.52 11.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -168.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.67 HD13 ' CB ' ' A' ' 35' ' ' GLU . 2.5 mp -135.83 112.27 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.122 166.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 33' ' ' VAL . 5.3 t -105.5 168.91 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.326 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.439 ' N ' HG12 ' A' ' 26' ' ' VAL . 15.8 t -73.04 153.51 40.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.123 164.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -106.49 20.77 18.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.345 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 -79.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.581 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.7 p -90.77 -4.68 56.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.631 -157.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.49 86.45 0.07 OUTLIER Glycine 0 CA--C 1.555 2.583 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -158.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -153.11 128.88 10.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 112.503 -1.849 . . . . 0.0 110.204 164.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 34' ' ' ILE . 93.2 t -79.17 166.74 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.211 167.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.539 ' N ' HG12 ' A' ' 33' ' ' VAL . 6.8 mt -126.25 -74.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.172 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.67 ' CB ' HD13 ' A' ' 25' ' ' ILE . 3.6 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.967 -162.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.638 ' C ' HD11 ' A' ' 16' ' ' LEU . 10.2 m . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.266 0.555 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.1 t -99.21 105.53 33.04 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.68 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 18.3 Cg_exo -58.93 -13.48 18.81 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.699 2.266 . . . . 0.0 113.944 166.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -88.72 -61.29 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.567 -171.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.5 -11.3 20.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.764 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 59.56 58.27 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.244 -162.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -113.71 172.05 7.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.208 160.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.18 -10.82 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.785 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 16.8 mp0 -70.27 73.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.044 168.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.638 HD11 ' C ' ' A' ' 7' ' ' VAL . 74.4 mt -87.13 176.6 7.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.332 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.64 ' O ' HG23 ' A' ' 25' ' ' ILE . 3.9 pt -144.32 176.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.453 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.512 ' CD1' HG13 ' A' ' 25' ' ' ILE . 14.4 t80 -138.34 142.0 39.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.309 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.37 89.0 34.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -167.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -60.74 -16.52 44.34 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.306 2.004 . . . . 0.0 113.534 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.4 -32.56 37.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.059 -172.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -113.52 -19.9 11.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.403 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.61 54.27 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -168.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -128.13 125.23 38.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.359 -0.42 . . . . 0.0 109.964 -171.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 17' ' ' ILE . 2.5 mp -97.66 124.41 50.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.097 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.7 t -126.86 177.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.023 -172.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.616 ' H ' HG12 ' A' ' 26' ' ' VAL . 15.6 t -87.91 139.94 30.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.249 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -96.14 25.51 4.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.329 168.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.4 -71.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.409 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.07 -16.24 30.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.605 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -10.76 57.46 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -68.65 129.63 40.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.503 -0.848 . . . . 0.0 110.201 -167.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.9 t -61.16 168.05 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.254 169.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' N ' HG12 ' A' ' 33' ' ' VAL . 14.4 mm -118.01 -71.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.728 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HG3' HD13 ' A' ' 25' ' ' ILE . 8.3 pt-20 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.144 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 21.8 m . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.9 t -112.74 117.24 46.9 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.212 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 -12.55 35.24 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.626 2.217 . . . . 0.0 114.022 168.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.94 -74.48 0.41 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.456 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -89.45 -9.26 50.79 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.961 -167.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.08 51.15 10.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.77 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -134.87 147.36 49.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.547 163.218 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -87.13 -16.35 35.71 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.55 -160.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 16' ' ' LEU . 1.7 mp0 -68.61 109.26 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.082 -171.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 15' ' ' GLU . 8.7 mt -128.51 168.98 14.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.457 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 pt -153.63 150.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.413 -172.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 8.8 t80 -105.65 155.97 18.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.305 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.39 78.31 22.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.773 -172.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -60.3 -19.37 57.55 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.546 2.164 . . . . 0.0 113.562 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.02 -38.72 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.034 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -86.19 -33.45 20.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.436 174.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.46 52.86 4.03 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.14 145.08 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.411 . . . . 0.0 109.952 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.3 mp -115.15 136.96 50.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.914 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.661 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.4 t -130.91 177.61 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.13 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.661 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.6 t -101.55 138.43 38.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.539 173.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.36 21.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.521 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -134.05 -24.74 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.234 -161.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 p -130.26 -16.74 3.5 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.939 161.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -11.01 59.78 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.457 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.57 137.76 56.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.991 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.1 t -60.69 167.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.293 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.574 HG13 HD13 ' A' ' 16' ' ' LEU . 10.8 mm -120.0 -74.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.627 174.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.058 -171.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.814 ' O ' HD11 ' A' ' 16' ' ' LEU . 17.6 m . . . . . 0 CA--C 1.534 0.329 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 23.9 t -83.28 118.13 70.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.809 157.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 2.4 Cg_endo -65.92 -10.02 25.34 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.575 2.183 . . . . 0.0 113.777 169.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -96.96 -74.7 0.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.37 -170.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -85.25 -9.89 57.19 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.568 -166.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 59.57 59.3 2.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.182 -160.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.0 p -99.3 167.68 10.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.206 160.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.17 -6.7 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.805 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -109.27 99.11 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.021 -168.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.814 HD11 ' O ' ' A' ' 7' ' ' VAL . 45.8 mt -104.77 175.11 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.388 167.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 28' ' ' ALA . 3.3 pt -161.93 132.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.458 -170.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.534 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.7 t80 -89.58 135.7 33.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.382 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -106.35 92.79 7.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.8 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 4.7 Cg_exo -63.28 -17.42 60.0 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.566 2.178 . . . . 0.0 113.52 -172.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.105 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.25 -21.88 14.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.437 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.11 40.84 6.85 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -168.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -104.69 169.36 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -169.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.534 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -137.78 115.73 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.285 163.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.757 HG22 HG22 ' A' ' 33' ' ' VAL . 6.2 t -115.39 172.76 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.096 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.483 ' N ' HG12 ' A' ' 26' ' ' VAL . 20.1 t -78.25 150.91 33.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.006 166.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 17' ' ' ILE . . . -94.03 13.33 23.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.311 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 -79.53 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.559 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.16 -14.81 49.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.545 -159.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.33 -10.21 33.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.287 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' CE2' HG13 ' A' ' 34' ' ' ILE . 70.3 t80 -70.29 119.05 13.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.38 -0.91 . . . . 0.0 110.175 -164.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.757 HG22 HG22 ' A' ' 26' ' ' VAL . 93.0 t -73.03 155.29 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.875 161.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.613 ' CD1' HD13 ' A' ' 16' ' ' LEU . 4.3 mt -108.59 -74.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.61 162.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.425 ' HB2' HD13 ' A' ' 25' ' ' ILE . 4.4 mm-40 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.02 -168.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 19.6 m . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.9 t -96.33 113.78 63.1 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.303 165.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 14.7 Cg_exo -61.84 -19.7 66.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.784 2.323 . . . . 0.0 113.781 167.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -83.76 -67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.642 -171.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -94.68 -11.35 29.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.64 -168.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 59.51 57.38 3.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.491 0.663 . . . . 0.0 110.256 -162.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -120.63 156.97 30.57 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.298 161.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.7 -0.44 18.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.698 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -91.47 111.22 22.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.091 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 HG13 ' A' ' 34' ' ' ILE . 26.7 mt -120.12 173.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.464 174.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 16' ' ' LEU . 10.3 pt -151.71 127.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.416 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 10.0 t80 -98.11 137.15 37.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.361 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.53 89.01 6.85 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.742 -173.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 7.3 Cg_exo -60.88 -14.59 33.31 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.553 2.168 . . . . 0.0 113.527 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -85.68 -34.97 21.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.053 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.3 mtt85 -101.0 -24.11 14.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.393 172.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.28 47.75 8.81 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -122.58 125.77 46.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.005 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.709 HD12 ' H ' ' A' ' 25' ' ' ILE . 1.9 mp -90.71 138.83 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.396 168.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 27' ' ' CYS . 6.0 t -132.67 177.26 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.981 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.591 ' H ' HG12 ' A' ' 26' ' ' VAL . 21.4 t -96.11 139.13 32.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.011 169.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.21 23.65 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.447 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -120.07 -66.53 1.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.531 171.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.28 -15.19 20.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.697 -168.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.5 -11.32 59.69 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.59 131.76 47.17 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.212 -0.994 . . . . 0.0 109.985 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 34' ' ' ILE . 94.7 t -61.27 167.93 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.083 164.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.607 HG13 HD13 ' A' ' 16' ' ' LEU . 31.4 mm -116.71 -76.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.839 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.936 164.253 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.4 t -105.73 116.23 60.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.42 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -68.39 -14.74 40.82 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.801 2.334 . . . . 0.0 113.856 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.585 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.51 -74.23 0.4 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.534 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -90.97 -9.46 45.96 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.675 -164.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.74 63.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.998 0.904 . . . . 0.0 110.257 -160.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -136.05 145.67 46.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.111 163.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.28 -16.59 19.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.646 -166.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 28' ' ' ALA . 3.7 mt-10 -72.12 129.45 38.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.055 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.677 HD13 HG13 ' A' ' 34' ' ' ILE . 8.1 mt -139.53 171.32 14.42 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.396 173.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.7 pt -157.62 146.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.475 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 11.1 t80 -97.3 151.35 19.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.259 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.485 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 1.4 t0 -133.28 96.81 16.91 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.29 -18.55 63.13 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.311 2.007 . . . . 0.0 113.506 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -47.78 70.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.09 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -104.84 -19.28 13.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.489 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.78 26.69 49.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -167.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.563 ' HG3' HG13 ' A' ' 33' ' ' VAL . 2.2 tp10 -110.66 122.97 49.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.32 -0.44 . . . . 0.0 109.972 -166.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.719 HD12 ' H ' ' A' ' 25' ' ' ILE . 2.0 mp -89.46 131.4 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.927 164.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.7 t -125.23 172.89 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.091 -171.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HA ' HD23 ' A' ' 16' ' ' LEU . 17.7 t -70.75 147.69 48.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.057 163.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . . . -94.59 14.69 20.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.353 170.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.01 -74.82 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.447 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.1 p -91.92 -15.68 27.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.645 -160.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.75 -11.99 42.02 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.365 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -63.15 125.35 23.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 113.965 -1.118 . . . . 0.0 109.647 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 24' ' ' GLU . 92.0 t -60.76 141.44 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.202 169.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.677 HG13 HD13 ' A' ' 16' ' ' LEU . 25.9 mm -90.17 -75.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.791 164.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.571 ' HB2' HD13 ' A' ' 25' ' ' ILE . 7.0 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.908 -168.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.3 m . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 34.0 t -80.0 118.92 74.86 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 153.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 6.0 Cg_endo -68.43 -12.69 35.57 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.68 2.253 . . . . 0.0 113.862 169.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.86 -75.32 0.38 Allowed 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.556 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.1 -11.39 41.43 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.65 -166.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.31 51.84 6.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.226 -164.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 m -103.61 148.33 26.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.208 158.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . . . -94.46 -7.31 41.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.753 -169.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.463 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -108.7 144.81 35.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.995 -168.219 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.833 HD13 HG13 ' A' ' 34' ' ' ILE . 12.7 mt -140.13 171.03 14.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.487 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 28' ' ' ALA . 8.2 pt -159.7 145.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.406 -170.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.8 t80 -97.9 138.99 34.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.398 -167.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.89 95.71 25.52 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.879 176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 14.3 Cg_exo -59.33 -15.03 27.32 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.14 1.893 . . . . 0.0 113.611 -174.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.74 -35.12 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.042 -168.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -28.19 15.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.417 169.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.39 44.76 5.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -168.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 33' ' ' VAL . 5.6 tp10 -119.31 160.26 22.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -168.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 35' ' ' GLU . 2.3 mp -120.37 133.05 68.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 162.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -129.15 169.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.056 -167.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HA ' HD23 ' A' ' 16' ' ' LEU . 20.1 t -63.64 149.17 47.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.926 163.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HA ' HD11 ' A' ' 17' ' ' ILE . . . -94.34 13.61 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.283 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.78 -74.78 0.59 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.66 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -87.11 -16.07 36.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.594 -164.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 -11.39 55.93 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.516 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -67.3 129.83 41.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.055 -170.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 24' ' ' GLU . 84.5 t -61.52 167.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.268 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.833 HG13 HD13 ' A' ' 16' ' ' LEU . 15.5 mm -121.8 -79.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.604 170.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.67 ' HB3' HD13 ' A' ' 25' ' ' ILE . 29.2 tt0 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.971 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.662 ' O ' HD11 ' A' ' 16' ' ' LEU . 21.1 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 21.8 t -93.48 115.67 65.39 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.063 160.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 16.2 Cg_exo -62.29 -19.71 67.83 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.745 2.297 . . . . 0.0 113.751 167.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.58 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.15 -68.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.625 -171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.51 -12.02 30.61 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.638 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 54.61 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -162.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.2 p -99.04 -172.04 2.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.048 159.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.78 -8.22 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.742 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -112.81 53.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.825 -163.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.662 HD11 ' O ' ' A' ' 7' ' ' VAL . 20.1 mt -60.72 171.43 1.16 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.562 175.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 16' ' ' LEU . 10.4 pt -160.07 179.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.5 t80 -131.59 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.417 -169.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.473 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 5.8 t0 -143.73 89.8 7.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.725 -171.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.3 -14.72 25.81 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 C-N-CA 122.54 2.16 . . . . 0.0 113.564 -171.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -88.24 -30.8 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.989 -168.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -96.92 -19.86 18.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.443 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.23 54.85 8.41 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -168.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.681 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -136.61 144.39 44.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -167.282 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -111.07 112.93 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.892 164.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 27' ' ' CYS . 5.1 t -112.39 169.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.165 -166.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 26' ' ' VAL . 21.9 t -69.73 154.65 41.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.887 164.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.12 15.9 27.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.302 172.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.3 -66.05 0.91 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.713 -173.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -94.45 -16.58 23.26 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.632 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 -10.53 58.73 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.499 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -66.08 129.96 41.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.475 -0.863 . . . . 0.0 110.166 -167.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.681 HG13 ' HG3' ' A' ' 24' ' ' GLU . 87.5 t -61.12 167.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.301 170.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 33' ' ' VAL . 14.1 mm -118.99 -75.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.739 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.159 -170.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 20.8 m . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 20.3 t -90.09 116.74 67.09 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.004 159.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 15.5 Cg_exo -61.19 -17.17 50.95 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.732 2.288 . . . . 0.0 113.721 167.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.582 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -91.84 -74.21 0.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.424 -168.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 p -86.17 -9.31 56.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.703 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 59.59 61.74 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.774 0.797 . . . . 0.0 110.285 -160.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 65.5 p -103.8 -165.06 1.12 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.294 163.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.45 -7.46 1.31 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.816 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.698 ' O ' HD23 ' A' ' 16' ' ' LEU . 10.3 mm-40 -115.53 133.0 56.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.02 -167.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 15' ' ' GLU . 19.8 mt -137.67 178.32 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.432 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 16' ' ' LEU . 7.1 pt -160.32 139.36 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.413 -170.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.4 t80 -104.55 136.72 43.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.42 -171.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.21 80.07 71.46 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.822 -169.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -59.26 -18.62 45.92 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 122.46 2.107 . . . . 0.0 113.598 -171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.93 -37.4 84.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.008 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.76 -25.95 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.407 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.14 51.64 4.62 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 1.5 tp10 -130.0 129.13 43.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -167.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 35' ' ' GLU . 2.4 mp -103.31 114.59 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.113 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.79 HG22 HG22 ' A' ' 33' ' ' VAL . 5.2 t -118.15 168.79 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.275 -166.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' N ' HG12 ' A' ' 26' ' ' VAL . 24.0 t -78.06 144.76 36.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.856 167.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.46 20.64 9.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.363 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -75.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.391 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -90.18 -14.85 32.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.648 -159.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.84 -9.82 34.5 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.401 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.48 126.18 29.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 114.539 -0.83 . . . . 0.0 110.126 -164.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG22 HG22 ' A' ' 26' ' ' VAL . 86.1 t -75.87 159.26 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.001 163.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 mt -114.88 -76.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.514 164.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 25' ' ' ILE . 38.8 tt0 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.017 -165.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.6 m . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.472 0.653 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.5 t -119.04 110.28 38.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.469 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.92 -4.59 9.07 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.605 2.203 . . . . 0.0 113.85 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -94.55 -67.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.493 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.9 p -97.56 -11.11 24.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.732 -165.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 59.59 57.7 3.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.305 -165.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.56 160.89 39.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.282 158.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -103.23 -10.97 18.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.791 -166.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.611 ' C ' HD23 ' A' ' 16' ' ' LEU . 14.7 mm-40 -75.71 106.55 7.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.157 -168.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD13 HG13 ' A' ' 34' ' ' ILE . 8.5 mt -129.98 171.65 12.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.356 -175.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 16' ' ' LEU . 8.7 pt -159.99 135.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.343 -169.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 27.7 t80 -98.82 149.7 22.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.331 -169.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 30.1 t70 -127.79 95.83 33.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.727 -167.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.73 -18.39 63.98 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.121 1.881 . . . . 0.0 113.543 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.98 -43.23 68.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.014 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.96 -19.31 13.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.487 -174.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.36 44.86 20.79 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -167.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 26' ' ' VAL . 41.4 tt0 -120.01 124.51 46.09 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -168.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.667 ' H ' HD12 ' A' ' 25' ' ' ILE . 1.9 mp -93.9 128.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.86 167.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 27' ' ' CYS . 6.0 t -128.88 178.86 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.162 -169.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.752 ' H ' HG12 ' A' ' 26' ' ' VAL . 33.8 t -108.67 135.34 50.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.574 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.75 25.68 4.48 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.401 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.69 -36.54 0.56 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -165.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -123.07 -15.65 7.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.845 166.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.73 63.66 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.497 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.59 139.89 56.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.417 -0.891 . . . . 0.0 110.116 -168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 34' ' ' ILE . 92.4 t -61.03 168.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 167.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 16' ' ' LEU . 16.5 mm -121.2 -75.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.462 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.949 168.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.5 t -111.79 111.53 54.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.415 171.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.94 -10.87 30.22 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 113.758 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.33 -73.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.456 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.45 -11.53 34.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.633 -164.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 59.48 57.81 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.254 -162.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.482 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 45.6 m -124.24 162.9 22.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.289 161.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.2 -7.84 15.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.779 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.85 ' O ' HD23 ' A' ' 16' ' ' LEU . 27.2 mt-10 -90.62 119.61 31.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.066 -167.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 15' ' ' GLU . 10.6 mt -138.04 159.63 41.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.368 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 28' ' ' ALA . 7.0 pt -150.99 146.58 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.433 -169.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 25' ' ' ILE . 3.5 t80 -98.55 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.42 -168.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.1 90.14 9.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.882 172.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.42 -19.5 51.65 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 122.472 2.114 . . . . 0.0 113.497 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.82 -50.49 72.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.103 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -29.83 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.401 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.55 27.65 14.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -167.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -92.06 165.31 13.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.341 -0.43 . . . . 0.0 110.0 -168.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 35' ' ' GLU . 1.9 mp -137.4 114.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.776 166.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.3 t -111.49 177.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.116 -167.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.686 ' H ' HG12 ' A' ' 26' ' ' VAL . 23.0 t -98.82 135.97 39.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.841 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -95.56 22.94 6.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.221 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -142.76 -25.08 0.63 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.197 -160.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -133.57 -17.33 2.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.846 163.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.59 58.35 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.476 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.86 138.75 50.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.156 -168.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.558 HG12 ' N ' ' A' ' 34' ' ' ILE . 64.9 t -61.17 168.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.277 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.663 HG13 HD13 ' A' ' 16' ' ' LEU . 16.8 mm -124.61 -74.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.243 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 25' ' ' ILE . 40.2 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 166.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.5 t -110.68 113.25 55.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.507 172.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -65.49 -16.92 56.11 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.749 2.299 . . . . 0.0 113.76 169.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -78.55 -72.16 0.39 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.564 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -91.07 -9.15 46.81 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.981 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.82 50.23 12.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.834 -167.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -97.03 -167.05 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.395 164.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.31 -10.12 3.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.844 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.68 116.42 25.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.056 -168.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.926 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -136.69 166.55 23.3 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.364 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.5 pt -151.28 133.16 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.476 -171.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 49.2 t80 -80.34 163.01 24.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.322 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.498 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -146.41 100.2 4.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 -167.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -62.28 -18.38 62.19 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.58 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.52 -47.09 77.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.008 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -109.29 -20.17 13.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.415 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.7 52.68 6.33 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -166.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.494 ' OE2' HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -139.57 144.5 37.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -166.156 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.469 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.4 mp -106.26 134.89 46.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.05 169.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.682 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.8 t -132.12 178.38 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.079 -167.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.682 ' H ' HG12 ' A' ' 26' ' ' VAL . 27.0 t -99.23 139.05 35.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.74 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.66 26.91 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.386 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 -34.66 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 -162.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -126.38 -16.71 5.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.9 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.57 -10.75 70.73 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.666 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -63.06 139.08 58.74 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.599 -0.801 . . . . 0.0 110.025 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.2 t -61.09 167.24 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.265 170.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.926 HG13 HD13 ' A' ' 16' ' ' LEU . 15.8 mm -121.67 -76.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.567 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.055 177.249 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 28.7 t -113.64 115.26 46.73 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.004 175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.67 -20.35 70.68 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.608 2.205 . . . . 0.0 113.717 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -76.36 -70.54 0.44 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.49 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -95.16 -9.7 32.7 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.022 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 7.3 pt-20 56.34 48.52 16.92 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.415 -0.803 . . . . 0.0 111.004 -168.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -85.46 -168.4 2.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.414 166.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.61 -13.07 5.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.741 167.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.534 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.3 mp0 -91.49 109.56 20.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.12 -169.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.738 HD13 HG13 ' A' ' 34' ' ' ILE . 15.8 mt -127.9 -177.95 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.387 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 16' ' ' LEU . 3.7 pt -160.4 145.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.414 -169.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.9 t80 -108.81 119.15 38.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.416 -169.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.98 83.84 0.52 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.795 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 6.2 Cg_endo -59.93 -19.68 56.31 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.434 2.09 . . . . 0.0 113.596 -172.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.09 -51.99 61.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.999 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -79.12 -30.36 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.407 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.31 40.87 7.68 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -168.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -118.07 159.64 22.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -129.47 133.13 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.037 163.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.8 t -131.93 178.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.114 -167.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.724 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.9 t -106.15 125.41 50.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.536 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.25 -2.44 31.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.868 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -77.59 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 171.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.5 p -83.2 -17.54 42.46 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.6 -162.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.83 60.52 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.43 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -68.93 139.93 55.09 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.547 -0.826 . . . . 0.0 110.265 -168.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 34' ' ' ILE . 95.7 t -62.17 167.68 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.038 165.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.738 HG13 HD13 ' A' ' 16' ' ' LEU . 16.9 mm -117.82 -74.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.725 171.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 166.707 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 16.9 m . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.7 t -111.57 112.61 53.92 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.175 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.25 -16.85 57.06 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.686 2.257 . . . . 0.0 113.735 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.52 -73.56 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.393 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.9 -11.01 40.44 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.645 -166.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 59.37 56.06 3.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.248 -163.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 52.6 p -109.57 -166.21 1.08 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.367 160.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -142.36 -16.96 0.73 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.662 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.787 ' O ' HD23 ' A' ' 16' ' ' LEU . 1.9 mm-40 -81.39 122.59 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.05 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.933 HD13 HG13 ' A' ' 34' ' ' ILE . 13.5 mt -137.28 160.43 39.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.466 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.37 132.01 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.369 -168.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CD1' HG13 ' A' ' 25' ' ' ILE . 7.4 t80 -88.47 132.7 34.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.379 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 80.76 1.11 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.653 168.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 5.6 Cg_endo -59.16 -20.23 53.48 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 122.558 2.172 . . . . 0.0 113.512 -168.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.03 -53.22 57.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.178 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -86.9 -19.13 29.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.26 30.55 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -168.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.46 162.31 15.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.929 -0.635 . . . . 0.0 109.993 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.535 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.1 mp -142.0 115.79 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.202 167.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -106.51 177.93 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.232 -170.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.713 ' H ' HG12 ' A' ' 26' ' ' VAL . 31.4 t -101.07 125.05 47.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.641 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.53 -4.61 43.64 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.882 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -92.97 -78.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.313 170.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -86.12 -16.6 37.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.612 -161.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 -10.38 54.56 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.455 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -72.61 133.97 44.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.592 -0.804 . . . . 0.0 110.172 -168.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 34' ' ' ILE . 88.3 t -61.27 167.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.133 165.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.933 HG13 HD13 ' A' ' 16' ' ' LEU . 33.4 mm -119.18 -76.53 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.644 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.079 168.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.5 t -107.72 113.52 61.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.279 170.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.68 -13.72 41.03 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 122.71 2.273 . . . . 0.0 113.721 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.605 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.95 -74.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.456 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -91.21 -11.02 39.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.691 -166.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 59.31 54.81 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.223 -163.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.5 p -88.85 176.55 7.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.038 162.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.33 -8.04 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.763 164.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.64 ' O ' HD23 ' A' ' 16' ' ' LEU . 19.0 mt-10 -99.04 116.18 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.988 -167.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.65 HD13 HG13 ' A' ' 34' ' ' ILE . 16.0 mt -132.62 166.59 21.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.379 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 28' ' ' ALA . 10.2 pt -155.15 148.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.399 -167.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.476 ' CD1' HG13 ' A' ' 25' ' ' ILE . 12.9 t80 -107.73 123.17 48.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.312 -170.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.96 98.0 7.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 -171.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.1 Cg_endo -59.09 -14.18 22.41 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.306 2.004 . . . . 0.0 113.505 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.55 -30.7 21.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.085 -169.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.31 -19.33 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.459 174.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.18 51.2 10.42 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -168.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 26' ' ' VAL . 31.9 tt0 -137.08 125.94 24.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.432 . . . . 0.0 109.9 -167.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.664 HD12 ' H ' ' A' ' 25' ' ' ILE . 2.4 mp -88.83 128.11 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.128 169.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -130.76 177.12 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.968 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.591 ' H ' HG12 ' A' ' 26' ' ' VAL . 19.7 t -93.33 124.01 37.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.916 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.73 7.31 4.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.753 176.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -112.95 -67.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.455 178.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.6 p -91.75 -19.14 22.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.512 -169.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.13 57.81 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.551 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -68.76 126.82 30.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.404 -0.898 . . . . 0.0 110.229 -170.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 34' ' ' ILE . 65.3 t -61.55 169.36 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.426 175.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.65 HG13 HD13 ' A' ' 16' ' ' LEU . 20.0 mm -124.75 -73.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.185 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 25' ' ' ILE . 5.0 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.958 166.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.476 0.655 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.4 t -113.84 111.04 48.64 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.537 175.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -67.77 -10.57 29.21 Favored 'Trans proline' 0 N--CA 1.482 0.846 0 C-N-CA 122.751 2.301 . . . . 0.0 113.881 169.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.72 -71.81 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.549 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -93.98 -11.33 31.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.635 -165.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 59.48 58.11 3.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.228 -161.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -110.8 -171.35 1.81 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.231 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.76 -16.44 1.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.717 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.852 ' O ' HD23 ' A' ' 16' ' ' LEU . 5.0 mm-40 -74.85 120.47 20.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.026 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.929 HD13 HG13 ' A' ' 34' ' ' ILE . 7.9 mt -135.77 165.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.411 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 28' ' ' ALA . 8.9 pt -150.02 140.37 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.394 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.525 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.0 t80 -101.66 149.48 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.236 -168.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 7.1 t70 -129.3 94.79 32.24 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.736 -167.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -59.89 -20.26 58.86 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.272 1.981 . . . . 0.0 113.571 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.92 -39.04 87.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.112 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -22.62 11.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.52 30.29 30.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.41 164.65 12.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -170.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.525 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.6 mp -126.76 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.999 163.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -132.82 178.5 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.155 -167.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.702 ' H ' HG12 ' A' ' 26' ' ' VAL . 22.0 t -101.87 136.85 41.0 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.858 175.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -95.89 29.57 2.67 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.33 176.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.74 -35.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.613 -165.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.3 p -125.57 -16.49 5.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.823 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.43 -11.11 69.02 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.576 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.04 137.67 58.33 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.639 -0.78 . . . . 0.0 109.976 -173.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.6 t -60.89 167.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.26 168.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.929 HG13 HD13 ' A' ' 16' ' ' LEU . 20.6 mm -120.78 -69.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.426 173.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.53 0.207 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.066 176.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.9 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.912 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 28' ' ' ALA . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.536 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 35' ' ' GLU . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.718 ' H ' HG12 ' A' ' 26' ' ' VAL . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 34' ' ' ILE . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.912 HG13 HD13 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 25' ' ' ILE . 7.8 tp10 . . . . . 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.9 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.912 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 28' ' ' ALA . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.536 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 35' ' ' GLU . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.718 ' H ' HG12 ' A' ' 26' ' ' VAL . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 34' ' ' ILE . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.912 HG13 HD13 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 25' ' ' ILE . 7.8 tp10 . . . . . 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 27.3 m . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.9 t -95.63 111.22 54.9 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.338 161.935 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 5.2 Cg_endo -69.99 -8.08 22.72 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.6 2.2 . . . . 0.0 113.968 169.421 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.32 -73.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.514 175.588 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -92.68 -11.45 34.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.663 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.53 57.15 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.209 -162.645 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -114.02 172.94 6.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.209 160.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.15 -9.32 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.715 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 65.8 mm-40 -96.83 52.64 1.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.977 -162.201 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.9 HD13 HG13 ' A' ' 34' ' ' ILE . 17.4 mt -69.71 175.97 3.89 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.449 -177.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 16' ' ' LEU . 9.5 pt -157.49 153.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.462 -168.295 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.3 t80 -106.8 132.36 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.434 -169.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.3 92.08 6.44 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.703 175.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 13.5 Cg_exo -59.07 -13.16 17.98 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.388 2.059 . . . . 0.0 113.602 -168.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -47.68 14.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.016 -170.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -90.05 -24.0 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.419 170.302 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 16.61 50.06 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -177.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -79.59 164.2 24.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.027 -171.313 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -130.84 113.0 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.938 165.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.719 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -114.04 177.61 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.147 -169.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.719 ' H ' HG12 ' A' ' 26' ' ' VAL . 15.4 t -90.5 126.17 35.83 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.076 178.03 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -76.48 7.05 4.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.774 175.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.23 -67.66 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.514 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.8 p -93.03 -20.13 20.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.48 -167.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.98 60.23 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.639 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -69.52 131.94 45.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.659 -0.771 . . . . 0.0 110.333 -172.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 34' ' ' ILE . 61.3 t -61.79 170.98 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.368 175.012 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.9 HG13 HD13 ' A' ' 16' ' ' LEU . 14.0 mm -128.07 -73.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.013 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.022 167.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.459 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.4 m . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.0 t -102.61 111.12 64.45 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.369 164.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 7.2 Cg_exo -68.45 -10.77 29.99 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.741 2.294 . . . . 0.0 113.751 169.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -81.14 -73.67 0.36 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.482 177.188 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -93.67 -11.86 30.64 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.596 -163.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 59.25 2.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.579 0.704 . . . . 0.0 110.193 -161.374 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 54.9 m -123.61 148.31 46.53 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.26 161.171 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.31 27.93 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.602 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.502 ' O ' HD23 ' A' ' 16' ' ' LEU . 15.3 mm-40 -75.89 118.05 18.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.158 -172.184 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.582 HD13 HG13 ' A' ' 34' ' ' ILE . 15.7 mt -141.95 158.04 44.24 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.315 178.038 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 pt -150.85 158.57 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.415 -167.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 2.8 t80 -108.68 121.79 45.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.375 -169.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.21 99.75 3.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.748 178.265 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -59.61 -15.53 31.55 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.362 2.041 . . . . 0.0 113.469 179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -78.21 -30.86 49.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.039 -169.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -111.98 -20.22 12.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.398 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 44.79 7.56 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.46 168.11 9.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.75 128.77 68.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.677 162.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 27' ' ' CYS . 3.7 t -130.88 176.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.93 -168.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' H ' HG12 ' A' ' 26' ' ' VAL . 17.8 t -94.54 136.78 34.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.01 176.118 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 20.91 8.1 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.237 178.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' CE ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -143.41 -23.79 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.357 -158.361 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.3 p -135.99 -18.06 1.6 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.838 164.726 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.15 -11.44 57.14 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.455 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -67.97 137.16 54.92 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.312 -0.944 . . . . 0.0 110.09 -170.24 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 34' ' ' ILE . 96.3 t -61.59 167.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.221 175.065 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.582 HG13 HD13 ' A' ' 16' ' ' LEU . 19.4 mm -124.21 -78.27 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.416 172.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.978 174.019 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.2 t -102.47 111.44 64.62 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.499 168.165 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.25 -11.76 33.41 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.706 2.271 . . . . 0.0 113.778 169.377 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.17 -69.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.619 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.2 p -96.53 -11.45 25.44 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.654 -166.175 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.62 58.32 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.242 -162.255 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -114.42 173.78 6.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.283 160.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.86 6.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.611 -169.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.22 126.97 35.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.043 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.973 HD13 HG13 ' A' ' 34' ' ' ILE . 17.6 mt -135.52 161.54 35.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.446 174.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 pt -135.64 140.29 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.367 -167.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -104.29 135.85 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.256 -169.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.65 92.23 49.15 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.794 -168.14 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -59.47 -20.12 55.15 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.44 2.093 . . . . 0.0 113.61 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 -46.99 61.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.076 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -91.76 -21.79 20.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.406 -178.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 41.79 60.62 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -167.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG13 ' A' ' 33' ' ' VAL . 17.6 tt0 -128.3 141.34 51.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.404 . . . . 0.0 109.968 -166.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.687 HD13 ' HG3' ' A' ' 35' ' ' GLU . 2.5 mp -108.04 137.67 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.091 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.6 t -134.06 176.95 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.908 -168.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.635 ' H ' HG12 ' A' ' 26' ' ' VAL . 18.1 t -92.6 131.09 38.01 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.841 174.138 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.15 43.24 1.14 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.379 170.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -53.05 0.16 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.464 -178.045 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.8 p -111.03 -18.23 13.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.717 -178.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.99 -10.61 68.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.671 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.17 132.59 53.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.999 -175.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 34' ' ' ILE . 88.8 t -61.06 167.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.279 170.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.973 HG13 HD13 ' A' ' 16' ' ' LEU . 21.1 mm -120.24 -77.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.698 173.315 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.687 ' HG3' HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.055 172.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 23.3 m . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 22.9 t -103.01 111.73 65.27 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.105 168.667 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 8.0 Cg_exo -66.8 -4.26 10.89 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.678 2.252 . . . . 0.0 113.776 170.331 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.599 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -93.45 -68.53 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.557 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.87 -11.29 29.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.555 -167.412 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 59.44 57.35 3.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.185 -162.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -101.82 -165.81 1.23 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.279 160.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.08 -16.91 1.23 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.681 175.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.843 ' O ' HD23 ' A' ' 16' ' ' LEU . 4.3 mm-40 -86.42 122.03 29.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.111 -175.358 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 ' O ' ' A' ' 15' ' ' GLU . 11.0 mt -137.81 -176.3 4.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.442 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.3 pt -161.81 138.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 -169.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.521 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.7 t80 -105.92 121.08 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.401 -177.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.75 94.56 3.71 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.869 -175.431 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -58.92 -15.17 25.85 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 C-N-CA 122.348 2.032 . . . . 0.0 113.449 -170.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.83 -31.69 23.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.988 -170.426 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -27.15 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.371 171.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.01 3.32 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -163.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' OE2' HG21 ' A' ' 33' ' ' VAL . 9.3 tt0 -140.78 114.88 9.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.93 -166.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.521 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.8 mp -93.36 116.05 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.886 HG22 HG22 ' A' ' 33' ' ' VAL . 5.3 t -121.17 177.66 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.246 -164.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.721 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.0 t -106.33 131.75 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.457 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.25 39.32 1.02 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 113.661 -1.608 . . . . 0.0 110.455 173.108 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 -50.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.371 -175.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.0 p -113.12 -17.19 12.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.65 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -11.0 63.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.28 137.02 56.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.406 -0.897 . . . . 0.0 110.037 -170.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.886 HG22 HG22 ' A' ' 26' ' ' VAL . 90.1 t -79.89 159.85 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.031 161.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.442 HG22 ' HB2' ' A' ' 35' ' ' GLU . 5.3 mt -116.38 -75.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.5 166.093 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HB2' HG22 ' A' ' 34' ' ' ILE . 4.6 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.079 -162.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.087 0.47 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.2 p -160.63 122.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.298 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 m120 70.15 -155.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.293 -168.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.534 ' HE2' ' HD3' ' A' ' 6' ' ' LYS . 2.0 mmmm -61.09 -43.53 98.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.444 -169.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 68.11 86.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.43 -171.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HD3' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -166.74 -176.47 3.5 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.2 168.39 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.803 ' O ' HD11 ' A' ' 16' ' ' LEU . 9.0 m 59.53 -163.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.13 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.6 t -104.59 112.41 65.34 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.329 168.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.32 -14.71 43.74 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.717 2.278 . . . . 0.0 113.854 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.43 -74.48 0.35 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.514 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.1 p -97.07 -6.54 34.93 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.928 -164.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.16 68.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.663 0.744 . . . . 0.0 110.168 -161.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 58.2 m -138.88 105.52 5.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.192 168.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -15.71 63.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.761 -167.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -77.19 104.85 7.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.023 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.803 HD11 ' O ' ' A' ' 7' ' ' VAL . 18.2 mt -109.03 -179.62 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.376 167.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 pt -158.86 153.2 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.402 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.71 ' OH ' HD13 ' A' ' 38' ' ' ILE . 6.3 t80 -100.15 159.74 14.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.386 -169.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -140.83 80.03 18.2 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.788 -172.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -60.28 -18.75 54.2 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.546 2.164 . . . . 0.0 113.493 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -75.02 -37.17 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.08 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -102.77 -24.42 13.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.32 36.01 11.41 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.9 tt0 -108.7 165.94 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.011 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.473 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.5 mp -140.82 116.04 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.259 168.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -109.21 170.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.889 -169.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' N ' HG12 ' A' ' 26' ' ' VAL . 15.9 t -72.38 151.03 42.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.072 164.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.73 14.23 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.306 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -128.0 -69.13 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.892 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.6 p -88.89 -16.02 32.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.601 -171.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 -11.04 59.33 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.4 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -66.86 126.88 30.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.14 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 34' ' ' ILE . 89.1 t -61.08 168.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.199 167.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.531 ' N ' HG12 ' A' ' 33' ' ' VAL . 31.6 mm -118.25 -75.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.716 173.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -125.07 159.75 30.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.911 164.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -151.51 48.74 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.991 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -158.9 56.9 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.368 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.71 HD13 ' OH ' ' A' ' 18' ' ' TYR . 1.1 pp -75.93 65.29 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.443 -170.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 tt -171.89 152.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.399 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -162.09 74.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.396 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 mtm -130.34 -55.64 1.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.326 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.23 67.69 1.54 Allowed Glycine 0 CA--C 1.541 1.71 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 171.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.3 -64.55 0.11 Allowed 'Trans proline' 0 N--CA 1.486 1.048 0 C-N-CA 122.256 1.97 . . . . 0.0 113.58 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -157.29 78.14 0.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.959 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -151.33 -40.59 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.432 -168.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -109.72 148.53 31.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.359 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.61 132.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.359 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -131.02 148.34 52.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.374 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -168.23 128.64 1.3 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.358 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.593 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.261 169.843 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mtm . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.149 0.499 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.62 -25.25 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.331 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 p30 61.11 -163.57 0.25 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.655 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -175.75 25.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.301 -168.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.522 ' O ' HG13 ' A' ' 7' ' ' VAL . 11.9 pt20 -127.87 38.66 3.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.247 -167.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -60.61 114.77 3.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.2 166.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 5' ' ' GLN . 20.2 m -95.61 154.28 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.118 -160.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 27.5 t -80.01 120.16 78.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 156.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -65.96 -14.85 46.42 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 122.768 2.312 . . . . 0.0 113.689 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -95.15 -50.09 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.597 -163.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -106.92 -11.74 15.63 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.908 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 58.91 47.38 12.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.384 -167.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.0 m -99.99 142.58 31.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.169 159.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 -7.95 59.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.81 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 16' ' ' LEU . 57.0 mt-10 -98.62 125.83 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.951 -166.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.799 HD13 HG13 ' A' ' 34' ' ' ILE . 14.1 mt -135.35 160.81 37.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.413 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 pt -144.07 156.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.492 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -103.67 148.29 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.377 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.81 90.03 33.32 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.866 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.87 -20.39 66.44 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 122.59 2.193 . . . . 0.0 113.598 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.23 -35.75 78.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.088 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.37 17.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.406 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.3 51.73 36.01 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.599 ' HG3' HG13 ' A' ' 33' ' ' VAL . 1.1 tt0 -143.0 124.71 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.636 HD12 ' H ' ' A' ' 25' ' ' ILE . 2.5 mp -91.63 134.19 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.145 168.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.8 t -126.79 175.29 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.078 -170.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' H ' HG12 ' A' ' 26' ' ' VAL . 20.8 t -84.84 140.72 30.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.983 169.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.15 27.3 3.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.308 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 -69.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.51 172.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -91.74 -16.23 27.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.681 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -10.61 59.61 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.55 136.37 54.41 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.522 -0.839 . . . . 0.0 110.133 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.599 HG13 ' HG3' ' A' ' 24' ' ' GLU . 85.3 t -60.75 167.71 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.235 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.799 HG13 HD13 ' A' ' 16' ' ' LEU . 10.8 mm -118.57 -71.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.809 171.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.41 149.86 41.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.026 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -122.25 51.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.954 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -143.9 77.2 1.54 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.388 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.8 tt -127.06 130.17 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.323 167.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 38' ' ' ILE . 1.5 tp 76.86 -54.61 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.632 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 103.56 0.29 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 -171.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 93.9 mtp -140.3 113.09 8.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.38 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.41 -85.95 0.24 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -53.46 131.03 41.53 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.609 2.206 . . . . 0.0 113.568 -172.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.65 -179.85 6.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.07 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -88.38 -75.49 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.397 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.52 157.12 28.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.407 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.23 19.94 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.304 170.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.64 -72.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.338 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.7 134.52 54.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.402 -169.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.562 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.24 -177.921 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' HG22 ' A' ' 2' ' ' VAL . 2.5 tpp . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 1' ' ' MET . 10.0 m 59.04 -177.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.205 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.35 116.42 2.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.367 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.35 -19.1 8.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.473 170.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -116.76 -76.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.287 -166.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 141.66 34.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.352 -164.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.3 m -96.5 -161.94 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.06 166.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.4 t -99.77 113.81 65.28 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.413 163.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 10.3 Cg_exo -68.12 -13.22 37.48 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.7 2.267 . . . . 0.0 113.95 168.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.597 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.34 -75.62 0.34 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.514 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -90.58 -9.4 47.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.728 -163.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 59.74 64.67 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.929 0.871 . . . . 0.0 110.258 -159.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 49.5 m -135.45 147.21 48.86 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.203 163.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.07 -16.89 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.573 -171.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.482 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.7 mt-10 -78.67 119.72 22.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.153 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 17' ' ' ILE . 37.6 mt -130.83 -178.16 4.68 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.331 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.0 pt -155.5 128.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.449 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.441 ' CE2' ' CG1' ' A' ' 25' ' ' ILE . 4.1 t80 -93.35 138.52 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.342 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.09 86.71 2.6 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.787 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 6.6 Cg_endo -59.31 -19.8 52.38 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.525 2.15 . . . . 0.0 113.547 -170.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.07 -54.26 19.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.038 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -84.84 -19.46 32.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.458 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.78 21.18 72.28 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -168.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HG3' HG13 ' A' ' 33' ' ' VAL . 21.3 tt0 -75.08 162.8 28.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.132 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.441 ' CG1' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mp -142.45 115.95 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.105 170.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.923 HG22 HG22 ' A' ' 33' ' ' VAL . 4.1 t -111.93 175.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.224 -168.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' H ' HG12 ' A' ' 26' ' ' VAL . 16.8 t -103.44 141.91 35.16 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.084 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.84 17.44 19.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.346 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -138.62 -25.84 0.9 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.35 -161.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.5 p -131.07 -16.17 3.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.84 163.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.12 -10.93 67.77 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.518 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.7 137.83 58.27 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.888 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.923 HG22 HG22 ' A' ' 26' ' ' VAL . 85.1 t -78.51 159.32 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.858 159.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' N ' HG12 ' A' ' 33' ' ' VAL . 4.4 mt -114.44 -74.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.717 164.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HG2' ' N ' ' A' ' 36' ' ' GLU . 35.7 tt0 -117.57 163.61 16.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.967 -168.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.466 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -141.81 49.29 1.59 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.961 177.213 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -157.93 157.93 34.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.394 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.6 tp -119.3 139.37 46.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.429 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 pt -60.91 133.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.466 -170.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.49 99.13 0.5 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.363 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' A' ' 43' ' ' PRO . 2.0 tpt -113.43 137.12 51.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 167.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' N ' ' HD2' ' A' ' 43' ' ' PRO . . . 130.61 -52.16 0.84 Allowed Glycine 0 CA--C 1.544 1.883 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 42' ' ' GLY . 6.9 Cg_exo -51.44 -85.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.537 2.158 . . . . 0.0 113.482 -164.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -90.97 100.07 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.984 -162.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 45' ' ' TRP . 0.1 OUTLIER 62.16 108.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.99 164.032 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -164.9 -80.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.442 163.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.6 177.96 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.361 171.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.11 82.72 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.246 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -174.14 -52.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.406 -168.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.584 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.251 -169.833 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tpp . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.091 0.472 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.32 64.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.377 173.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -165.06 101.71 0.76 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.443 -169.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -153.06 150.53 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.396 170.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -142.22 24.31 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.44 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -121.36 123.38 41.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.305 168.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.718 ' C ' HD11 ' A' ' 16' ' ' LEU . 19.2 m -142.43 169.25 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.22 -168.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 t -89.17 118.07 68.83 Favored Pre-proline 0 C--O 1.246 0.88 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.181 161.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.51 -11.47 32.27 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.761 2.307 . . . . 0.0 113.832 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -89.09 -76.78 0.4 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.493 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 p -86.48 -7.8 58.11 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.064 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 56.76 50.02 13.27 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.371 -0.831 . . . . 0.0 110.903 -167.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -101.7 150.82 22.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.275 163.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.96 -16.77 22.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.666 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.92 110.46 18.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.144 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.718 HD11 ' C ' ' A' ' 7' ' ' VAL . 19.9 mt -120.95 167.07 12.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.362 168.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 pt -144.14 129.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 -169.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.513 ' CD1' HG13 ' A' ' 25' ' ' ILE . 18.2 t80 -74.1 166.78 22.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.37 173.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -149.93 89.28 4.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.734 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.51 -17.92 60.68 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.609 2.206 . . . . 0.0 113.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.37 -36.87 60.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.169 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.1 -20.71 12.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.33 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.05 8.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -168.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.3 tt0 -119.48 167.52 11.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -168.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.67 HD13 ' CB ' ' A' ' 35' ' ' GLU . 2.5 mp -135.83 112.27 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.122 166.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 33' ' ' VAL . 5.3 t -105.5 168.91 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.326 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.439 ' N ' HG12 ' A' ' 26' ' ' VAL . 15.8 t -73.04 153.51 40.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.123 164.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -106.49 20.77 18.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.345 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 -79.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.581 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.7 p -90.77 -4.68 56.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.631 -157.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.49 86.45 0.07 OUTLIER Glycine 0 CA--C 1.555 2.583 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -158.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -153.11 128.88 10.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 112.503 -1.849 . . . . 0.0 110.204 164.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 34' ' ' ILE . 93.2 t -79.17 166.74 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.211 167.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.539 ' N ' HG12 ' A' ' 33' ' ' VAL . 6.8 mt -126.25 -74.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.172 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.67 ' CB ' HD13 ' A' ' 25' ' ' ILE . 3.6 mm-40 -100.07 133.86 43.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.967 -162.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -110.09 131.78 54.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.079 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.27 155.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.303 168.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 111.86 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.349 168.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 39' ' ' ILE . 4.3 mp -79.42 145.8 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.441 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.21 -96.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.311 169.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.3 mmt -88.39 140.86 29.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.578 -177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.36 99.65 0.22 Allowed Glycine 0 CA--C 1.541 1.698 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -55.71 110.12 0.51 Allowed 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.283 1.989 . . . . 0.0 113.462 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 -66.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.022 168.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -176.03 38.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.448 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.26 118.2 8.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.406 169.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.35 -49.61 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.338 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -105.37 109.69 21.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.406 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -130.07 -68.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.408 -170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.603 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.268 -169.774 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 121.149 0.5 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -91.79 -59.56 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.385 -170.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -62.45 -98.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.325 -166.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -133.46 79.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.595 -166.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 61.38 -168.1 0.19 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.626 164.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.921 ' HG3' HG13 ' A' ' 7' ' ' VAL . 19.8 ptmt -113.72 -168.94 1.41 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.308 169.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.921 HG13 ' HG3' ' A' ' 6' ' ' LYS . 10.2 m 60.41 -165.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.087 173.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.1 t -99.21 105.53 33.04 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.68 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 18.3 Cg_exo -58.93 -13.48 18.81 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.699 2.266 . . . . 0.0 113.944 166.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -88.72 -61.29 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.567 -171.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.5 -11.3 20.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.764 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 59.56 58.27 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.244 -162.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -113.71 172.05 7.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.208 160.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.18 -10.82 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.785 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 16.8 mp0 -70.27 73.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.044 168.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.638 HD11 ' C ' ' A' ' 7' ' ' VAL . 74.4 mt -87.13 176.6 7.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.332 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.64 ' O ' HG23 ' A' ' 25' ' ' ILE . 3.9 pt -144.32 176.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.453 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.719 ' OH ' HD12 ' A' ' 38' ' ' ILE . 14.4 t80 -138.34 142.0 39.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.309 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.37 89.0 34.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -167.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -60.74 -16.52 44.34 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.306 2.004 . . . . 0.0 113.534 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.4 -32.56 37.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.059 -172.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -113.52 -19.9 11.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.403 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.61 54.27 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -168.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -128.13 125.23 38.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.359 -0.42 . . . . 0.0 109.964 -171.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 17' ' ' ILE . 2.5 mp -97.66 124.41 50.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.097 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.7 t -126.86 177.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.023 -172.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.616 ' H ' HG12 ' A' ' 26' ' ' VAL . 15.6 t -87.91 139.94 30.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.249 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -96.14 25.51 4.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.329 168.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.4 -71.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.409 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.07 -16.24 30.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.605 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -10.76 57.46 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -68.65 129.63 40.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.503 -0.848 . . . . 0.0 110.201 -167.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.9 t -61.16 168.05 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.254 169.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' N ' HG12 ' A' ' 33' ' ' VAL . 14.4 mm -118.01 -71.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.728 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HG3' HD13 ' A' ' 25' ' ' ILE . 8.3 pt-20 -145.9 179.08 7.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.144 176.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -142.65 77.73 1.59 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.072 168.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.68 44.23 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.42 -172.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.719 HD12 ' OH ' ' A' ' 18' ' ' TYR . 23.6 mt -138.96 82.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.379 168.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.6 ' N ' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -61.23 123.87 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.569 -166.164 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -146.4 41.57 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.207 171.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.483 ' HE3' ' HB2' ' A' ' 44' ' ' GLU . 3.5 ttp -109.46 131.38 55.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.388 -165.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.597 ' H ' ' HD2' ' A' ' 43' ' ' PRO . . . -98.05 -51.26 1.51 Allowed Glycine 0 CA--C 1.541 1.698 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -171.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.597 ' HD2' ' H ' ' A' ' 42' ' ' GLY . 7.0 Cg_endo -65.27 -0.01 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 C-N-CA 122.268 1.979 . . . . 0.0 113.708 -168.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.483 ' HB2' ' HE3' ' A' ' 41' ' ' MET . 3.1 tp10 -90.89 51.1 1.9 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.89 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 67.87 112.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.349 167.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.7 25.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.357 -169.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.37 -39.08 16.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.249 -169.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -80.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.5 -166.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 53.89 -102.02 0.13 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.344 0.658 . . . . 0.0 111.904 170.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.583 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.304 169.396 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 121.188 0.518 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.561 HG23 ' H ' ' A' ' 4' ' ' LYS . 2.9 m -73.11 -163.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.315 170.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -92.25 22.8 4.21 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.647 171.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.561 ' H ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -125.13 -12.96 6.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.471 170.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 70.7 120.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.408 172.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 141.61 57.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.192 166.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 21.8 m -122.5 -171.2 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.279 -164.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.9 t -112.74 117.24 46.9 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.212 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 -12.55 35.24 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.626 2.217 . . . . 0.0 114.022 168.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.94 -74.48 0.41 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.456 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -89.45 -9.26 50.79 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.961 -167.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.08 51.15 10.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.77 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -134.87 147.36 49.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.547 163.218 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -87.13 -16.35 35.71 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.55 -160.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 16' ' ' LEU . 1.7 mp0 -68.61 109.26 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.082 -171.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 15' ' ' GLU . 8.7 mt -128.51 168.98 14.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.457 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 pt -153.63 150.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.413 -172.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 8.8 t80 -105.65 155.97 18.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.305 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.39 78.31 22.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.773 -172.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -60.3 -19.37 57.55 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.546 2.164 . . . . 0.0 113.562 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.02 -38.72 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.034 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -86.19 -33.45 20.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.436 174.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.46 52.86 4.03 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.14 145.08 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.411 . . . . 0.0 109.952 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.3 mp -115.15 136.96 50.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.914 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.661 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.4 t -130.91 177.61 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.13 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.661 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.6 t -101.55 138.43 38.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.539 173.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.36 21.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.521 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -134.05 -24.74 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.234 -161.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 p -130.26 -16.74 3.5 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.939 161.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -11.01 59.78 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.457 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.57 137.76 56.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.991 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.1 t -60.69 167.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.293 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 HG13 HD13 ' A' ' 16' ' ' LEU . 10.8 mm -120.0 -74.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.627 174.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -128.8 -165.49 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.058 -171.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 2.1 tp10 -116.09 -170.78 1.86 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.972 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' C ' HG22 ' A' ' 38' ' ' ILE . 11.0 p30 -65.05 98.73 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.537 -165.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.418 HG22 ' C ' ' A' ' 37' ' ' ASN . 3.9 tp 55.53 94.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.031 167.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 39' ' ' ILE . 1.1 tt -76.26 116.77 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.352 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.48 -76.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.378 170.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.1 mtm -175.76 87.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.342 169.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.88 -161.7 12.25 Favored Glycine 0 CA--C 1.543 1.791 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.99 -156.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 122.329 2.019 . . . . 0.0 113.498 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -118.69 -73.25 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.073 168.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.407 ' CD1' ' HG2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -134.82 -179.64 5.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.384 -178.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 65.23 -76.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.242 -167.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.0 -171.81 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.278 165.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -171.39 97.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.251 165.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.54 132.66 37.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.351 -168.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.631 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.284 176.853 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 ptm . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.049 0.452 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -170.67 -29.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.343 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 71.12 -98.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.4 169.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 166.68 13.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.379 -167.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -117.66 72.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.459 -170.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.56 117.15 28.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.259 173.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.814 ' O ' HD11 ' A' ' 16' ' ' LEU . 17.6 m -116.22 173.13 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.16 -166.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 23.9 t -83.28 118.13 70.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.809 157.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 2.4 Cg_endo -65.92 -10.02 25.34 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.575 2.183 . . . . 0.0 113.777 169.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -96.96 -74.7 0.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.37 -170.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -85.25 -9.89 57.19 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.568 -166.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 59.57 59.3 2.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.182 -160.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.0 p -99.3 167.68 10.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.206 160.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.17 -6.7 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.805 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -109.27 99.11 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.021 -168.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.814 HD11 ' O ' ' A' ' 7' ' ' VAL . 45.8 mt -104.77 175.11 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.388 167.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 28' ' ' ALA . 3.3 pt -161.93 132.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.458 -170.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.534 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.7 t80 -89.58 135.7 33.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.382 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -106.35 92.79 7.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.8 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 4.7 Cg_exo -63.28 -17.42 60.0 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.566 2.178 . . . . 0.0 113.52 -172.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.105 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.25 -21.88 14.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.437 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.11 40.84 6.85 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -168.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -104.69 169.36 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -169.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 38' ' ' ILE . 2.7 mp -137.78 115.73 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.285 163.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.757 HG22 HG22 ' A' ' 33' ' ' VAL . 6.2 t -115.39 172.76 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.096 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.483 ' N ' HG12 ' A' ' 26' ' ' VAL . 20.1 t -78.25 150.91 33.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.006 166.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 17' ' ' ILE . . . -94.03 13.33 23.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.311 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 -79.53 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.559 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.16 -14.81 49.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.545 -159.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.33 -10.21 33.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.287 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' CE2' HG13 ' A' ' 34' ' ' ILE . 70.3 t80 -70.29 119.05 13.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.38 -0.91 . . . . 0.0 110.175 -164.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.757 HG22 HG22 ' A' ' 26' ' ' VAL . 93.0 t -73.03 155.29 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.875 161.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.613 ' CD1' HD13 ' A' ' 16' ' ' LEU . 4.3 mt -108.59 -74.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.61 162.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.425 ' HB2' HD13 ' A' ' 25' ' ' ILE . 4.4 mm-40 -107.71 122.17 46.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.02 -168.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.52 136.53 35.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.093 172.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 67.36 103.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.355 168.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 25' ' ' ILE . 14.9 mt -116.23 47.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.369 168.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.3 mm -113.08 -11.85 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.508 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 70.56 -156.12 0.13 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.451 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 70.9 mtm 65.62 43.18 3.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.264 -169.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.77 90.07 1.51 Allowed Glycine 0 CA--C 1.544 1.862 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.55 -88.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 122.317 2.011 . . . . 0.0 113.493 -168.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.69 -161.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.102 -168.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.4 p90 61.18 16.13 6.95 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.806 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.91 102.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.638 164.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -175.88 160.17 2.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.245 168.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -91.21 77.83 5.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.236 166.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.91 109.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.368 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.514 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.269 -169.276 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 mtt . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.404 HG12 ' HD2' ' A' ' 4' ' ' LYS . 10.7 t -103.25 87.01 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.386 174.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.92 129.52 55.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.383 169.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.554 ' NZ ' ' HB1' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -131.52 -62.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.394 -169.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 69.39 19.02 7.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.349 -168.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.533 ' HG2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -126.3 150.69 48.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.264 168.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 19.6 m -153.17 -172.01 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.242 -166.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.9 t -96.33 113.78 63.1 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.303 165.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 14.7 Cg_exo -61.84 -19.7 66.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.784 2.323 . . . . 0.0 113.781 167.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -83.76 -67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.642 -171.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -94.68 -11.35 29.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.64 -168.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 59.51 57.38 3.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.491 0.663 . . . . 0.0 110.256 -162.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -120.63 156.97 30.57 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.298 161.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB1' ' NZ ' ' A' ' 4' ' ' LYS . . . -109.7 -0.44 18.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.698 -173.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -91.47 111.22 22.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.091 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 HG13 ' A' ' 34' ' ' ILE . 26.7 mt -120.12 173.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.464 174.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 16' ' ' LEU . 10.3 pt -151.71 127.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.416 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.557 ' OH ' HD13 ' A' ' 38' ' ' ILE . 10.0 t80 -98.11 137.15 37.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.361 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.53 89.01 6.85 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.742 -173.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 7.3 Cg_exo -60.88 -14.59 33.31 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.553 2.168 . . . . 0.0 113.527 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -85.68 -34.97 21.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.053 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.3 mtt85 -101.0 -24.11 14.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.393 172.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.28 47.75 8.81 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -122.58 125.77 46.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.005 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.709 ' H ' HD12 ' A' ' 25' ' ' ILE . 1.9 mp -90.71 138.83 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.396 168.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 27' ' ' CYS . 6.0 t -132.67 177.26 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.981 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.591 ' H ' HG12 ' A' ' 26' ' ' VAL . 21.4 t -96.11 139.13 32.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.011 169.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.21 23.65 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.447 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -120.07 -66.53 1.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.531 171.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.28 -15.19 20.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.697 -168.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.5 -11.32 59.69 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.59 131.76 47.17 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.212 -0.994 . . . . 0.0 109.985 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 34' ' ' ILE . 94.7 t -61.27 167.93 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.083 164.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.607 HG13 HD13 ' A' ' 16' ' ' LEU . 31.4 mm -116.71 -76.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.839 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -138.95 -171.42 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.936 164.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -144.09 89.74 2.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.134 167.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -173.54 93.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.392 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.65 ' C ' HD13 ' A' ' 39' ' ' ILE . 19.7 pt -105.29 123.99 59.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.189 166.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.65 HD13 ' C ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER 52.73 20.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.405 -169.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -117.11 -163.87 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.423 -168.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.76 -77.75 0.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.503 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 162.08 -151.14 21.06 Favored Glycine 0 CA--C 1.543 1.816 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.79 169.67 4.29 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.542 2.161 . . . . 0.0 113.514 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -99.02 173.94 6.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.965 168.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.6 m95 66.71 154.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.42 -169.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mmt-85 61.52 79.47 0.25 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.429 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.65 161.02 3.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.289 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.52 -13.31 12.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.321 -170.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.19 79.34 3.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.368 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.24 169.791 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttm . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.87 106.89 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.358 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -156.66 129.68 7.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.338 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.488 ' HD2' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 58.3 -172.4 0.1 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.603 175.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.34 136.94 25.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.471 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.25 74.79 0.35 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.52 167.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' CG2' ' HD2' ' A' ' 4' ' ' LYS . 19.8 m -140.96 -164.09 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.819 169.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.4 t -105.73 116.23 60.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.42 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -68.39 -14.74 40.82 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.801 2.334 . . . . 0.0 113.856 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.585 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.51 -74.23 0.4 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.534 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -90.97 -9.46 45.96 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.675 -164.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.74 63.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.998 0.904 . . . . 0.0 110.257 -160.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -136.05 145.67 46.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.111 163.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.28 -16.59 19.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.646 -166.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 28' ' ' ALA . 3.7 mt-10 -72.12 129.45 38.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.055 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.677 HD13 HG13 ' A' ' 34' ' ' ILE . 8.1 mt -139.53 171.32 14.42 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.396 173.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.7 pt -157.62 146.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.475 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 11.1 t80 -97.3 151.35 19.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.259 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.485 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 1.4 t0 -133.28 96.81 16.91 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.29 -18.55 63.13 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.311 2.007 . . . . 0.0 113.506 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -47.78 70.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.09 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -104.84 -19.28 13.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.489 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.587 ' HA3' HG22 ' A' ' 38' ' ' ILE . . . 81.78 26.69 49.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -167.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.563 ' HG3' HG13 ' A' ' 33' ' ' VAL . 2.2 tp10 -110.66 122.97 49.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.32 -0.44 . . . . 0.0 109.972 -166.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 25' ' ' ILE . 2.0 mp -89.46 131.4 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.927 164.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.7 t -125.23 172.89 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.091 -171.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HA ' HD23 ' A' ' 16' ' ' LEU . 17.7 t -70.75 147.69 48.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.057 163.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . . . -94.59 14.69 20.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.353 170.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.01 -74.82 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.447 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.1 p -91.92 -15.68 27.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.645 -160.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.75 -11.99 42.02 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.365 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -63.15 125.35 23.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 113.965 -1.118 . . . . 0.0 109.647 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 24' ' ' GLU . 92.0 t -60.76 141.44 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.202 169.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.677 HG13 HD13 ' A' ' 16' ' ' LEU . 25.9 mm -90.17 -75.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.791 164.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.571 ' HB2' HD13 ' A' ' 25' ' ' ILE . 7.0 mt-10 -123.59 -169.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.908 -168.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.81 155.19 39.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.015 166.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.557 ' O ' HG22 ' A' ' 38' ' ' ILE . 0.6 OUTLIER -160.8 -174.42 4.41 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.387 -174.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.587 HG22 ' HA3' ' A' ' 23' ' ' GLY . 1.0 OUTLIER 59.74 172.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.709 -177.327 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.426 HG13 HG23 ' A' ' 38' ' ' ILE . 26.4 mt 66.7 88.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.098 -162.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 70.68 72.96 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.054 -162.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.6 ttt -60.59 -45.89 92.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.407 -165.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.11 -140.83 3.61 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -172.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -54.3 -42.28 68.91 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 C-N-CA 122.567 2.178 . . . . 0.0 113.64 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 58.5 176.38 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.558 -168.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -87.31 88.78 7.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.331 -169.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -173.39 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.407 169.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.26 94.05 6.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.235 169.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -100.98 -49.87 3.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.373 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.04 -44.13 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.338 169.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.589 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.246 -169.875 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttp . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.139 0.495 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 p -171.21 91.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.371 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 63.38 -176.04 0.15 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.351 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.82 79.82 1.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.283 168.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 61.59 -165.56 0.22 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.451 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HB3' ' NZ ' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -169.12 43.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.937 -172.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.3 m -157.67 177.52 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.143 -173.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 34.0 t -80.0 118.92 74.86 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 153.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 6.0 Cg_endo -68.43 -12.69 35.57 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.68 2.253 . . . . 0.0 113.862 169.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.86 -75.32 0.38 Allowed 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.556 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.1 -11.39 41.43 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.65 -166.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.31 51.84 6.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.226 -164.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 m -103.61 148.33 26.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.208 158.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . . . -94.46 -7.31 41.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.753 -169.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.463 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -108.7 144.81 35.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.995 -168.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.833 HD13 HG13 ' A' ' 34' ' ' ILE . 12.7 mt -140.13 171.03 14.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.487 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 28' ' ' ALA . 8.2 pt -159.7 145.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.406 -170.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.8 t80 -97.9 138.99 34.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.398 -167.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.89 95.71 25.52 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.879 176.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 14.3 Cg_exo -59.33 -15.03 27.32 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.14 1.893 . . . . 0.0 113.611 -174.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.74 -35.12 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.042 -168.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -28.19 15.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.417 169.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.39 44.76 5.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -168.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 33' ' ' VAL . 5.6 tp10 -119.31 160.26 22.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -168.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 35' ' ' GLU . 2.3 mp -120.37 133.05 68.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 162.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -129.15 169.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.056 -167.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HA ' HD23 ' A' ' 16' ' ' LEU . 20.1 t -63.64 149.17 47.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.926 163.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HA ' HD11 ' A' ' 17' ' ' ILE . . . -94.34 13.61 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.283 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.78 -74.78 0.59 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.66 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -87.11 -16.07 36.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.594 -164.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 -11.39 55.93 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.516 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -67.3 129.83 41.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.055 -170.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 24' ' ' GLU . 84.5 t -61.52 167.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.268 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.833 HG13 HD13 ' A' ' 16' ' ' LEU . 15.5 mm -121.8 -79.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.604 170.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.67 ' HB3' HD13 ' A' ' 25' ' ' ILE . 29.2 tt0 -105.38 170.86 7.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.971 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -127.68 148.5 50.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.225 -166.235 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.2 p30 61.12 176.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.593 170.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.8 tp -110.25 138.19 39.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.481 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 40' ' ' ASP . 5.3 tp -130.44 -54.57 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.438 -168.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -107.04 -64.05 1.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.368 -167.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.7 tpp -60.86 159.19 11.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.357 -167.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.57 -84.32 0.18 Allowed Glycine 0 CA--C 1.543 1.842 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 170.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -60.96 139.9 87.28 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.532 2.155 . . . . 0.0 113.559 -169.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -101.89 117.98 35.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.952 166.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -113.39 43.64 1.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.337 -165.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -156.99 -172.05 3.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.394 170.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 46' ' ' ARG . . . 62.03 75.2 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.204 -166.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -79.16 -51.34 9.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.399 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.27 150.59 25.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.337 169.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.611 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.295 178.594 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' HG22 ' A' ' 2' ' ' VAL . 15.2 ptp . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 1' ' ' MET . 10.2 m 59.52 34.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.211 172.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.475 ' HB3' ' HE3' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -101.99 -22.0 14.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.285 169.316 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -103.02 173.53 6.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.274 168.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -119.23 -58.73 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.347 -168.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.21 95.2 2.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.257 -169.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.662 ' O ' HD11 ' A' ' 16' ' ' LEU . 21.1 m -152.41 -169.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.192 -163.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 21.8 t -93.48 115.67 65.39 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.063 160.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 16.2 Cg_exo -62.29 -19.71 67.83 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.745 2.297 . . . . 0.0 113.751 167.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.58 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.15 -68.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.625 -171.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.51 -12.02 30.61 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.638 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 54.61 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -162.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.2 p -99.04 -172.04 2.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.048 159.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.78 -8.22 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.742 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -112.81 53.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.825 -163.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.662 HD11 ' O ' ' A' ' 7' ' ' VAL . 20.1 mt -60.72 171.43 1.16 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.562 175.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 16' ' ' LEU . 10.4 pt -160.07 179.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.5 t80 -131.59 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.417 -169.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.473 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 5.8 t0 -143.73 89.8 7.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.725 -171.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.3 -14.72 25.81 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 C-N-CA 122.54 2.16 . . . . 0.0 113.564 -171.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -88.24 -30.8 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.989 -168.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -96.92 -19.86 18.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.443 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 38' ' ' ILE . . . 71.23 54.85 8.41 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -168.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.681 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -136.61 144.39 44.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -167.282 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -111.07 112.93 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.892 164.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 27' ' ' CYS . 5.1 t -112.39 169.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.165 -166.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 26' ' ' VAL . 21.9 t -69.73 154.65 41.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.887 164.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.12 15.9 27.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.302 172.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.3 -66.05 0.91 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.713 -173.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -94.45 -16.58 23.26 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.632 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 -10.53 58.73 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.499 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -66.08 129.96 41.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.475 -0.863 . . . . 0.0 110.166 -167.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.681 HG13 ' HG3' ' A' ' 24' ' ' GLU . 87.5 t -61.12 167.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.301 170.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 33' ' ' VAL . 14.1 mm -118.99 -75.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.739 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -156.19 102.15 2.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.159 -170.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.94 140.01 57.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.947 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -174.26 119.73 0.25 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.287 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.471 HG21 ' HA2' ' A' ' 23' ' ' GLY . 6.2 tt -175.15 48.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.381 170.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.9 mt -102.93 -51.67 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.435 169.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -173.41 151.39 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.387 169.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 32.2 mtp -67.66 92.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.328 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.55 141.3 8.39 Favored Glycine 0 CA--C 1.543 1.822 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -55.82 -28.56 68.0 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 122.519 2.146 . . . . 0.0 113.601 175.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.5 30.59 19.95 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.686 168.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.57 111.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.468 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.07 -64.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.419 168.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.89 17.7 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.456 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.16 -169.9 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.359 167.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t70 70.42 164.39 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.346 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.585 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.288 -169.465 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtm . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.14 178.74 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.385 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -61.07 173.44 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.333 169.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.582 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.38 -77.13 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.465 169.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.68 -74.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.428 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.8 108.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.341 172.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 4' ' ' LYS . 20.8 m -135.76 -177.34 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.129 -166.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 20.3 t -90.09 116.74 67.09 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.004 159.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 15.5 Cg_exo -61.19 -17.17 50.95 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.732 2.288 . . . . 0.0 113.721 167.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.582 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -91.84 -74.21 0.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.424 -168.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 p -86.17 -9.31 56.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.703 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 59.59 61.74 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.774 0.797 . . . . 0.0 110.285 -160.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 65.5 p -103.8 -165.06 1.12 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.294 163.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.45 -7.46 1.31 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.816 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.698 ' O ' HD23 ' A' ' 16' ' ' LEU . 10.3 mm-40 -115.53 133.0 56.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.02 -167.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 15' ' ' GLU . 19.8 mt -137.67 178.32 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.432 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 16' ' ' LEU . 7.1 pt -160.32 139.36 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.413 -170.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.4 t80 -104.55 136.72 43.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.42 -171.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.21 80.07 71.46 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.822 -169.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -59.26 -18.62 45.92 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 122.46 2.107 . . . . 0.0 113.598 -171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.93 -37.4 84.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.008 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.76 -25.95 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.407 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.14 51.64 4.62 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 1.5 tp10 -130.0 129.13 43.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -167.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 35' ' ' GLU . 2.4 mp -103.31 114.59 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.113 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.79 HG22 HG22 ' A' ' 33' ' ' VAL . 5.2 t -118.15 168.79 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.275 -166.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' N ' HG12 ' A' ' 26' ' ' VAL . 24.0 t -78.06 144.76 36.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.856 167.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.46 20.64 9.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.363 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -75.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.391 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -90.18 -14.85 32.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.648 -159.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.84 -9.82 34.5 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.401 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.48 126.18 29.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 114.539 -0.83 . . . . 0.0 110.126 -164.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG22 HG22 ' A' ' 26' ' ' VAL . 86.1 t -75.87 159.26 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.001 163.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 mt -114.88 -76.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.514 164.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 25' ' ' ILE . 38.8 tt0 -110.22 169.0 9.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.017 -165.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.89 146.78 36.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.163 -166.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 43' ' ' PRO . 3.6 p-10 60.63 97.48 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.835 168.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.628 HD11 ' OE1' ' A' ' 35' ' ' GLU . 22.0 mt -147.19 63.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.372 166.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.0 mm -99.41 -79.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.554 -174.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.78 35.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.398 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 55.4 mtt 62.1 85.39 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.419 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' H ' ' HD3' ' A' ' 43' ' ' PRO . . . 88.06 51.95 3.05 Favored Glycine 0 CA--C 1.542 1.766 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HD3' ' H ' ' A' ' 42' ' ' GLY . 2.0 Cg_endo -58.82 -154.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 122.487 2.125 . . . . 0.0 113.499 167.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.79 -174.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.609 -170.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -99.23 42.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.321 -166.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -103.96 18.4 22.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.382 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.74 -165.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.187 -169.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -152.81 -75.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.346 169.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.36 -89.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.409 170.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.56 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.295 169.819 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.055 0.455 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t 62.21 -83.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.394 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p30 60.85 177.2 0.1 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.648 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -130.65 -73.88 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.334 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 62.19 12.23 4.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.445 174.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.36 118.47 24.19 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.523 -177.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.6 m 59.52 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.25 169.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.5 t -119.04 110.28 38.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.469 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.92 -4.59 9.07 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.605 2.203 . . . . 0.0 113.85 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -94.55 -67.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.493 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.9 p -97.56 -11.11 24.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.732 -165.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 59.59 57.7 3.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.305 -165.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.56 160.89 39.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.282 158.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -103.23 -10.97 18.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.791 -166.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.611 ' C ' HD23 ' A' ' 16' ' ' LEU . 14.7 mm-40 -75.71 106.55 7.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.157 -168.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD13 HG13 ' A' ' 34' ' ' ILE . 8.5 mt -129.98 171.65 12.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.356 -175.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 16' ' ' LEU . 8.7 pt -159.99 135.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.343 -169.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 27.7 t80 -98.82 149.7 22.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.331 -169.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 30.1 t70 -127.79 95.83 33.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.727 -167.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.73 -18.39 63.98 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.121 1.881 . . . . 0.0 113.543 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.98 -43.23 68.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.014 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.96 -19.31 13.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.487 -174.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.36 44.86 20.79 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -167.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 26' ' ' VAL . 41.4 tt0 -120.01 124.51 46.09 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -168.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.667 ' H ' HD12 ' A' ' 25' ' ' ILE . 1.9 mp -93.9 128.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.86 167.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 27' ' ' CYS . 6.0 t -128.88 178.86 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.162 -169.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.752 ' H ' HG12 ' A' ' 26' ' ' VAL . 33.8 t -108.67 135.34 50.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.574 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.75 25.68 4.48 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.401 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.69 -36.54 0.56 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -165.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -123.07 -15.65 7.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.845 166.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.73 63.66 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.497 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.59 139.89 56.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.417 -0.891 . . . . 0.0 110.116 -168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 34' ' ' ILE . 92.4 t -61.03 168.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 167.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 16' ' ' LEU . 16.5 mm -121.2 -75.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.462 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.79 -171.18 3.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.949 168.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.19 126.46 3.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.122 169.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' C ' HD12 ' A' ' 38' ' ' ILE . 1.6 m-80 -137.7 44.41 2.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.44 -171.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.477 HD12 ' C ' ' A' ' 37' ' ' ASN . 5.3 mp -143.08 104.9 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.227 168.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.409 HG22 ' C ' ' A' ' 38' ' ' ILE . 8.1 tp 55.83 83.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.011 -177.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -126.67 -24.73 3.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.294 -166.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 7.6 mtp -60.93 -87.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.427 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.38 137.48 12.2 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -169.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.44 -154.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.403 2.069 . . . . 0.0 113.499 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.09 43.11 3.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.063 -170.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.59 -48.95 58.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.399 169.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.49 87.03 7.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.495 170.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.96 -82.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.297 -169.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -80.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.331 -167.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -136.68 94.34 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.419 -169.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.54 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.287 -170.124 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.964 ' HG3' HG13 ' A' ' 2' ' ' VAL . 4.1 ptt? . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.964 HG13 ' HG3' ' A' ' 1' ' ' MET . 6.2 m 59.63 33.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.101 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 60.23 97.66 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.851 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.36 166.03 30.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.368 168.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.98 134.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.473 -170.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.63 94.98 2.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.389 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -154.78 -164.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.305 -168.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.5 t -111.79 111.53 54.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.415 171.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.94 -10.87 30.22 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 113.758 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.33 -73.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.456 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.45 -11.53 34.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.633 -164.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 59.48 57.81 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.254 -162.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.482 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 45.6 m -124.24 162.9 22.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.289 161.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.2 -7.84 15.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.779 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.85 ' O ' HD23 ' A' ' 16' ' ' LEU . 27.2 mt-10 -90.62 119.61 31.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.066 -167.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 15' ' ' GLU . 10.6 mt -138.04 159.63 41.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.368 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 28' ' ' ALA . 7.0 pt -150.99 146.58 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.433 -169.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 25' ' ' ILE . 3.5 t80 -98.55 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.42 -168.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.1 90.14 9.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.882 172.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.42 -19.5 51.65 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 122.472 2.114 . . . . 0.0 113.497 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.82 -50.49 72.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.103 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -29.83 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.401 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.55 27.65 14.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -167.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -92.06 165.31 13.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.341 -0.43 . . . . 0.0 110.0 -168.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 35' ' ' GLU . 1.9 mp -137.4 114.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.776 166.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.3 t -111.49 177.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.116 -167.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.686 ' H ' HG12 ' A' ' 26' ' ' VAL . 23.0 t -98.82 135.97 39.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.841 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -95.56 22.94 6.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.221 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HA ' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -142.76 -25.08 0.63 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.197 -160.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -133.57 -17.33 2.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.846 163.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.59 58.35 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.476 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.86 138.75 50.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.156 -168.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.558 HG12 ' N ' ' A' ' 34' ' ' ILE . 64.9 t -61.17 168.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.277 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.663 HG13 HD13 ' A' ' 16' ' ' LEU . 16.8 mm -124.61 -74.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.243 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 25' ' ' ILE . 40.2 tt0 -143.64 168.26 20.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 166.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HB3' ' OE2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -149.12 -169.77 3.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.094 -166.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 t30 70.84 80.76 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.465 172.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.5 mt -149.7 65.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.334 167.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.3 pt -99.52 79.34 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.433 -176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.77 70.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.423 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttp 61.71 109.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.384 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.91 92.76 0.09 OUTLIER Glycine 0 CA--C 1.543 1.834 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -57.77 -66.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 122.577 2.185 . . . . 0.0 113.504 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 58.58 20.75 7.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.559 -166.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.54 -37.75 1.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.371 -167.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -107.0 -167.85 1.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.439 -168.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.79 28.66 8.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.324 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 71.16 -74.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.336 -170.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -155.37 -178.58 7.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.351 170.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.516 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.234 169.825 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 mtt . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.107 0.48 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.3 m -111.22 127.76 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.314 -171.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -149.48 -78.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.414 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -129.11 -39.11 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.39 -168.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' HG2' ' H ' ' A' ' 6' ' ' LYS . 21.2 tt0 70.06 172.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.348 -169.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.698 ' HD3' HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER 61.64 98.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.344 -168.088 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.45 -176.66 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.329 -166.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.5 t -110.68 113.25 55.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.507 172.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -65.49 -16.92 56.11 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.749 2.299 . . . . 0.0 113.76 169.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -78.55 -72.16 0.39 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.564 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -91.07 -9.15 46.81 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.981 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.82 50.23 12.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.834 -167.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -97.03 -167.05 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.395 164.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.31 -10.12 3.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.844 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.68 116.42 25.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.056 -168.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.926 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -136.69 166.55 23.3 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.364 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.5 pt -151.28 133.16 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.476 -171.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 49.2 t80 -80.34 163.01 24.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.322 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.498 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -146.41 100.2 4.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 -167.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -62.28 -18.38 62.19 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.58 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.52 -47.09 77.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.008 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -109.29 -20.17 13.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.415 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.7 52.68 6.33 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -166.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.494 ' OE2' HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -139.57 144.5 37.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -166.156 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.469 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.4 mp -106.26 134.89 46.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.05 169.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.682 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.8 t -132.12 178.38 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.079 -167.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.682 ' H ' HG12 ' A' ' 26' ' ' VAL . 27.0 t -99.23 139.05 35.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.74 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.66 26.91 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.386 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 -34.66 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 -162.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -126.38 -16.71 5.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.9 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.57 -10.75 70.73 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.666 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -63.06 139.08 58.74 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.599 -0.801 . . . . 0.0 110.025 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.2 t -61.09 167.24 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.265 170.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.926 HG13 HD13 ' A' ' 16' ' ' LEU . 15.8 mm -121.67 -76.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.567 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 36' ' ' GLU . 2.0 tt0 -125.2 151.41 45.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.055 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 9.6 mt-10 -111.99 165.75 11.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.953 -167.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 t30 69.64 121.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.258 167.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 39' ' ' ILE . 5.2 tt -64.77 111.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.133 166.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 38' ' ' ILE . 4.0 tp 58.19 166.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.007 -172.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' H ' HG13 ' A' ' 39' ' ' ILE . 28.7 t70 -129.79 128.88 43.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.383 -171.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 tpt -176.3 -73.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.246 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' H ' ' HD3' ' A' ' 43' ' ' PRO . . . 127.57 68.15 0.15 Allowed Glycine 0 CA--C 1.544 1.875 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.487 ' HD3' ' H ' ' A' ' 42' ' ' GLY . 3.0 Cg_exo -60.76 116.32 3.27 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.688 2.259 . . . . 0.0 113.448 -172.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER 58.89 -82.0 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.662 172.177 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.413 ' H ' ' HB2' ' A' ' 44' ' ' GLU . 8.1 p-90 -154.18 144.71 22.31 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.521 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' HA ' ' NH1' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -75.38 159.22 31.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.342 169.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.63 134.5 37.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.325 -169.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.63 -80.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.38 169.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.07 144.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.35 169.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.58 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.292 169.522 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 121.142 0.496 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.1 m -122.53 144.71 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.329 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.5 m120 64.27 23.86 13.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.34 170.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -125.2 -169.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.408 170.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -80.04 -86.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.406 -167.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.591 ' HB3' HD12 ' A' ' 16' ' ' LEU . 4.1 tmtp? -178.75 127.87 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.197 -169.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m -92.87 172.35 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.233 -162.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 28.7 t -113.64 115.26 46.73 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.004 175.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.67 -20.35 70.68 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.608 2.205 . . . . 0.0 113.717 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -76.36 -70.54 0.44 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.49 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -95.16 -9.7 32.7 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.022 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 7.3 pt-20 56.34 48.52 16.92 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.415 -0.803 . . . . 0.0 111.004 -168.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -85.46 -168.4 2.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.414 166.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.61 -13.07 5.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.741 167.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.534 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.3 mp0 -91.49 109.56 20.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.12 -169.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.738 HD13 HG13 ' A' ' 34' ' ' ILE . 15.8 mt -127.9 -177.95 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.387 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 16' ' ' LEU . 3.7 pt -160.4 145.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.414 -169.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.58 ' OH ' HD13 ' A' ' 38' ' ' ILE . 5.9 t80 -108.81 119.15 38.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.416 -169.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.98 83.84 0.52 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.795 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 6.2 Cg_endo -59.93 -19.68 56.31 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.434 2.09 . . . . 0.0 113.596 -172.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.09 -51.99 61.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.999 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -79.12 -30.36 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.407 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.592 ' HA2' HD11 ' A' ' 38' ' ' ILE . . . 85.31 40.87 7.68 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -168.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -118.07 159.64 22.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -129.47 133.13 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.037 163.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.8 t -131.93 178.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.114 -167.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.724 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.9 t -106.15 125.41 50.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.536 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.25 -2.44 31.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.868 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -77.59 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 171.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.5 p -83.2 -17.54 42.46 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.6 -162.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.83 60.52 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.43 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -68.93 139.93 55.09 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.547 -0.826 . . . . 0.0 110.265 -168.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 34' ' ' ILE . 95.7 t -62.17 167.68 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.038 165.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.738 HG13 HD13 ' A' ' 16' ' ' LEU . 16.9 mm -117.82 -74.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.725 171.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 36' ' ' GLU . 48.1 tp10 -142.2 168.14 20.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 166.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' N ' ' HG3' ' A' ' 35' ' ' GLU . 20.6 pm0 -154.22 -174.47 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.092 -168.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 t30 65.73 55.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.404 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.592 HD11 ' HA2' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -91.28 156.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.419 170.328 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 38' ' ' ILE . 17.5 mm 66.19 115.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.409 -170.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.63 148.57 2.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.358 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 35.6 mtm -128.43 128.97 45.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.408 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' N ' ' HD3' ' A' ' 43' ' ' PRO . . . 63.72 50.45 61.38 Favored Glycine 0 CA--C 1.542 1.726 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 171.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER -56.9 76.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 122.391 2.06 . . . . 0.0 113.511 172.452 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -170.92 134.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.032 169.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 20.1 m95 61.3 86.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.266 -167.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -108.56 -80.73 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.366 -166.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.44 -161.42 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.122 -165.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 73.09 -71.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.407 -168.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.4 -171.58 3.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.446 173.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.602 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.368 -176.951 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtp . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 121.153 0.501 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.59 110.92 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.349 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 68.89 -152.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.399 175.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 mttt 65.2 175.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.299 -171.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -79.64 0.09 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.147 -163.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.547 ' CD ' HG21 ' A' ' 34' ' ' ILE . 0.1 OUTLIER 55.02 179.75 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.555 -168.078 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 16.9 m -135.78 -174.12 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.538 -166.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.7 t -111.57 112.61 53.92 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.175 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.25 -16.85 57.06 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.686 2.257 . . . . 0.0 113.735 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.52 -73.56 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.393 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.9 -11.01 40.44 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.645 -166.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 59.37 56.06 3.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.248 -163.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 52.6 p -109.57 -166.21 1.08 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.367 160.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -142.36 -16.96 0.73 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.662 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.787 ' O ' HD23 ' A' ' 16' ' ' LEU . 1.9 mm-40 -81.39 122.59 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.05 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.933 HD13 HG13 ' A' ' 34' ' ' ILE . 13.5 mt -137.28 160.43 39.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.466 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.37 132.01 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.369 -168.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CD1' HG13 ' A' ' 25' ' ' ILE . 7.4 t80 -88.47 132.7 34.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.379 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 80.76 1.11 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.653 168.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 5.6 Cg_endo -59.16 -20.23 53.48 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 122.558 2.172 . . . . 0.0 113.512 -168.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.03 -53.22 57.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.178 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -86.9 -19.13 29.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.738 ' HA3' HG22 ' A' ' 38' ' ' ILE . . . 77.26 30.55 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -168.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -89.46 162.31 15.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.929 -0.635 . . . . 0.0 109.993 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.535 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.1 mp -142.0 115.79 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.202 167.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -106.51 177.93 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.232 -170.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.713 ' H ' HG12 ' A' ' 26' ' ' VAL . 31.4 t -101.07 125.05 47.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.641 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.53 -4.61 43.64 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.882 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -92.97 -78.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.313 170.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -86.12 -16.6 37.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.612 -161.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 -10.38 54.56 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.455 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -72.61 133.97 44.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.592 -0.804 . . . . 0.0 110.172 -168.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 34' ' ' ILE . 88.3 t -61.27 167.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.133 165.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.933 HG13 HD13 ' A' ' 16' ' ' LEU . 33.4 mm -119.18 -76.53 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.644 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.87 -177.5 4.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.079 168.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 2.3 pt-20 -146.47 -171.71 3.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.946 -168.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t30 70.92 112.97 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.42 168.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.738 HG22 ' HA3' ' A' ' 23' ' ' GLY . 1.6 tt -151.06 164.55 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.26 167.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 38' ' ' ILE . 2.8 tt 59.74 171.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.826 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.17 -99.0 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.318 -166.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -144.48 -161.67 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.435 -164.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.19 -67.57 0.68 Allowed Glycine 0 CA--C 1.544 1.85 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -52.46 102.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.529 2.153 . . . . 0.0 113.598 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -98.28 -25.65 14.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.05 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.596 ' NE1' ' HB3' ' A' ' 47' ' ' ALA . 18.8 p90 60.54 177.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.67 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -66.45 -34.35 77.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.394 -162.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' NE1' ' A' ' 45' ' ' TRP . . . -64.92 -164.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.302 -166.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 71.71 -76.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.3 -168.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -132.82 149.39 52.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.347 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.621 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.245 169.616 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttm . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.119 0.485 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 p -74.61 135.89 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.342 171.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -61.11 100.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.396 -169.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -121.05 83.37 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.34 173.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 61.84 84.53 0.13 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.368 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 157.95 40.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.284 166.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 m -104.59 -176.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.247 -164.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.5 t -107.72 113.52 61.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.279 170.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.68 -13.72 41.03 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 122.71 2.273 . . . . 0.0 113.721 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.605 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.95 -74.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.456 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -91.21 -11.02 39.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.691 -166.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 59.31 54.81 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.223 -163.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.5 p -88.85 176.55 7.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.038 162.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.33 -8.04 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.763 164.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.64 ' O ' HD23 ' A' ' 16' ' ' LEU . 19.0 mt-10 -99.04 116.18 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.988 -167.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.65 HD13 HG13 ' A' ' 34' ' ' ILE . 16.0 mt -132.62 166.59 21.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.379 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 28' ' ' ALA . 10.2 pt -155.15 148.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.399 -167.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.476 ' CD1' HG13 ' A' ' 25' ' ' ILE . 12.9 t80 -107.73 123.17 48.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.312 -170.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.96 98.0 7.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 -171.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.1 Cg_endo -59.09 -14.18 22.41 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.306 2.004 . . . . 0.0 113.505 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.55 -30.7 21.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.085 -169.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.31 -19.33 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.459 174.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.18 51.2 10.42 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -168.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 26' ' ' VAL . 31.9 tt0 -137.08 125.94 24.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.432 . . . . 0.0 109.9 -167.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.664 ' H ' HD12 ' A' ' 25' ' ' ILE . 2.4 mp -88.83 128.11 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.128 169.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -130.76 177.12 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.968 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.591 ' H ' HG12 ' A' ' 26' ' ' VAL . 19.7 t -93.33 124.01 37.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.916 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.73 7.31 4.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.753 176.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -112.95 -67.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.455 178.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.6 p -91.75 -19.14 22.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.512 -169.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.13 57.81 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.551 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -68.76 126.82 30.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.404 -0.898 . . . . 0.0 110.229 -170.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 34' ' ' ILE . 65.3 t -61.55 169.36 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.426 175.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.65 HG13 HD13 ' A' ' 16' ' ' LEU . 20.0 mm -124.75 -73.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.185 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 25' ' ' ILE . 5.0 tp10 -136.27 153.59 51.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.958 166.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 24' ' ' GLU . 1.4 tt0 -133.16 -179.23 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.965 -165.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 71.5 87.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.428 167.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 27.7 mt -150.75 141.34 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.309 166.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.478 ' O ' HD12 ' A' ' 39' ' ' ILE . 1.7 pp -153.55 22.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.38 169.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 68.98 -157.41 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.446 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 7.3 ttp -106.28 153.88 21.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.292 -169.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.07 -98.86 0.22 Allowed Glycine 0 CA--C 1.542 1.778 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 172.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.52 96.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.413 2.076 . . . . 0.0 113.6 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -170.04 40.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.056 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 61.55 101.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.393 -173.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -56.88 10.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.369 -167.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.98 139.23 48.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.272 -167.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.12 -51.99 3.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.334 168.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t0 66.62 -81.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.644 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.285 -169.607 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' HG12 ' A' ' 2' ' ' VAL . 7.5 ptt? . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 3' ' ' ASN . 4.0 p 60.88 174.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.586 172.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.675 ' H ' HG22 ' A' ' 2' ' ' VAL . 82.2 m-20 72.06 -68.09 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.458 -168.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -61.17 82.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.411 169.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.0 -54.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.224 175.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.49 ' O ' HG22 ' A' ' 7' ' ' VAL . 3.4 ttpp 64.1 -172.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.461 163.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 6' ' ' LYS . 9.7 m 59.55 -167.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.248 169.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.4 t -113.84 111.04 48.64 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.537 175.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -67.77 -10.57 29.21 Favored 'Trans proline' 0 N--CA 1.482 0.846 0 C-N-CA 122.751 2.301 . . . . 0.0 113.881 169.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.72 -71.81 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.549 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -93.98 -11.33 31.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.635 -165.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 59.48 58.11 3.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.228 -161.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -110.8 -171.35 1.81 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.231 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.76 -16.44 1.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.717 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.852 ' O ' HD23 ' A' ' 16' ' ' LEU . 5.0 mm-40 -74.85 120.47 20.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.026 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.929 HD13 HG13 ' A' ' 34' ' ' ILE . 7.9 mt -135.77 165.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.411 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 28' ' ' ALA . 8.9 pt -150.02 140.37 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.394 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.525 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.0 t80 -101.66 149.48 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.236 -168.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 7.1 t70 -129.3 94.79 32.24 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.736 -167.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -59.89 -20.26 58.86 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.272 1.981 . . . . 0.0 113.571 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.92 -39.04 87.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.112 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -22.62 11.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.52 30.29 30.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.41 164.65 12.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -170.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.999 HD11 HD11 ' A' ' 38' ' ' ILE . 2.6 mp -126.76 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.999 163.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -132.82 178.5 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.155 -167.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.702 ' H ' HG12 ' A' ' 26' ' ' VAL . 22.0 t -101.87 136.85 41.0 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.858 175.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -95.89 29.57 2.67 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.33 176.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.74 -35.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.613 -165.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.3 p -125.57 -16.49 5.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.823 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.43 -11.11 69.02 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.576 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.04 137.67 58.33 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.639 -0.78 . . . . 0.0 109.976 -173.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.6 t -60.89 167.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.26 168.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.929 HG13 HD13 ' A' ' 16' ' ' LEU . 20.6 mm -120.78 -69.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.426 173.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.52 140.23 49.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.066 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.92 -161.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.171 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -61.53 141.61 57.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.418 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.999 HD11 HD11 ' A' ' 25' ' ' ILE . 26.7 mt -107.09 120.83 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.367 -167.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.554 HG13 HG22 ' A' ' 38' ' ' ILE . 11.3 mt 61.26 86.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.414 169.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -149.51 -97.49 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.325 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 76.4 mtp 65.23 -79.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.363 -169.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.76 142.68 4.26 Favored Glycine 0 CA--C 1.543 1.793 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 171.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 13.6 Cg_exo -57.58 -32.78 95.29 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.427 2.085 . . . . 0.0 113.613 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 2.7 mt-10 58.87 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.764 175.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 8.4 m95 68.33 -90.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.286 -165.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.3 -80.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.402 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -168.9 -162.76 0.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.188 168.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -86.2 111.17 20.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.311 168.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -110.85 -81.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.379 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.551 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.203 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttt . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.122 0.487 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 m -61.52 145.03 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.299 -173.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 70.18 -59.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.374 -169.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.34 99.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.368 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.85 150.04 34.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.457 -170.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -143.69 46.82 1.47 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.9 171.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.9 m -145.79 -165.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.31 -172.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.912 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 28' ' ' ALA . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.604 ' CZ ' HG23 ' A' ' 38' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 35' ' ' GLU . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.718 ' H ' HG12 ' A' ' 26' ' ' VAL . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 34' ' ' ILE . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.912 HG13 HD13 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 25' ' ' ILE . 7.8 tp10 -160.33 170.19 21.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' N ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 tt0 -138.13 91.85 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.099 -166.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -173.94 105.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.399 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.604 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -121.04 168.42 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.204 164.097 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -82.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.811 -168.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -68.81 77.45 0.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.298 -166.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -152.24 -172.87 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.397 169.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.22 -74.13 0.2 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.2 114.08 1.71 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.501 2.134 . . . . 0.0 113.576 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.86 -160.25 1.03 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.048 -168.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -31.7 51.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.368 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -13.68 18.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.394 -170.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.5 106.31 5.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.321 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -112.0 -29.87 7.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.335 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.63 -162.14 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.414 169.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.542 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.267 -169.588 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttt . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.122 0.487 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 m -61.52 145.03 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.299 -173.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 70.18 -59.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.374 -169.027 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.34 99.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.368 -178.639 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.85 150.04 34.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.457 -170.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -143.69 46.82 1.47 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.9 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.9 m -145.79 -165.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.31 -172.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.912 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 28' ' ' ALA . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.604 ' CZ ' HG23 ' A' ' 38' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 35' ' ' GLU . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.718 ' H ' HG12 ' A' ' 26' ' ' VAL . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 34' ' ' ILE . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.912 HG13 HD13 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 25' ' ' ILE . 7.8 tp10 -160.33 170.19 21.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' N ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 tt0 -138.13 91.85 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.099 -166.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -173.94 105.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.399 -171.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.604 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -121.04 168.42 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.204 164.097 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -82.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.811 -168.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -68.81 77.45 0.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.298 -166.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -152.24 -172.87 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.397 169.2 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.22 -74.13 0.2 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -174.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.2 114.08 1.71 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.501 2.134 . . . . 0.0 113.576 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.86 -160.25 1.03 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.048 -168.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -31.7 51.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.368 -169.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -13.68 18.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.394 -170.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.5 106.31 5.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.321 -177.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -112.0 -29.87 7.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.335 169.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.63 -162.14 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.414 169.058 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.542 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.267 -169.588 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.632 HG12 ' HG3' ' A' ' 4' ' ' LYS . 20.6 t 66.55 -85.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.459 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 62.28 99.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.441 -170.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.632 ' HG3' HG12 ' A' ' 2' ' ' VAL . 1.8 mtmm -154.35 32.96 0.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.267 -168.314 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -95.64 33.62 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.541 173.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -82.84 106.41 14.65 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.282 -169.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 27.3 m -59.84 -161.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.293 166.119 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.9 t -95.63 111.22 54.9 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.338 161.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 5.2 Cg_endo -69.99 -8.08 22.72 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.6 2.2 . . . . 0.0 113.968 169.421 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.32 -73.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.514 175.588 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -92.68 -11.45 34.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.663 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.53 57.15 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.209 -162.645 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -114.02 172.94 6.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.209 160.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.15 -9.32 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.715 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 65.8 mm-40 -96.83 52.64 1.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.977 -162.201 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.9 HD13 HG13 ' A' ' 34' ' ' ILE . 17.4 mt -69.71 175.97 3.89 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.449 -177.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 16' ' ' LEU . 9.5 pt -157.49 153.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.462 -168.295 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.3 t80 -106.8 132.36 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.434 -169.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.3 92.08 6.44 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.703 175.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 13.5 Cg_exo -59.07 -13.16 17.98 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.388 2.059 . . . . 0.0 113.602 -168.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -47.68 14.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.016 -170.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -90.05 -24.0 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.419 170.302 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 16.61 50.06 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -177.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -79.59 164.2 24.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.027 -171.313 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -130.84 113.0 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.938 165.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.719 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -114.04 177.61 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.147 -169.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.719 ' H ' HG12 ' A' ' 26' ' ' VAL . 15.4 t -90.5 126.17 35.83 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.076 178.03 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -76.48 7.05 4.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.774 175.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.23 -67.66 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.514 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.8 p -93.03 -20.13 20.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.48 -167.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.98 60.23 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.639 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -69.52 131.94 45.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.659 -0.771 . . . . 0.0 110.333 -172.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 34' ' ' ILE . 61.3 t -61.79 170.98 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.368 175.012 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.9 HG13 HD13 ' A' ' 16' ' ' LEU . 14.0 mm -128.07 -73.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.013 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.07 174.35 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.022 167.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -130.32 107.89 9.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.113 -167.06 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 p30 61.43 176.24 0.11 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.498 171.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 79.2 mt -145.9 92.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.397 -170.57 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm 66.2 142.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.393 -168.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.55 -17.52 3.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.443 -167.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.3 ttm -95.3 38.72 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.371 -167.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.6 98.25 0.03 OUTLIER Glycine 0 CA--C 1.543 1.837 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 168.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.03 161.27 13.61 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.557 2.172 . . . . 0.0 113.494 170.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.59 106.03 2.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.992 167.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -100.4 98.42 9.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.422 -167.151 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.99 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.436 167.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -169.87 -162.0 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.28 -165.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 72.62 -60.68 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.475 171.537 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 t0 70.13 79.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.382 -170.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.582 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.243 169.528 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmm? . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.075 0.464 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 p -120.59 81.09 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.327 -170.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.1 m120 64.37 -84.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.364 168.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.3 16.16 9.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.703 -178.554 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 60.73 105.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.51 166.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.25 177.36 4.71 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.339 -171.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.459 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.4 m -97.58 -160.57 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.19 -175.142 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.0 t -102.61 111.12 64.45 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.369 164.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 7.2 Cg_exo -68.45 -10.77 29.99 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.741 2.294 . . . . 0.0 113.751 169.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -81.14 -73.67 0.36 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.482 177.188 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -93.67 -11.86 30.64 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.596 -163.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 59.25 2.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.579 0.704 . . . . 0.0 110.193 -161.374 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 54.9 m -123.61 148.31 46.53 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.26 161.171 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.31 27.93 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.602 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.502 ' O ' HD23 ' A' ' 16' ' ' LEU . 15.3 mm-40 -75.89 118.05 18.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.158 -172.184 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.582 HD13 HG13 ' A' ' 34' ' ' ILE . 15.7 mt -141.95 158.04 44.24 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.315 178.038 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 pt -150.85 158.57 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.415 -167.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.768 ' OH ' HD13 ' A' ' 38' ' ' ILE . 2.8 t80 -108.68 121.79 45.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.375 -169.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.21 99.75 3.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.748 178.265 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -59.61 -15.53 31.55 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.362 2.041 . . . . 0.0 113.469 179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -78.21 -30.86 49.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.039 -169.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -111.98 -20.22 12.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.398 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 44.79 7.56 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' OE1' ' HB3' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -112.46 168.11 9.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.173 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.75 128.77 68.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.677 162.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 27' ' ' CYS . 3.7 t -130.88 176.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.93 -168.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' H ' HG12 ' A' ' 26' ' ' VAL . 17.8 t -94.54 136.78 34.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.01 176.118 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 20.91 8.1 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.237 178.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' CE ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -143.41 -23.79 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.357 -158.361 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.3 p -135.99 -18.06 1.6 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.838 164.726 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.15 -11.44 57.14 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.455 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -67.97 137.16 54.92 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.312 -0.944 . . . . 0.0 110.09 -170.24 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 34' ' ' ILE . 96.3 t -61.59 167.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.221 175.065 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.582 HG13 HD13 ' A' ' 16' ' ' LEU . 19.4 mm -124.21 -78.27 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.416 172.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.22 -164.05 1.28 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.978 174.019 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HB3' ' OE1' ' A' ' 24' ' ' GLU . 4.5 pt-20 -165.68 -170.83 1.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.14 171.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.687 ' C ' HD12 ' A' ' 38' ' ' ILE . 3.3 m120 70.84 103.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.428 169.006 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.768 HD13 ' OH ' ' A' ' 18' ' ' TYR . 3.6 mp -128.23 165.06 28.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.406 176.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.43 ' N ' HG22 ' A' ' 38' ' ' ILE . 1.1 pt -66.16 115.33 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.391 -168.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.1 -97.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.392 167.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.6 ttm 61.53 18.37 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.566 173.328 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.19 -157.81 31.6 Favored Glycine 0 CA--C 1.544 1.847 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 170.107 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.88 171.4 1.07 Allowed 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.509 2.14 . . . . 0.0 113.597 169.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.88 93.31 0.18 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.084 168.049 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -136.57 117.41 14.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.336 169.007 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -171.08 -74.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.331 170.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.72 104.36 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.277 -170.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -123.7 110.87 15.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.393 170.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.45 -41.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.408 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.617 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.234 169.599 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttm . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.152 0.501 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 m -145.31 108.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.369 172.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -156.5 58.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.368 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.97 149.83 35.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.344 169.006 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -99.15 33.05 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.365 -167.164 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -169.26 79.45 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.297 166.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m -146.87 -174.15 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.29 -175.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.2 t -102.47 111.44 64.62 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.499 168.165 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.25 -11.76 33.41 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.706 2.271 . . . . 0.0 113.778 169.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.17 -69.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.619 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.2 p -96.53 -11.45 25.44 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.654 -166.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.62 58.32 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.242 -162.255 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -114.42 173.78 6.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.283 160.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.86 6.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.611 -169.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.22 126.97 35.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.043 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.973 HD13 HG13 ' A' ' 34' ' ' ILE . 17.6 mt -135.52 161.54 35.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.446 174.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 pt -135.64 140.29 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.367 -167.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.422 ' HE2' HD13 ' A' ' 38' ' ' ILE . 4.5 t80 -104.29 135.85 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.256 -169.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.65 92.23 49.15 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.794 -168.14 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -59.47 -20.12 55.15 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.44 2.093 . . . . 0.0 113.61 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 -46.99 61.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.076 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -91.76 -21.79 20.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.406 -178.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 41.79 60.62 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -167.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG13 ' A' ' 33' ' ' VAL . 17.6 tt0 -128.3 141.34 51.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.404 . . . . 0.0 109.968 -166.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.72 HD11 HD11 ' A' ' 38' ' ' ILE . 2.5 mp -108.04 137.67 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.091 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.6 t -134.06 176.95 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.908 -168.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.635 ' H ' HG12 ' A' ' 26' ' ' VAL . 18.1 t -92.6 131.09 38.01 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.841 174.138 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.15 43.24 1.14 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.379 170.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -53.05 0.16 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.464 -178.045 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.8 p -111.03 -18.23 13.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.717 -178.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.99 -10.61 68.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.671 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.17 132.59 53.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.999 -175.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 34' ' ' ILE . 88.8 t -61.06 167.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.279 170.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.973 HG13 HD13 ' A' ' 16' ' ' LEU . 21.1 mm -120.24 -77.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.698 173.315 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.687 ' HG3' HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -136.33 169.15 18.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.055 172.952 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.58 148.09 35.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.068 -168.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 60.7 94.54 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.764 176.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.72 HD11 HD11 ' A' ' 25' ' ' ILE . 3.0 mp -92.18 114.3 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.477 170.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -171.53 -35.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.473 171.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 p30 61.25 179.29 0.11 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.584 172.286 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 61.44 -85.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.434 -169.519 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.17 153.18 25.02 Favored Glycine 0 CA--C 1.541 1.701 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 175.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.81 -156.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 122.354 2.036 . . . . 0.0 113.627 177.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -91.93 137.07 32.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.1 179.394 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -60.89 -75.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.393 168.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 65.57 -80.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.493 170.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -176.06 123.36 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.229 168.377 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.31 107.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.3 167.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -148.02 -72.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.343 168.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.559 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.241 -170.973 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 mtt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.179 0.514 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.81 -44.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.377 -172.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -86.53 -179.37 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.322 167.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.11 139.17 13.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.298 -167.16 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 70.39 145.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.383 164.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 144.7 55.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.109 164.135 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 23.3 m -124.53 -176.03 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.333 -163.025 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 22.9 t -103.01 111.73 65.27 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.105 168.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 8.0 Cg_exo -66.8 -4.26 10.89 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.678 2.252 . . . . 0.0 113.776 170.331 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.599 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -93.45 -68.53 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.557 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.87 -11.29 29.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.555 -167.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 59.44 57.35 3.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.185 -162.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -101.82 -165.81 1.23 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.279 160.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.08 -16.91 1.23 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.681 175.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.843 ' O ' HD23 ' A' ' 16' ' ' LEU . 4.3 mm-40 -86.42 122.03 29.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.111 -175.358 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 ' O ' ' A' ' 15' ' ' GLU . 11.0 mt -137.81 -176.3 4.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.442 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.3 pt -161.81 138.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 -169.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.755 ' OH ' HG22 ' A' ' 38' ' ' ILE . 13.7 t80 -105.92 121.08 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.401 -177.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.75 94.56 3.71 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.869 -175.431 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -58.92 -15.17 25.85 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 C-N-CA 122.348 2.032 . . . . 0.0 113.449 -170.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.83 -31.69 23.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.988 -170.426 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -27.15 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.371 171.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.01 3.32 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -163.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' OE2' HG21 ' A' ' 33' ' ' VAL . 9.3 tt0 -140.78 114.88 9.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.93 -166.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.521 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.8 mp -93.36 116.05 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.886 HG22 HG22 ' A' ' 33' ' ' VAL . 5.3 t -121.17 177.66 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.246 -164.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.721 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.0 t -106.33 131.75 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.457 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.25 39.32 1.02 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 113.661 -1.608 . . . . 0.0 110.455 173.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 -50.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.371 -175.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.0 p -113.12 -17.19 12.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.65 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -11.0 63.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.28 137.02 56.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.406 -0.897 . . . . 0.0 110.037 -170.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.886 HG22 HG22 ' A' ' 26' ' ' VAL . 90.1 t -79.89 159.85 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.031 161.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.442 HG22 ' HB2' ' A' ' 35' ' ' GLU . 5.3 mt -116.38 -75.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.5 166.093 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HB2' HG22 ' A' ' 34' ' ' ILE . 4.6 tt0 -120.46 165.42 14.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.079 -162.842 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 29.2 mt-10 -128.3 134.64 48.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.979 -169.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 60.31 170.41 0.09 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.73 -177.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.755 HG22 ' OH ' ' A' ' 18' ' ' TYR . 7.4 tt -170.11 46.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.349 -177.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.9 mt 60.86 -88.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.474 169.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -139.85 -156.6 0.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.445 170.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ttt -130.11 113.18 14.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.344 169.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.36 102.58 0.16 Allowed Glycine 0 CA--C 1.542 1.764 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 178.43 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.65 -156.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.552 2.168 . . . . 0.0 113.6 -175.118 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.37 43.18 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.935 -168.241 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.44 97.39 0.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.333 169.225 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.27 79.96 6.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.445 -170.289 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.46 106.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.272 177.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.94 -78.64 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.335 -177.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -99.87 -55.75 2.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.363 -169.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.629 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.215 177.416 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.803 ' O ' HD11 ' A' ' 16' ' ' LEU . 9.0 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.452 0.644 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.6 t -104.59 112.41 65.34 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.329 168.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.32 -14.71 43.74 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.717 2.278 . . . . 0.0 113.854 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.43 -74.48 0.35 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.514 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.1 p -97.07 -6.54 34.93 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.928 -164.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.16 68.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.663 0.744 . . . . 0.0 110.168 -161.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 58.2 m -138.88 105.52 5.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.192 168.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -15.71 63.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.761 -167.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -77.19 104.85 7.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.023 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.803 HD11 ' O ' ' A' ' 7' ' ' VAL . 18.2 mt -109.03 -179.62 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.376 167.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 pt -158.86 153.2 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.402 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.473 ' CD1' HG13 ' A' ' 25' ' ' ILE . 6.3 t80 -100.15 159.74 14.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.386 -169.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -140.83 80.03 18.2 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.788 -172.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -60.28 -18.75 54.2 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.546 2.164 . . . . 0.0 113.493 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -75.02 -37.17 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.08 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -102.77 -24.42 13.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.32 36.01 11.41 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.9 tt0 -108.7 165.94 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.011 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.473 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.5 mp -140.82 116.04 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.259 168.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -109.21 170.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.889 -169.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.435 ' N ' HG12 ' A' ' 26' ' ' VAL . 15.9 t -72.38 151.03 42.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.072 164.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.73 14.23 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.306 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -128.0 -69.13 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.892 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.6 p -88.89 -16.02 32.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.601 -171.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 -11.04 59.33 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.4 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -66.86 126.88 30.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.14 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 34' ' ' ILE . 89.1 t -61.08 168.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.199 167.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.531 ' N ' HG12 ' A' ' 33' ' ' VAL . 31.6 mm -118.25 -75.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.716 173.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.911 164.045 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 27.5 t -80.01 120.16 78.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 156.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -65.96 -14.85 46.42 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 122.768 2.312 . . . . 0.0 113.689 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -95.15 -50.09 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.597 -163.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -106.92 -11.74 15.63 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.908 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 58.91 47.38 12.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.384 -167.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.0 m -99.99 142.58 31.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.169 159.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 -7.95 59.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.81 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 16' ' ' LEU . 57.0 mt-10 -98.62 125.83 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.951 -166.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.799 HD13 HG13 ' A' ' 34' ' ' ILE . 14.1 mt -135.35 160.81 37.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.413 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 pt -144.07 156.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.492 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -103.67 148.29 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.377 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.81 90.03 33.32 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.866 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.87 -20.39 66.44 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 122.59 2.193 . . . . 0.0 113.598 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.23 -35.75 78.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.088 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.37 17.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.406 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.3 51.73 36.01 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.599 ' HG3' HG13 ' A' ' 33' ' ' VAL . 1.1 tt0 -143.0 124.71 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 25' ' ' ILE . 2.5 mp -91.63 134.19 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.145 168.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.8 t -126.79 175.29 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.078 -170.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.525 ' H ' HG12 ' A' ' 26' ' ' VAL . 20.8 t -84.84 140.72 30.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.983 169.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.15 27.3 3.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.308 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 -69.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.51 172.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -91.74 -16.23 27.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.681 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -10.61 59.61 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.55 136.37 54.41 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.522 -0.839 . . . . 0.0 110.133 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.599 HG13 ' HG3' ' A' ' 24' ' ' GLU . 85.3 t -60.75 167.71 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.235 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.799 HG13 HD13 ' A' ' 16' ' ' LEU . 10.8 mm -118.57 -71.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.809 171.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.026 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.3 m . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.4 t -99.77 113.81 65.28 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.413 163.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 10.3 Cg_exo -68.12 -13.22 37.48 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.7 2.267 . . . . 0.0 113.95 168.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.597 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.34 -75.62 0.34 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.514 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -90.58 -9.4 47.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.728 -163.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 59.74 64.67 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.929 0.871 . . . . 0.0 110.258 -159.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 49.5 m -135.45 147.21 48.86 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.203 163.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.07 -16.89 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.573 -171.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.482 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.7 mt-10 -78.67 119.72 22.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.153 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 17' ' ' ILE . 37.6 mt -130.83 -178.16 4.68 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.331 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.0 pt -155.5 128.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.449 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.441 ' CE2' ' CG1' ' A' ' 25' ' ' ILE . 4.1 t80 -93.35 138.52 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.342 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.09 86.71 2.6 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.787 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 6.6 Cg_endo -59.31 -19.8 52.38 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.525 2.15 . . . . 0.0 113.547 -170.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.07 -54.26 19.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.038 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -84.84 -19.46 32.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.458 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.78 21.18 72.28 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -168.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HG3' HG13 ' A' ' 33' ' ' VAL . 21.3 tt0 -75.08 162.8 28.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.132 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.441 ' CG1' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mp -142.45 115.95 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.105 170.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.923 HG22 HG22 ' A' ' 33' ' ' VAL . 4.1 t -111.93 175.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.224 -168.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' H ' HG12 ' A' ' 26' ' ' VAL . 16.8 t -103.44 141.91 35.16 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.084 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.84 17.44 19.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.346 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -138.62 -25.84 0.9 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.35 -161.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.5 p -131.07 -16.17 3.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.84 163.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.12 -10.93 67.77 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.518 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.7 137.83 58.27 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.888 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.923 HG22 HG22 ' A' ' 26' ' ' VAL . 85.1 t -78.51 159.32 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.858 159.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.403 ' N ' HG12 ' A' ' 33' ' ' VAL . 4.4 mt -114.44 -74.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.717 164.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.967 -168.345 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.718 ' C ' HD11 ' A' ' 16' ' ' LEU . 19.2 m . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 t -89.17 118.07 68.83 Favored Pre-proline 0 C--O 1.246 0.88 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.181 161.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.51 -11.47 32.27 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.761 2.307 . . . . 0.0 113.832 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -89.09 -76.78 0.4 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.493 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 p -86.48 -7.8 58.11 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.064 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 56.76 50.02 13.27 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.371 -0.831 . . . . 0.0 110.903 -167.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -101.7 150.82 22.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.275 163.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.96 -16.77 22.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.666 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.92 110.46 18.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.144 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.718 HD11 ' C ' ' A' ' 7' ' ' VAL . 19.9 mt -120.95 167.07 12.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.362 168.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 pt -144.14 129.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 -169.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.513 ' CD1' HG13 ' A' ' 25' ' ' ILE . 18.2 t80 -74.1 166.78 22.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.37 173.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -149.93 89.28 4.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.734 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.51 -17.92 60.68 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.609 2.206 . . . . 0.0 113.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.37 -36.87 60.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.169 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.1 -20.71 12.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.33 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.05 8.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -168.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.3 tt0 -119.48 167.52 11.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -168.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.67 HD13 ' CB ' ' A' ' 35' ' ' GLU . 2.5 mp -135.83 112.27 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.122 166.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 33' ' ' VAL . 5.3 t -105.5 168.91 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.326 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.439 ' N ' HG12 ' A' ' 26' ' ' VAL . 15.8 t -73.04 153.51 40.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.123 164.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -106.49 20.77 18.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.345 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 -79.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.581 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.7 p -90.77 -4.68 56.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.631 -157.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.49 86.45 0.07 OUTLIER Glycine 0 CA--C 1.555 2.583 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -158.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -153.11 128.88 10.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 112.503 -1.849 . . . . 0.0 110.204 164.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 34' ' ' ILE . 93.2 t -79.17 166.74 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.211 167.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.539 ' N ' HG12 ' A' ' 33' ' ' VAL . 6.8 mt -126.25 -74.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.172 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.67 ' CB ' HD13 ' A' ' 25' ' ' ILE . 3.6 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.967 -162.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.638 ' C ' HD11 ' A' ' 16' ' ' LEU . 10.2 m . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.266 0.555 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.1 t -99.21 105.53 33.04 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.68 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 18.3 Cg_exo -58.93 -13.48 18.81 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.699 2.266 . . . . 0.0 113.944 166.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -88.72 -61.29 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.567 -171.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.5 -11.3 20.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.764 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 59.56 58.27 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.244 -162.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -113.71 172.05 7.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.208 160.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.18 -10.82 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.785 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 16.8 mp0 -70.27 73.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.044 168.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.638 HD11 ' C ' ' A' ' 7' ' ' VAL . 74.4 mt -87.13 176.6 7.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.332 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.64 ' O ' HG23 ' A' ' 25' ' ' ILE . 3.9 pt -144.32 176.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.453 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.512 ' CD1' HG13 ' A' ' 25' ' ' ILE . 14.4 t80 -138.34 142.0 39.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.309 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.37 89.0 34.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -167.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -60.74 -16.52 44.34 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.306 2.004 . . . . 0.0 113.534 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.4 -32.56 37.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.059 -172.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -113.52 -19.9 11.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.403 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.61 54.27 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -168.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -128.13 125.23 38.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.359 -0.42 . . . . 0.0 109.964 -171.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 17' ' ' ILE . 2.5 mp -97.66 124.41 50.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.097 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.7 t -126.86 177.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.023 -172.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.616 ' H ' HG12 ' A' ' 26' ' ' VAL . 15.6 t -87.91 139.94 30.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.249 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -96.14 25.51 4.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.329 168.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.4 -71.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.409 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.07 -16.24 30.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.605 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -10.76 57.46 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -68.65 129.63 40.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.503 -0.848 . . . . 0.0 110.201 -167.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.9 t -61.16 168.05 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.254 169.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.52 ' N ' HG12 ' A' ' 33' ' ' VAL . 14.4 mm -118.01 -71.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.728 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HG3' HD13 ' A' ' 25' ' ' ILE . 8.3 pt-20 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.144 176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 21.8 m . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.9 t -112.74 117.24 46.9 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.212 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 -12.55 35.24 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.626 2.217 . . . . 0.0 114.022 168.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.94 -74.48 0.41 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.456 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -89.45 -9.26 50.79 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.961 -167.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.08 51.15 10.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.77 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -134.87 147.36 49.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.547 163.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -87.13 -16.35 35.71 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.55 -160.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 16' ' ' LEU . 1.7 mp0 -68.61 109.26 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.082 -171.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 15' ' ' GLU . 8.7 mt -128.51 168.98 14.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.457 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 pt -153.63 150.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.413 -172.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 8.8 t80 -105.65 155.97 18.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.305 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.39 78.31 22.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.773 -172.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -60.3 -19.37 57.55 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.546 2.164 . . . . 0.0 113.562 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.02 -38.72 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.034 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -86.19 -33.45 20.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.436 174.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.46 52.86 4.03 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.14 145.08 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.411 . . . . 0.0 109.952 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.3 mp -115.15 136.96 50.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.914 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.661 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.4 t -130.91 177.61 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.13 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.661 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.6 t -101.55 138.43 38.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.539 173.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.36 21.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.521 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -134.05 -24.74 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.234 -161.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 p -130.26 -16.74 3.5 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.939 161.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -11.01 59.78 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.457 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.57 137.76 56.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.991 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.1 t -60.69 167.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.293 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.574 HG13 HD13 ' A' ' 16' ' ' LEU . 10.8 mm -120.0 -74.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.627 174.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.058 -171.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.814 ' O ' HD11 ' A' ' 16' ' ' LEU . 17.6 m . . . . . 0 CA--C 1.534 0.329 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 23.9 t -83.28 118.13 70.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.809 157.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 2.4 Cg_endo -65.92 -10.02 25.34 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.575 2.183 . . . . 0.0 113.777 169.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -96.96 -74.7 0.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.37 -170.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -85.25 -9.89 57.19 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.568 -166.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 59.57 59.3 2.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.182 -160.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.0 p -99.3 167.68 10.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.206 160.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.17 -6.7 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.805 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -109.27 99.11 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.021 -168.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.814 HD11 ' O ' ' A' ' 7' ' ' VAL . 45.8 mt -104.77 175.11 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.388 167.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 28' ' ' ALA . 3.3 pt -161.93 132.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.458 -170.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.534 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.7 t80 -89.58 135.7 33.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.382 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -106.35 92.79 7.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.8 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 4.7 Cg_exo -63.28 -17.42 60.0 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.566 2.178 . . . . 0.0 113.52 -172.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.105 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.25 -21.88 14.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.437 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.11 40.84 6.85 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -168.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -104.69 169.36 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -169.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.534 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -137.78 115.73 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.285 163.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.757 HG22 HG22 ' A' ' 33' ' ' VAL . 6.2 t -115.39 172.76 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.096 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.483 ' N ' HG12 ' A' ' 26' ' ' VAL . 20.1 t -78.25 150.91 33.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.006 166.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 17' ' ' ILE . . . -94.03 13.33 23.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.311 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 -79.53 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.559 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.16 -14.81 49.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.545 -159.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.33 -10.21 33.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.287 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' CE2' HG13 ' A' ' 34' ' ' ILE . 70.3 t80 -70.29 119.05 13.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.38 -0.91 . . . . 0.0 110.175 -164.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.757 HG22 HG22 ' A' ' 26' ' ' VAL . 93.0 t -73.03 155.29 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.875 161.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.613 ' CD1' HD13 ' A' ' 16' ' ' LEU . 4.3 mt -108.59 -74.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.61 162.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.425 ' HB2' HD13 ' A' ' 25' ' ' ILE . 4.4 mm-40 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.02 -168.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 19.6 m . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.9 t -96.33 113.78 63.1 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.303 165.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 14.7 Cg_exo -61.84 -19.7 66.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.784 2.323 . . . . 0.0 113.781 167.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -83.76 -67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.642 -171.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -94.68 -11.35 29.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.64 -168.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 59.51 57.38 3.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.491 0.663 . . . . 0.0 110.256 -162.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -120.63 156.97 30.57 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.298 161.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.7 -0.44 18.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.698 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -91.47 111.22 22.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.091 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 HG13 ' A' ' 34' ' ' ILE . 26.7 mt -120.12 173.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.464 174.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 16' ' ' LEU . 10.3 pt -151.71 127.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.416 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 10.0 t80 -98.11 137.15 37.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.361 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.53 89.01 6.85 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.742 -173.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 7.3 Cg_exo -60.88 -14.59 33.31 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.553 2.168 . . . . 0.0 113.527 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -85.68 -34.97 21.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.053 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.3 mtt85 -101.0 -24.11 14.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.393 172.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.28 47.75 8.81 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -122.58 125.77 46.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.005 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.709 ' H ' HD12 ' A' ' 25' ' ' ILE . 1.9 mp -90.71 138.83 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.396 168.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 27' ' ' CYS . 6.0 t -132.67 177.26 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.981 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.591 ' H ' HG12 ' A' ' 26' ' ' VAL . 21.4 t -96.11 139.13 32.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.011 169.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.21 23.65 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.447 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -120.07 -66.53 1.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.531 171.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.28 -15.19 20.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.697 -168.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.5 -11.32 59.69 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.59 131.76 47.17 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.212 -0.994 . . . . 0.0 109.985 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 34' ' ' ILE . 94.7 t -61.27 167.93 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.083 164.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.607 HG13 HD13 ' A' ' 16' ' ' LEU . 31.4 mm -116.71 -76.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.839 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.936 164.253 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.8 m . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.4 t -105.73 116.23 60.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.42 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -68.39 -14.74 40.82 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.801 2.334 . . . . 0.0 113.856 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.585 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.51 -74.23 0.4 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.534 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -90.97 -9.46 45.96 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.675 -164.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.74 63.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.998 0.904 . . . . 0.0 110.257 -160.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -136.05 145.67 46.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.111 163.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.28 -16.59 19.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.646 -166.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 28' ' ' ALA . 3.7 mt-10 -72.12 129.45 38.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.055 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.677 HD13 HG13 ' A' ' 34' ' ' ILE . 8.1 mt -139.53 171.32 14.42 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.396 173.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.7 pt -157.62 146.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.475 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 11.1 t80 -97.3 151.35 19.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.259 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.485 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 1.4 t0 -133.28 96.81 16.91 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.29 -18.55 63.13 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.311 2.007 . . . . 0.0 113.506 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -47.78 70.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.09 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -104.84 -19.28 13.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.489 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.78 26.69 49.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -167.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.563 ' HG3' HG13 ' A' ' 33' ' ' VAL . 2.2 tp10 -110.66 122.97 49.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.32 -0.44 . . . . 0.0 109.972 -166.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 25' ' ' ILE . 2.0 mp -89.46 131.4 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.927 164.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.7 t -125.23 172.89 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.091 -171.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HA ' HD23 ' A' ' 16' ' ' LEU . 17.7 t -70.75 147.69 48.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.057 163.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . . . -94.59 14.69 20.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.353 170.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.01 -74.82 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.447 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.1 p -91.92 -15.68 27.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.645 -160.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.75 -11.99 42.02 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.365 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -63.15 125.35 23.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 113.965 -1.118 . . . . 0.0 109.647 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 24' ' ' GLU . 92.0 t -60.76 141.44 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.202 169.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.677 HG13 HD13 ' A' ' 16' ' ' LEU . 25.9 mm -90.17 -75.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.791 164.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.571 ' HB2' HD13 ' A' ' 25' ' ' ILE . 7.0 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.908 -168.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.3 m . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 34.0 t -80.0 118.92 74.86 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 153.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 6.0 Cg_endo -68.43 -12.69 35.57 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.68 2.253 . . . . 0.0 113.862 169.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.86 -75.32 0.38 Allowed 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.556 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.1 -11.39 41.43 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.65 -166.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.31 51.84 6.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.226 -164.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 m -103.61 148.33 26.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.208 158.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . . . -94.46 -7.31 41.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.753 -169.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.463 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -108.7 144.81 35.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.995 -168.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.833 HD13 HG13 ' A' ' 34' ' ' ILE . 12.7 mt -140.13 171.03 14.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.487 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 28' ' ' ALA . 8.2 pt -159.7 145.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.406 -170.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.8 t80 -97.9 138.99 34.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.398 -167.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.89 95.71 25.52 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.879 176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 14.3 Cg_exo -59.33 -15.03 27.32 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.14 1.893 . . . . 0.0 113.611 -174.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.74 -35.12 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.042 -168.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -28.19 15.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.417 169.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.39 44.76 5.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -168.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 33' ' ' VAL . 5.6 tp10 -119.31 160.26 22.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -168.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 35' ' ' GLU . 2.3 mp -120.37 133.05 68.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 162.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -129.15 169.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.056 -167.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HA ' HD23 ' A' ' 16' ' ' LEU . 20.1 t -63.64 149.17 47.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.926 163.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HA ' HD11 ' A' ' 17' ' ' ILE . . . -94.34 13.61 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.283 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.78 -74.78 0.59 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.66 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -87.11 -16.07 36.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.594 -164.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 -11.39 55.93 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.516 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -67.3 129.83 41.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.055 -170.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 24' ' ' GLU . 84.5 t -61.52 167.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.268 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.833 HG13 HD13 ' A' ' 16' ' ' LEU . 15.5 mm -121.8 -79.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.604 170.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.67 ' HB3' HD13 ' A' ' 25' ' ' ILE . 29.2 tt0 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.971 173.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.662 ' O ' HD11 ' A' ' 16' ' ' LEU . 21.1 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 21.8 t -93.48 115.67 65.39 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.063 160.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 16.2 Cg_exo -62.29 -19.71 67.83 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.745 2.297 . . . . 0.0 113.751 167.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.58 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.15 -68.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.625 -171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.51 -12.02 30.61 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.638 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 54.61 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -162.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.2 p -99.04 -172.04 2.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.048 159.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.78 -8.22 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.742 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -112.81 53.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.825 -163.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.662 HD11 ' O ' ' A' ' 7' ' ' VAL . 20.1 mt -60.72 171.43 1.16 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.562 175.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 16' ' ' LEU . 10.4 pt -160.07 179.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.5 t80 -131.59 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.417 -169.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.473 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 5.8 t0 -143.73 89.8 7.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.725 -171.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.3 -14.72 25.81 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 C-N-CA 122.54 2.16 . . . . 0.0 113.564 -171.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -88.24 -30.8 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.989 -168.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -96.92 -19.86 18.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.443 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 71.23 54.85 8.41 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -168.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.681 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -136.61 144.39 44.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -167.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -111.07 112.93 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.892 164.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 27' ' ' CYS . 5.1 t -112.39 169.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.165 -166.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 26' ' ' VAL . 21.9 t -69.73 154.65 41.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.887 164.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.12 15.9 27.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.302 172.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HE3' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.3 -66.05 0.91 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.713 -173.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -94.45 -16.58 23.26 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.632 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 -10.53 58.73 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.499 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -66.08 129.96 41.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.475 -0.863 . . . . 0.0 110.166 -167.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.681 HG13 ' HG3' ' A' ' 24' ' ' GLU . 87.5 t -61.12 167.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.301 170.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 33' ' ' VAL . 14.1 mm -118.99 -75.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.739 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.159 -170.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 20.8 m . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 110.129 -0.322 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 20.3 t -90.09 116.74 67.09 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.004 159.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 15.5 Cg_exo -61.19 -17.17 50.95 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.732 2.288 . . . . 0.0 113.721 167.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.582 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -91.84 -74.21 0.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.424 -168.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 p -86.17 -9.31 56.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.703 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 59.59 61.74 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.774 0.797 . . . . 0.0 110.285 -160.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 65.5 p -103.8 -165.06 1.12 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.294 163.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.45 -7.46 1.31 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.816 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.698 ' O ' HD23 ' A' ' 16' ' ' LEU . 10.3 mm-40 -115.53 133.0 56.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.02 -167.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 15' ' ' GLU . 19.8 mt -137.67 178.32 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.432 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 16' ' ' LEU . 7.1 pt -160.32 139.36 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.413 -170.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.4 t80 -104.55 136.72 43.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.42 -171.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.21 80.07 71.46 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.822 -169.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -59.26 -18.62 45.92 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 122.46 2.107 . . . . 0.0 113.598 -171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.93 -37.4 84.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.008 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.76 -25.95 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.407 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.14 51.64 4.62 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 1.5 tp10 -130.0 129.13 43.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -167.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 35' ' ' GLU . 2.4 mp -103.31 114.59 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.113 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.79 HG22 HG22 ' A' ' 33' ' ' VAL . 5.2 t -118.15 168.79 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.275 -166.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.432 ' N ' HG12 ' A' ' 26' ' ' VAL . 24.0 t -78.06 144.76 36.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.856 167.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.46 20.64 9.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.363 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -75.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.391 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -90.18 -14.85 32.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.648 -159.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.84 -9.82 34.5 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.401 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.48 126.18 29.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 114.539 -0.83 . . . . 0.0 110.126 -164.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.79 HG22 HG22 ' A' ' 26' ' ' VAL . 86.1 t -75.87 159.26 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.001 163.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 mt -114.88 -76.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.514 164.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 25' ' ' ILE . 38.8 tt0 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.017 -165.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.6 m . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.472 0.653 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.5 t -119.04 110.28 38.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.469 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.92 -4.59 9.07 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.605 2.203 . . . . 0.0 113.85 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -94.55 -67.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.493 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.9 p -97.56 -11.11 24.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.732 -165.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 59.59 57.7 3.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.305 -165.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.56 160.89 39.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.282 158.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -103.23 -10.97 18.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.791 -166.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.611 ' C ' HD23 ' A' ' 16' ' ' LEU . 14.7 mm-40 -75.71 106.55 7.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.157 -168.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.626 HD13 HG13 ' A' ' 34' ' ' ILE . 8.5 mt -129.98 171.65 12.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.356 -175.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 16' ' ' LEU . 8.7 pt -159.99 135.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.343 -169.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 27.7 t80 -98.82 149.7 22.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.331 -169.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 30.1 t70 -127.79 95.83 33.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.727 -167.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.73 -18.39 63.98 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.121 1.881 . . . . 0.0 113.543 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.98 -43.23 68.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.014 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.501 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.96 -19.31 13.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.487 -174.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.36 44.86 20.79 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -167.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 26' ' ' VAL . 41.4 tt0 -120.01 124.51 46.09 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -168.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.667 ' H ' HD12 ' A' ' 25' ' ' ILE . 1.9 mp -93.9 128.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.86 167.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 27' ' ' CYS . 6.0 t -128.88 178.86 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.162 -169.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.752 ' H ' HG12 ' A' ' 26' ' ' VAL . 33.8 t -108.67 135.34 50.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.574 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.75 25.68 4.48 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.401 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.69 -36.54 0.56 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -165.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -123.07 -15.65 7.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.845 166.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.73 63.66 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.497 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.59 139.89 56.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.417 -0.891 . . . . 0.0 110.116 -168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 34' ' ' ILE . 92.4 t -61.03 168.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 167.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 16' ' ' LEU . 16.5 mm -121.2 -75.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.462 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.949 168.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m . . . . . 0 CA--C 1.531 0.233 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.5 t -111.79 111.53 54.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.415 171.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.94 -10.87 30.22 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 113.758 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.33 -73.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.456 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.45 -11.53 34.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.633 -164.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 59.48 57.81 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.254 -162.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.482 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 45.6 m -124.24 162.9 22.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.289 161.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.2 -7.84 15.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.779 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.85 ' O ' HD23 ' A' ' 16' ' ' LEU . 27.2 mt-10 -90.62 119.61 31.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.066 -167.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 15' ' ' GLU . 10.6 mt -138.04 159.63 41.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.368 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 28' ' ' ALA . 7.0 pt -150.99 146.58 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.433 -169.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 25' ' ' ILE . 3.5 t80 -98.55 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.42 -168.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.1 90.14 9.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.882 172.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.42 -19.5 51.65 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 122.472 2.114 . . . . 0.0 113.497 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.82 -50.49 72.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.103 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -29.83 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.401 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.55 27.65 14.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -167.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -92.06 165.31 13.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.341 -0.43 . . . . 0.0 110.0 -168.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 35' ' ' GLU . 1.9 mp -137.4 114.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.776 166.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.3 t -111.49 177.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.116 -167.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.686 ' H ' HG12 ' A' ' 26' ' ' VAL . 23.0 t -98.82 135.97 39.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.841 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.424 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -95.56 22.94 6.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.221 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' NZ ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -142.76 -25.08 0.63 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.197 -160.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -133.57 -17.33 2.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.846 163.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.59 58.35 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.476 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.86 138.75 50.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.156 -168.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.558 HG12 ' N ' ' A' ' 34' ' ' ILE . 64.9 t -61.17 168.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.277 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.663 HG13 HD13 ' A' ' 16' ' ' LEU . 16.8 mm -124.61 -74.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.243 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 25' ' ' ILE . 40.2 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 166.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.456 -0.153 0 N-CA-C 110.329 -0.249 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.5 t -110.68 113.25 55.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.507 172.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -65.49 -16.92 56.11 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.749 2.299 . . . . 0.0 113.76 169.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -78.55 -72.16 0.39 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.564 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -91.07 -9.15 46.81 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.981 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.82 50.23 12.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.834 -167.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -97.03 -167.05 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.395 164.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.31 -10.12 3.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.844 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.68 116.42 25.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.056 -168.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.926 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -136.69 166.55 23.3 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.364 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.5 pt -151.28 133.16 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.476 -171.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 49.2 t80 -80.34 163.01 24.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.322 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.498 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -146.41 100.2 4.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 -167.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -62.28 -18.38 62.19 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.58 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.52 -47.09 77.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.008 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -109.29 -20.17 13.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.415 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.7 52.68 6.33 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -166.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.494 ' OE2' HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -139.57 144.5 37.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -166.156 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.469 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.4 mp -106.26 134.89 46.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.05 169.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.682 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.8 t -132.12 178.38 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.079 -167.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.682 ' H ' HG12 ' A' ' 26' ' ' VAL . 27.0 t -99.23 139.05 35.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.74 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.66 26.91 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.386 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 -34.66 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 -162.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -126.38 -16.71 5.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.9 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.57 -10.75 70.73 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.666 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -63.06 139.08 58.74 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.599 -0.801 . . . . 0.0 110.025 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.2 t -61.09 167.24 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.265 170.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.926 HG13 HD13 ' A' ' 16' ' ' LEU . 15.8 mm -121.67 -76.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.567 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.055 177.249 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 CA--C 1.529 0.169 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 28.7 t -113.64 115.26 46.73 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.004 175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.67 -20.35 70.68 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.608 2.205 . . . . 0.0 113.717 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -76.36 -70.54 0.44 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.49 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -95.16 -9.7 32.7 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.022 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 7.3 pt-20 56.34 48.52 16.92 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.415 -0.803 . . . . 0.0 111.004 -168.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -85.46 -168.4 2.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.414 166.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.61 -13.07 5.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.741 167.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.534 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.3 mp0 -91.49 109.56 20.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.12 -169.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.738 HD13 HG13 ' A' ' 34' ' ' ILE . 15.8 mt -127.9 -177.95 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.387 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 16' ' ' LEU . 3.7 pt -160.4 145.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.414 -169.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.9 t80 -108.81 119.15 38.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.416 -169.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.98 83.84 0.52 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.795 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 6.2 Cg_endo -59.93 -19.68 56.31 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.434 2.09 . . . . 0.0 113.596 -172.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.09 -51.99 61.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.999 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -79.12 -30.36 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.407 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.31 40.87 7.68 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -168.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -118.07 159.64 22.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -129.47 133.13 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.037 163.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.8 t -131.93 178.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.114 -167.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.724 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.9 t -106.15 125.41 50.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.536 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.25 -2.44 31.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.868 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -77.59 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 171.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.5 p -83.2 -17.54 42.46 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.6 -162.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.83 60.52 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.43 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -68.93 139.93 55.09 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.547 -0.826 . . . . 0.0 110.265 -168.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 34' ' ' ILE . 95.7 t -62.17 167.68 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.038 165.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.738 HG13 HD13 ' A' ' 16' ' ' LEU . 16.9 mm -117.82 -74.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.725 171.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 166.707 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 16.9 m . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.538 -0.171 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.7 t -111.57 112.61 53.92 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.175 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.25 -16.85 57.06 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.686 2.257 . . . . 0.0 113.735 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.52 -73.56 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.393 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.9 -11.01 40.44 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.645 -166.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 59.37 56.06 3.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.248 -163.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 52.6 p -109.57 -166.21 1.08 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.367 160.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -142.36 -16.96 0.73 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.662 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.787 ' O ' HD23 ' A' ' 16' ' ' LEU . 1.9 mm-40 -81.39 122.59 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.05 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.933 HD13 HG13 ' A' ' 34' ' ' ILE . 13.5 mt -137.28 160.43 39.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.466 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.37 132.01 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.369 -168.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CD1' HG13 ' A' ' 25' ' ' ILE . 7.4 t80 -88.47 132.7 34.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.379 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 80.76 1.11 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.653 168.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 5.6 Cg_endo -59.16 -20.23 53.48 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 122.558 2.172 . . . . 0.0 113.512 -168.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.03 -53.22 57.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.178 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -86.9 -19.13 29.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.26 30.55 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -168.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.46 162.31 15.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.929 -0.635 . . . . 0.0 109.993 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.535 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.1 mp -142.0 115.79 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.202 167.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -106.51 177.93 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.232 -170.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.713 ' H ' HG12 ' A' ' 26' ' ' VAL . 31.4 t -101.07 125.05 47.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.641 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.53 -4.61 43.64 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.882 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -92.97 -78.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.313 170.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -86.12 -16.6 37.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.612 -161.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 -10.38 54.56 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.455 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -72.61 133.97 44.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.592 -0.804 . . . . 0.0 110.172 -168.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 34' ' ' ILE . 88.3 t -61.27 167.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.133 165.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.933 HG13 HD13 ' A' ' 16' ' ' LEU . 33.4 mm -119.18 -76.53 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.644 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.079 168.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.5 t -107.72 113.52 61.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.279 170.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.68 -13.72 41.03 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 122.71 2.273 . . . . 0.0 113.721 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.605 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.95 -74.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.456 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -91.21 -11.02 39.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.691 -166.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 59.31 54.81 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.223 -163.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.5 p -88.85 176.55 7.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.038 162.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.33 -8.04 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.763 164.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.64 ' O ' HD23 ' A' ' 16' ' ' LEU . 19.0 mt-10 -99.04 116.18 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.988 -167.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.65 HD13 HG13 ' A' ' 34' ' ' ILE . 16.0 mt -132.62 166.59 21.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.379 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 28' ' ' ALA . 10.2 pt -155.15 148.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.399 -167.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.476 ' CD1' HG13 ' A' ' 25' ' ' ILE . 12.9 t80 -107.73 123.17 48.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.312 -170.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.96 98.0 7.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 -171.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.1 Cg_endo -59.09 -14.18 22.41 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.306 2.004 . . . . 0.0 113.505 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.55 -30.7 21.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.085 -169.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.31 -19.33 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.459 174.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.18 51.2 10.42 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -168.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 26' ' ' VAL . 31.9 tt0 -137.08 125.94 24.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.432 . . . . 0.0 109.9 -167.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.664 ' H ' HD12 ' A' ' 25' ' ' ILE . 2.4 mp -88.83 128.11 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.128 169.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -130.76 177.12 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.968 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.591 ' H ' HG12 ' A' ' 26' ' ' VAL . 19.7 t -93.33 124.01 37.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.916 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.73 7.31 4.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.753 176.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -112.95 -67.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.455 178.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.6 p -91.75 -19.14 22.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.512 -169.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.13 57.81 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.551 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -68.76 126.82 30.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.404 -0.898 . . . . 0.0 110.229 -170.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 34' ' ' ILE . 65.3 t -61.55 169.36 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.426 175.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.65 HG13 HD13 ' A' ' 16' ' ' LEU . 20.0 mm -124.75 -73.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.185 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 25' ' ' ILE . 5.0 tp10 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.958 166.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 m . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.476 0.655 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.4 t -113.84 111.04 48.64 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.537 175.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -67.77 -10.57 29.21 Favored 'Trans proline' 0 N--CA 1.482 0.846 0 C-N-CA 122.751 2.301 . . . . 0.0 113.881 169.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.72 -71.81 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.549 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -93.98 -11.33 31.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.635 -165.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 59.48 58.11 3.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.228 -161.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -110.8 -171.35 1.81 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.231 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.76 -16.44 1.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.717 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.852 ' O ' HD23 ' A' ' 16' ' ' LEU . 5.0 mm-40 -74.85 120.47 20.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.026 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.929 HD13 HG13 ' A' ' 34' ' ' ILE . 7.9 mt -135.77 165.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.411 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 28' ' ' ALA . 8.9 pt -150.02 140.37 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.394 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.525 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.0 t80 -101.66 149.48 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.236 -168.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 7.1 t70 -129.3 94.79 32.24 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.736 -167.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -59.89 -20.26 58.86 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.272 1.981 . . . . 0.0 113.571 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.92 -39.04 87.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.112 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -22.62 11.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.52 30.29 30.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.41 164.65 12.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -170.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.525 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.6 mp -126.76 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.999 163.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -132.82 178.5 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.155 -167.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.702 ' H ' HG12 ' A' ' 26' ' ' VAL . 22.0 t -101.87 136.85 41.0 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.858 175.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -95.89 29.57 2.67 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.33 176.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.74 -35.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.613 -165.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.3 p -125.57 -16.49 5.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.823 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.43 -11.11 69.02 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.576 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.04 137.67 58.33 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.639 -0.78 . . . . 0.0 109.976 -173.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.6 t -60.89 167.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.26 168.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.929 HG13 HD13 ' A' ' 16' ' ' LEU . 20.6 mm -120.78 -69.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.426 173.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.53 0.207 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.066 176.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.9 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.912 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 28' ' ' ALA . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.536 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 35' ' ' GLU . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.718 ' H ' HG12 ' A' ' 26' ' ' VAL . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 34' ' ' ILE . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.912 HG13 HD13 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 25' ' ' ILE . 7.8 tp10 . . . . . 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.9 m . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.912 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 28' ' ' ALA . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.536 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 35' ' ' GLU . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.718 ' H ' HG12 ' A' ' 26' ' ' VAL . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 34' ' ' ILE . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.912 HG13 HD13 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 25' ' ' ILE . 7.8 tp10 . . . . . 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 27.3 m . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.9 t -95.63 111.22 54.9 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.338 161.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 5.2 Cg_endo -69.99 -8.08 22.72 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.6 2.2 . . . . 0.0 113.968 169.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.32 -73.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.514 175.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -92.68 -11.45 34.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.663 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.53 57.15 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.209 -162.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -114.02 172.94 6.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.209 160.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.15 -9.32 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.715 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 65.8 mm-40 -96.83 52.64 1.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.977 -162.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.9 HD13 HG13 ' A' ' 34' ' ' ILE . 17.4 mt -69.71 175.97 3.89 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.449 -177.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 16' ' ' LEU . 9.5 pt -157.49 153.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.462 -168.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.3 t80 -106.8 132.36 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.434 -169.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.3 92.08 6.44 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.703 175.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 13.5 Cg_exo -59.07 -13.16 17.98 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.388 2.059 . . . . 0.0 113.602 -168.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -47.68 14.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.016 -170.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.403 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -90.05 -24.0 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.419 170.302 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 16.61 50.06 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -177.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -79.59 164.2 24.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.027 -171.313 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -130.84 113.0 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.938 165.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.719 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -114.04 177.61 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.147 -169.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.719 ' H ' HG12 ' A' ' 26' ' ' VAL . 15.4 t -90.5 126.17 35.83 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.076 178.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -76.48 7.05 4.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.774 175.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.23 -67.66 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.514 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.8 p -93.03 -20.13 20.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.48 -167.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.98 60.23 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.639 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -69.52 131.94 45.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.659 -0.771 . . . . 0.0 110.333 -172.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 34' ' ' ILE . 61.3 t -61.79 170.98 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.368 175.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.9 HG13 HD13 ' A' ' 16' ' ' LEU . 14.0 mm -128.07 -73.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.013 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.022 167.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.459 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.4 m . . . . . 0 N--CA 1.451 -0.408 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.0 t -102.61 111.12 64.45 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.369 164.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 7.2 Cg_exo -68.45 -10.77 29.99 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.741 2.294 . . . . 0.0 113.751 169.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -81.14 -73.67 0.36 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.482 177.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -93.67 -11.86 30.64 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.596 -163.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 59.25 2.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.579 0.704 . . . . 0.0 110.193 -161.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 54.9 m -123.61 148.31 46.53 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.26 161.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.31 27.93 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.602 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.502 ' O ' HD23 ' A' ' 16' ' ' LEU . 15.3 mm-40 -75.89 118.05 18.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.158 -172.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.582 HD13 HG13 ' A' ' 34' ' ' ILE . 15.7 mt -141.95 158.04 44.24 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.315 178.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 pt -150.85 158.57 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.415 -167.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 2.8 t80 -108.68 121.79 45.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.375 -169.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.21 99.75 3.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.748 178.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -59.61 -15.53 31.55 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.362 2.041 . . . . 0.0 113.469 179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -78.21 -30.86 49.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.039 -169.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -111.98 -20.22 12.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.398 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 44.79 7.56 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.46 168.11 9.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.75 128.77 68.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.677 162.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 27' ' ' CYS . 3.7 t -130.88 176.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.93 -168.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.676 ' H ' HG12 ' A' ' 26' ' ' VAL . 17.8 t -94.54 136.78 34.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.01 176.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 20.91 8.1 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.237 178.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -143.41 -23.79 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.357 -158.361 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.3 p -135.99 -18.06 1.6 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.838 164.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.15 -11.44 57.14 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.455 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -67.97 137.16 54.92 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.312 -0.944 . . . . 0.0 110.09 -170.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 34' ' ' ILE . 96.3 t -61.59 167.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.221 175.065 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.582 HG13 HD13 ' A' ' 16' ' ' LEU . 19.4 mm -124.21 -78.27 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.416 172.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.978 174.019 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.2 t -102.47 111.44 64.62 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.499 168.165 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.25 -11.76 33.41 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.706 2.271 . . . . 0.0 113.778 169.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.17 -69.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.619 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.2 p -96.53 -11.45 25.44 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.654 -166.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.62 58.32 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.242 -162.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -114.42 173.78 6.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.283 160.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.86 6.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.611 -169.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.22 126.97 35.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.043 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.973 HD13 HG13 ' A' ' 34' ' ' ILE . 17.6 mt -135.52 161.54 35.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.446 174.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 pt -135.64 140.29 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.367 -167.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -104.29 135.85 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.256 -169.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.65 92.23 49.15 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.794 -168.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -59.47 -20.12 55.15 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.44 2.093 . . . . 0.0 113.61 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 -46.99 61.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.076 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -91.76 -21.79 20.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.406 -178.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 41.79 60.62 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -167.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG13 ' A' ' 33' ' ' VAL . 17.6 tt0 -128.3 141.34 51.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.404 . . . . 0.0 109.968 -166.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.687 HD13 ' HG3' ' A' ' 35' ' ' GLU . 2.5 mp -108.04 137.67 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.091 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.6 t -134.06 176.95 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.908 -168.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.635 ' H ' HG12 ' A' ' 26' ' ' VAL . 18.1 t -92.6 131.09 38.01 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.841 174.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.15 43.24 1.14 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.379 170.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -53.05 0.16 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.464 -178.045 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.8 p -111.03 -18.23 13.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.717 -178.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.99 -10.61 68.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.671 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.17 132.59 53.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.999 -175.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 34' ' ' ILE . 88.8 t -61.06 167.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.279 170.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.973 HG13 HD13 ' A' ' 16' ' ' LEU . 21.1 mm -120.24 -77.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.698 173.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.687 ' HG3' HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.055 172.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 23.3 m . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 22.9 t -103.01 111.73 65.27 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.105 168.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 8.0 Cg_exo -66.8 -4.26 10.89 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.678 2.252 . . . . 0.0 113.776 170.331 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.599 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -93.45 -68.53 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.557 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.87 -11.29 29.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.555 -167.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 59.44 57.35 3.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.185 -162.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -101.82 -165.81 1.23 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.279 160.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.08 -16.91 1.23 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.681 175.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.843 ' O ' HD23 ' A' ' 16' ' ' LEU . 4.3 mm-40 -86.42 122.03 29.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.111 -175.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 ' O ' ' A' ' 15' ' ' GLU . 11.0 mt -137.81 -176.3 4.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.442 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.3 pt -161.81 138.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 -169.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.521 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.7 t80 -105.92 121.08 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.401 -177.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.75 94.56 3.71 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.869 -175.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -58.92 -15.17 25.85 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 C-N-CA 122.348 2.032 . . . . 0.0 113.449 -170.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.83 -31.69 23.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.988 -170.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -27.15 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.371 171.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.01 3.32 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -163.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.507 ' OE2' HG21 ' A' ' 33' ' ' VAL . 9.3 tt0 -140.78 114.88 9.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.93 -166.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.521 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.8 mp -93.36 116.05 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.886 HG22 HG22 ' A' ' 33' ' ' VAL . 5.3 t -121.17 177.66 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.246 -164.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.721 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.0 t -106.33 131.75 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.457 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.25 39.32 1.02 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 113.661 -1.608 . . . . 0.0 110.455 173.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 -50.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.371 -175.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.0 p -113.12 -17.19 12.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.65 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -11.0 63.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.28 137.02 56.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.406 -0.897 . . . . 0.0 110.037 -170.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.886 HG22 HG22 ' A' ' 26' ' ' VAL . 90.1 t -79.89 159.85 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.031 161.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.442 HG22 ' HB2' ' A' ' 35' ' ' GLU . 5.3 mt -116.38 -75.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.5 166.093 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HB2' HG22 ' A' ' 34' ' ' ILE . 4.6 tt0 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.079 -162.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 N--CA 1.473 0.693 0 CA-C-O 121.087 0.47 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.2 p -160.63 122.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.298 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.4 m120 70.15 -155.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.293 -168.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.534 ' HE2' ' HD3' ' A' ' 6' ' ' LYS . 2.0 mmmm -61.09 -43.53 98.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.444 -169.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 68.11 86.8 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.43 -171.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.534 ' HD3' ' HE2' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -166.74 -176.47 3.5 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.2 168.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.803 ' O ' HD11 ' A' ' 16' ' ' LEU . 9.0 m 59.53 -163.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.13 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.6 t -104.59 112.41 65.34 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.329 168.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -67.32 -14.71 43.74 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.717 2.278 . . . . 0.0 113.854 168.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.593 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.43 -74.48 0.35 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.514 -174.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.1 p -97.07 -6.54 34.93 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.928 -164.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 60.16 68.68 0.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.663 0.744 . . . . 0.0 110.168 -161.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.418 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 58.2 m -138.88 105.52 5.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.192 168.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.11 -15.71 63.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.761 -167.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -77.19 104.85 7.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.023 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.803 HD11 ' O ' ' A' ' 7' ' ' VAL . 18.2 mt -109.03 -179.62 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.376 167.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 pt -158.86 153.2 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.402 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.71 ' OH ' HD13 ' A' ' 38' ' ' ILE . 6.3 t80 -100.15 159.74 14.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.386 -169.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.3 OUTLIER -140.83 80.03 18.2 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.788 -172.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -60.28 -18.75 54.2 Favored 'Trans proline' 0 N--CA 1.485 0.974 0 C-N-CA 122.546 2.164 . . . . 0.0 113.493 -171.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -75.02 -37.17 61.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.08 -174.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -102.77 -24.42 13.72 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.437 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.32 36.01 11.41 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.9 tt0 -108.7 165.94 11.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.011 -168.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.473 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.5 mp -140.82 116.04 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.259 168.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.517 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -109.21 170.82 2.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.889 -169.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.435 ' N ' HG12 ' A' ' 26' ' ' VAL . 15.9 t -72.38 151.03 42.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.072 164.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -99.73 14.23 30.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.306 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -128.0 -69.13 0.74 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.892 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.6 p -88.89 -16.02 32.94 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.601 -171.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.68 -11.04 59.33 Favored Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.4 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -66.86 126.88 30.48 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.14 -168.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 34' ' ' ILE . 89.1 t -61.08 168.32 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.199 167.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.531 ' N ' HG12 ' A' ' 33' ' ' VAL . 31.6 mm -118.25 -75.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.345 -1.298 . . . . 0.0 109.716 173.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -125.07 159.75 30.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.911 164.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -151.51 48.74 0.82 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.991 -177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -158.9 56.9 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.368 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.71 HD13 ' OH ' ' A' ' 18' ' ' TYR . 1.1 pp -75.93 65.29 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.443 -170.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 tt -171.89 152.96 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.399 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -162.09 74.45 0.43 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.396 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 mtm -130.34 -55.64 1.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.326 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.23 67.69 1.54 Allowed Glycine 0 CA--C 1.541 1.71 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 171.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.3 -64.55 0.11 Allowed 'Trans proline' 0 N--CA 1.486 1.048 0 C-N-CA 122.256 1.97 . . . . 0.0 113.58 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -157.29 78.14 0.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.959 -175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -151.33 -40.59 0.12 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.432 -168.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -109.72 148.53 31.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.359 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.61 132.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.359 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -131.02 148.34 52.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.374 175.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -168.23 128.64 1.3 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.358 177.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.593 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.261 169.843 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 mtm . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.149 0.499 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.8 m -62.62 -25.25 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.331 171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 p30 61.11 -163.57 0.25 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.655 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -175.75 25.74 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.301 -168.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.522 ' O ' HG13 ' A' ' 7' ' ' VAL . 11.9 pt20 -127.87 38.66 3.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.247 -167.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -60.61 114.77 3.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.2 166.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 5' ' ' GLN . 20.2 m -95.61 154.28 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.118 -160.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 27.5 t -80.01 120.16 78.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 156.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -65.96 -14.85 46.42 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 122.768 2.312 . . . . 0.0 113.689 166.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -95.15 -50.09 5.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.597 -163.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -106.92 -11.74 15.63 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.908 178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 58.91 47.38 12.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.384 -167.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 74.0 m -99.99 142.58 31.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.169 159.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.05 -7.95 59.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.81 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 16' ' ' LEU . 57.0 mt-10 -98.62 125.83 44.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.951 -166.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.799 HD13 HG13 ' A' ' 34' ' ' ILE . 14.1 mt -135.35 160.81 37.27 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.413 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 pt -144.07 156.22 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.492 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -103.67 148.29 26.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.377 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.81 90.03 33.32 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.866 -177.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -60.87 -20.39 66.44 Favored 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 122.59 2.193 . . . . 0.0 113.598 -173.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -68.23 -35.75 78.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.088 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -19.37 17.52 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.406 177.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 67.3 51.73 36.01 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -165.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.599 ' HG3' HG13 ' A' ' 33' ' ' VAL . 1.1 tt0 -143.0 124.71 14.97 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -163.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 25' ' ' ILE . 2.5 mp -91.63 134.19 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.145 168.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.8 t -126.79 175.29 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.078 -170.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.525 ' H ' HG12 ' A' ' 26' ' ' VAL . 20.8 t -84.84 140.72 30.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.983 169.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.15 27.3 3.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.308 168.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.7 -69.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.51 172.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -91.74 -16.23 27.19 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.681 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -10.61 59.61 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.496 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.55 136.37 54.41 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 114.522 -0.839 . . . . 0.0 110.133 -170.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.599 HG13 ' HG3' ' A' ' 24' ' ' GLU . 85.3 t -60.75 167.71 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.235 169.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.799 HG13 HD13 ' A' ' 16' ' ' LEU . 10.8 mm -118.57 -71.67 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.809 171.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.41 149.86 41.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.026 -178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -122.25 51.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.954 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -143.9 77.2 1.54 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.388 -175.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.641 ' O ' HG22 ' A' ' 39' ' ' ILE . 4.8 tt -127.06 130.17 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.323 167.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 38' ' ' ILE . 1.5 tp 76.86 -54.61 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.632 178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.05 103.56 0.29 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.409 -171.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 93.9 mtp -140.3 113.09 8.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.38 169.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.41 -85.95 0.24 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -53.46 131.03 41.53 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.609 2.206 . . . . 0.0 113.568 -172.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.65 -179.85 6.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.07 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -88.38 -75.49 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.766 -1.106 . . . . 0.0 110.397 -175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.52 157.12 28.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.407 176.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.23 19.94 11.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.304 170.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -92.64 -72.37 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.338 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.7 134.52 54.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.402 -169.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.562 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.24 -177.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' HG22 ' A' ' 2' ' ' VAL . 2.5 tpp . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 1' ' ' MET . 10.0 m 59.04 -177.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.205 176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -160.35 116.42 2.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.367 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -119.35 -19.1 8.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.473 170.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -116.76 -76.34 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.287 -166.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.52 141.66 34.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.352 -164.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.3 m -96.5 -161.94 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.06 166.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.4 t -99.77 113.81 65.28 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.413 163.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 10.3 Cg_exo -68.12 -13.22 37.48 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.7 2.267 . . . . 0.0 113.95 168.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.597 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.34 -75.62 0.34 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.514 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.1 p -90.58 -9.4 47.25 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.728 -163.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 59.74 64.67 1.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.929 0.871 . . . . 0.0 110.258 -159.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.421 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 49.5 m -135.45 147.21 48.86 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.203 163.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.07 -16.89 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.573 -171.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.482 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.7 mt-10 -78.67 119.72 22.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.153 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 17' ' ' ILE . 37.6 mt -130.83 -178.16 4.68 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.331 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.0 pt -155.5 128.8 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.449 -176.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.441 ' CE2' ' CG1' ' A' ' 25' ' ' ILE . 4.1 t80 -93.35 138.52 31.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.342 -167.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.09 86.71 2.6 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.787 171.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 6.6 Cg_endo -59.31 -19.8 52.38 Favored 'Trans proline' 0 N--CA 1.484 0.96 0 C-N-CA 122.525 2.15 . . . . 0.0 113.547 -170.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -68.07 -54.26 19.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.038 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -84.84 -19.46 32.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.458 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.78 21.18 72.28 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 -168.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HG3' HG13 ' A' ' 33' ' ' VAL . 21.3 tt0 -75.08 162.8 28.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.965 -0.618 . . . . 0.0 110.132 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.441 ' CG1' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mp -142.45 115.95 4.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.105 170.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.923 HG22 HG22 ' A' ' 33' ' ' VAL . 4.1 t -111.93 175.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.224 -168.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' H ' HG12 ' A' ' 26' ' ' VAL . 16.8 t -103.44 141.91 35.16 Favored 'General case' 0 C--N 1.334 -0.109 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.084 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -98.84 17.44 19.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.346 175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.48 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -138.62 -25.84 0.9 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.35 -161.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.5 p -131.07 -16.17 3.23 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.84 163.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.12 -10.93 67.77 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.518 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -61.7 137.83 58.27 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.525 -0.838 . . . . 0.0 109.888 -172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.923 HG22 HG22 ' A' ' 26' ' ' VAL . 85.1 t -78.51 159.32 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.858 159.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' N ' HG12 ' A' ' 33' ' ' VAL . 4.4 mt -114.44 -74.46 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 113.526 -1.67 . . . . 0.0 109.717 164.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HG2' ' N ' ' A' ' 36' ' ' GLU . 35.7 tt0 -117.57 163.61 16.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.967 -168.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.466 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -141.81 49.29 1.59 Allowed 'General case' 0 C--O 1.233 0.201 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.961 177.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -157.93 157.93 34.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.394 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.6 tp -119.3 139.37 46.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.429 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 46.4 pt -60.91 133.52 26.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.466 -170.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -167.49 99.13 0.5 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.363 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' A' ' 43' ' ' PRO . 2.0 tpt -113.43 137.12 51.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 167.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' N ' ' HD2' ' A' ' 43' ' ' PRO . . . 130.61 -52.16 0.84 Allowed Glycine 0 CA--C 1.544 1.883 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 42' ' ' GLY . 6.9 Cg_exo -51.44 -85.18 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.537 2.158 . . . . 0.0 113.482 -164.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -90.97 100.07 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.984 -162.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 45' ' ' TRP . 0.1 OUTLIER 62.16 108.73 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.99 164.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.433 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -164.9 -80.85 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.442 163.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.6 177.96 0.12 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.361 171.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.11 82.72 1.5 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.246 167.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -174.14 -52.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.406 -168.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.584 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.251 -169.833 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 tpp . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 121.091 0.472 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.1 t -123.32 64.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.377 173.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -165.06 101.71 0.76 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.443 -169.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -153.06 150.53 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.396 170.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -142.22 24.31 1.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.44 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -121.36 123.38 41.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.305 168.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.718 ' C ' HD11 ' A' ' 16' ' ' LEU . 19.2 m -142.43 169.25 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.22 -168.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.8 t -89.17 118.07 68.83 Favored Pre-proline 0 C--O 1.246 0.88 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.181 161.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -67.51 -11.47 32.27 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.761 2.307 . . . . 0.0 113.832 168.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.584 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -89.09 -76.78 0.4 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.493 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.8 p -86.48 -7.8 58.11 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 118.531 -0.747 . . . . 0.0 112.064 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 56.76 50.02 13.27 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.371 -0.831 . . . . 0.0 110.903 -167.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -101.7 150.82 22.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.275 163.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.96 -16.77 22.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.666 -177.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.92 110.46 18.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.144 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.718 HD11 ' C ' ' A' ' 7' ' ' VAL . 19.9 mt -120.95 167.07 12.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.052 -0.977 . . . . 0.0 110.362 168.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.4 pt -144.14 129.75 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 -169.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.513 ' CD1' HG13 ' A' ' 25' ' ' ILE . 18.2 t80 -74.1 166.78 22.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.37 173.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -149.93 89.28 4.66 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.734 -169.377 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -62.51 -17.92 60.68 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.609 2.206 . . . . 0.0 113.531 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.37 -36.87 60.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.169 -174.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -110.1 -20.71 12.6 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.33 -177.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.05 8.56 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -168.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' HB3' ' HB3' ' A' ' 19' ' ' ASP . 12.3 tt0 -119.48 167.52 11.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -168.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.67 HD13 ' CB ' ' A' ' 35' ' ' GLU . 2.5 mp -135.83 112.27 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.122 166.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.534 HG22 HG22 ' A' ' 33' ' ' VAL . 5.3 t -105.5 168.91 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.326 -171.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.439 ' N ' HG12 ' A' ' 26' ' ' VAL . 15.8 t -73.04 153.51 40.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.123 164.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -106.49 20.77 18.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.345 170.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 -79.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.581 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.7 p -90.77 -4.68 56.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.631 -157.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.49 86.45 0.07 OUTLIER Glycine 0 CA--C 1.555 2.583 0 N-CA-C 107.856 -2.098 . . . . 0.0 107.856 -158.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -153.11 128.88 10.16 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 112.503 -1.849 . . . . 0.0 110.204 164.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.539 HG12 ' N ' ' A' ' 34' ' ' ILE . 93.2 t -79.17 166.74 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.211 167.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.539 ' N ' HG12 ' A' ' 33' ' ' VAL . 6.8 mt -126.25 -74.96 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.172 168.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.67 ' CB ' HD13 ' A' ' 25' ' ' ILE . 3.6 mm-40 -100.07 133.86 43.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.967 -162.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -110.09 131.78 54.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.079 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.27 155.15 0.13 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.303 168.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -99.78 111.86 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.349 168.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 39' ' ' ILE . 4.3 mp -79.42 145.8 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.441 -168.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.21 -96.59 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.311 169.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.3 mmt -88.39 140.86 29.04 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.578 -177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.36 99.65 0.22 Allowed Glycine 0 CA--C 1.541 1.698 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -55.71 110.12 0.51 Allowed 'Trans proline' 0 N--CA 1.486 1.086 0 C-N-CA 122.283 1.989 . . . . 0.0 113.462 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 -66.11 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.022 168.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -176.03 38.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.448 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.26 118.2 8.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.406 169.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.35 -49.61 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.338 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -105.37 109.69 21.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.406 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -130.07 -68.13 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.408 -170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.603 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.268 -169.774 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 121.149 0.5 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -91.79 -59.56 2.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.385 -170.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -62.45 -98.68 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.325 -166.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -133.46 79.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.595 -166.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 61.38 -168.1 0.19 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.626 164.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.921 ' HG3' HG13 ' A' ' 7' ' ' VAL . 19.8 ptmt -113.72 -168.94 1.41 Allowed 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.308 169.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.921 HG13 ' HG3' ' A' ' 6' ' ' LYS . 10.2 m 60.41 -165.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.087 173.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 12.1 t -99.21 105.53 33.04 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.68 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 18.3 Cg_exo -58.93 -13.48 18.81 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.699 2.266 . . . . 0.0 113.944 166.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -88.72 -61.29 1.74 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.567 -171.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.6 p -100.5 -11.3 20.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.764 -171.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 59.56 58.27 2.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.244 -162.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 58.2 m -113.71 172.05 7.21 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.208 160.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.18 -10.82 1.96 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.785 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 16.8 mp0 -70.27 73.1 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.044 168.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.638 HD11 ' C ' ' A' ' 7' ' ' VAL . 74.4 mt -87.13 176.6 7.52 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.332 175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.64 ' O ' HG23 ' A' ' 25' ' ' ILE . 3.9 pt -144.32 176.18 2.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.453 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.719 ' OH ' HD12 ' A' ' 38' ' ' ILE . 14.4 t80 -138.34 142.0 39.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.309 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -118.37 89.0 34.97 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.745 -167.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -60.74 -16.52 44.34 Favored 'Trans proline' 0 N--CA 1.485 1.013 0 C-N-CA 122.306 2.004 . . . . 0.0 113.534 -169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.4 -32.56 37.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.059 -172.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 11.1 mtt-85 -113.52 -19.9 11.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.403 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.61 54.27 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -168.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -128.13 125.23 38.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.359 -0.42 . . . . 0.0 109.964 -171.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 17' ' ' ILE . 2.5 mp -97.66 124.41 50.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.097 170.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.7 t -126.86 177.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.023 -172.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.616 ' H ' HG12 ' A' ' 26' ' ' VAL . 15.6 t -87.91 139.94 30.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.249 170.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -96.14 25.51 4.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.329 168.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.4 -71.3 0.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.409 173.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.0 p -90.07 -16.24 30.1 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.605 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.81 -10.76 57.46 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.367 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -68.65 129.63 40.49 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 114.503 -0.848 . . . . 0.0 110.201 -167.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' VAL . 88.9 t -61.16 168.05 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.254 169.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.52 ' N ' HG12 ' A' ' 33' ' ' VAL . 14.4 mm -118.01 -71.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.728 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HG3' HD13 ' A' ' 25' ' ' ILE . 8.3 pt-20 -145.9 179.08 7.71 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.144 176.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -142.65 77.73 1.59 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.072 168.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.68 44.23 1.03 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.42 -172.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.719 HD12 ' OH ' ' A' ' 18' ' ' TYR . 23.6 mt -138.96 82.01 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.379 168.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.6 HD13 ' N ' ' A' ' 39' ' ' ILE . 0.2 OUTLIER -61.23 123.87 14.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.569 -166.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -146.4 41.57 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.207 171.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.483 ' HE3' ' HB2' ' A' ' 44' ' ' GLU . 3.5 ttp -109.46 131.38 55.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.388 -165.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.597 ' H ' ' HD2' ' A' ' 43' ' ' PRO . . . -98.05 -51.26 1.51 Allowed Glycine 0 CA--C 1.541 1.698 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -171.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.597 ' HD2' ' H ' ' A' ' 42' ' ' GLY . 7.0 Cg_endo -65.27 -0.01 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.06 0 C-N-CA 122.268 1.979 . . . . 0.0 113.708 -168.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.483 ' HB2' ' HE3' ' A' ' 41' ' ' MET . 3.1 tp10 -90.89 51.1 1.9 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.89 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER 67.87 112.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.349 167.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.7 25.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.357 -169.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.37 -39.08 16.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.249 -169.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.2 -80.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.5 -166.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 53.89 -102.02 0.13 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.344 0.658 . . . . 0.0 111.904 170.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.583 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.304 169.396 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 121.188 0.518 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.561 HG23 ' H ' ' A' ' 4' ' ' LYS . 2.9 m -73.11 -163.39 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.315 170.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -92.25 22.8 4.21 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.647 171.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.561 ' H ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -125.13 -12.96 6.87 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.471 170.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 70.7 120.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.408 172.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.2 141.61 57.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.192 166.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 21.8 m -122.5 -171.2 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.279 -164.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.9 t -112.74 117.24 46.9 Favored Pre-proline 0 CA--C 1.552 1.021 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.212 172.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 -12.55 35.24 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.626 2.217 . . . . 0.0 114.022 168.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.94 -74.48 0.41 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.456 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.2 p -89.45 -9.26 50.79 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.961 -167.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 57.08 51.15 10.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.77 -168.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -134.87 147.36 49.85 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.547 163.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -87.13 -16.35 35.71 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.55 -160.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.604 ' O ' HD23 ' A' ' 16' ' ' LEU . 1.7 mp0 -68.61 109.26 3.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.082 -171.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.604 HD23 ' O ' ' A' ' 15' ' ' GLU . 8.7 mt -128.51 168.98 14.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.457 173.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 10.9 pt -153.63 150.12 12.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.413 -172.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 8.8 t80 -105.65 155.97 18.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.305 -168.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.39 78.31 22.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.773 -172.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -60.3 -19.37 57.55 Favored 'Trans proline' 0 N--CA 1.485 0.99 0 C-N-CA 122.546 2.164 . . . . 0.0 113.562 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.02 -38.72 44.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.034 -177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -86.19 -33.45 20.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.436 174.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.46 52.86 4.03 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 -167.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -141.14 145.08 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.379 -0.411 . . . . 0.0 109.952 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.3 mp -115.15 136.96 50.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.914 166.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.661 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.4 t -130.91 177.61 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.13 -169.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.661 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.6 t -101.55 138.43 38.56 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.539 173.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.5 15.36 21.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.521 175.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 13' ' ' SER . 0.1 OUTLIER -134.05 -24.74 1.64 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.234 -161.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.2 p -130.26 -16.74 3.5 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.939 161.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.42 -11.01 59.78 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.457 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -66.57 137.76 56.99 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.991 -169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.1 t -60.69 167.49 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.293 169.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 HG13 HD13 ' A' ' 16' ' ' LEU . 10.8 mm -120.0 -74.17 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.296 -1.32 . . . . 0.0 109.627 174.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -128.8 -165.49 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.058 -171.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HG2' ' CD1' ' A' ' 45' ' ' TRP . 2.1 tp10 -116.09 -170.78 1.86 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.972 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.418 ' C ' HG22 ' A' ' 38' ' ' ILE . 11.0 p30 -65.05 98.73 0.31 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.537 -165.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.418 HG22 ' C ' ' A' ' 37' ' ' ASN . 3.9 tp 55.53 94.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.031 167.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 39' ' ' ILE . 1.1 tt -76.26 116.77 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.352 169.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.48 -76.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.378 170.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.1 mtm -175.76 87.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.342 169.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -161.88 -161.7 12.25 Favored Glycine 0 CA--C 1.543 1.791 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -54.99 -156.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 122.329 2.019 . . . . 0.0 113.498 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -118.69 -73.25 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.073 168.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.407 ' CD1' ' HG2' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -134.82 -179.64 5.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.384 -178.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 65.23 -76.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.242 -167.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . 61.0 -171.81 0.14 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.278 165.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -171.39 97.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.251 165.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.54 132.66 37.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.351 -168.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.631 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.284 176.853 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 ptm . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 121.049 0.452 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.0 p -170.67 -29.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.343 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 71.12 -98.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.4 169.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.09 166.68 13.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.379 -167.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -117.66 72.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.459 -170.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.56 117.15 28.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.259 173.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.814 ' O ' HD11 ' A' ' 16' ' ' LEU . 17.6 m -116.22 173.13 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.16 -166.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 23.9 t -83.28 118.13 70.69 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 115.206 -0.907 . . . . 0.0 108.809 157.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 2.4 Cg_endo -65.92 -10.02 25.34 Favored 'Trans proline' 0 N--CA 1.484 0.953 0 C-N-CA 122.575 2.183 . . . . 0.0 113.777 169.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -96.96 -74.7 0.56 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.37 -170.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -85.25 -9.89 57.19 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.568 -166.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 59.57 59.3 2.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.182 -160.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.0 p -99.3 167.68 10.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.206 160.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.17 -6.7 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.805 173.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -109.27 99.11 8.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.021 -168.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.814 HD11 ' O ' ' A' ' 7' ' ' VAL . 45.8 mt -104.77 175.11 5.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.388 167.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 28' ' ' ALA . 3.3 pt -161.93 132.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.458 -170.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.534 ' CD2' HG13 ' A' ' 25' ' ' ILE . 5.7 t80 -89.58 135.7 33.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.382 -170.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 24' ' ' GLU . 0.4 OUTLIER -106.35 92.79 7.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.8 -177.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 4.7 Cg_exo -63.28 -17.42 60.0 Favored 'Trans proline' 0 N--CA 1.484 0.93 0 C-N-CA 122.566 2.178 . . . . 0.0 113.52 -172.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.29 -45.28 73.47 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.105 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.25 -21.88 14.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.437 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.11 40.84 6.85 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -168.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 19' ' ' ASP . 1.0 OUTLIER -104.69 169.36 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 -169.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 38' ' ' ILE . 2.7 mp -137.78 115.73 13.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.285 163.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.757 HG22 HG22 ' A' ' 33' ' ' VAL . 6.2 t -115.39 172.76 3.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.096 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.483 ' N ' HG12 ' A' ' 26' ' ' VAL . 20.1 t -78.25 150.91 33.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.006 166.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.567 ' HA ' HD11 ' A' ' 17' ' ' ILE . . . -94.03 13.33 23.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.311 170.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.66 -79.53 0.55 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.559 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.8 p -84.16 -14.81 49.21 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.545 -159.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.33 -10.21 33.37 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.287 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' CE2' HG13 ' A' ' 34' ' ' ILE . 70.3 t80 -70.29 119.05 13.89 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 114.38 -0.91 . . . . 0.0 110.175 -164.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.757 HG22 HG22 ' A' ' 26' ' ' VAL . 93.0 t -73.03 155.29 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.875 161.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.613 ' CD1' HD13 ' A' ' 16' ' ' LEU . 4.3 mt -108.59 -74.44 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.61 162.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.425 ' HB2' HD13 ' A' ' 25' ' ' ILE . 4.4 mm-40 -107.71 122.17 46.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.02 -168.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.52 136.53 35.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.093 172.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 12.0 m120 67.36 103.5 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.355 168.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.763 HD11 HD11 ' A' ' 25' ' ' ILE . 14.9 mt -116.23 47.73 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.369 168.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.3 mm -113.08 -11.85 11.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.508 176.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 70.56 -156.12 0.13 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.451 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 70.9 mtm 65.62 43.18 3.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.264 -169.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.77 90.07 1.51 Allowed Glycine 0 CA--C 1.544 1.862 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -56.55 -88.94 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 122.317 2.011 . . . . 0.0 113.493 -168.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.69 -161.71 0.2 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.102 -168.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.4 p90 61.18 16.13 6.95 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.806 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.91 102.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.638 164.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -175.88 160.17 2.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.245 168.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -91.21 77.83 5.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.236 166.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.91 109.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.368 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.514 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.269 -169.276 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 mtt . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.404 HG12 ' HD2' ' A' ' 4' ' ' LYS . 10.7 t -103.25 87.01 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.386 174.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.92 129.52 55.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.383 169.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.554 ' NZ ' ' HB1' ' A' ' 14' ' ' ALA . 1.0 OUTLIER -131.52 -62.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.394 -169.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 69.39 19.02 7.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.349 -168.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.533 ' HG2' ' HB3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -126.3 150.69 48.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.264 168.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 19.6 m -153.17 -172.01 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.242 -166.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.9 t -96.33 113.78 63.1 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.303 165.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 14.7 Cg_exo -61.84 -19.7 66.56 Favored 'Trans proline' 0 N--CA 1.483 0.893 0 C-N-CA 122.784 2.323 . . . . 0.0 113.781 167.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -83.76 -67.49 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.642 -171.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -94.68 -11.35 29.38 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.64 -168.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 59.51 57.38 3.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.491 0.663 . . . . 0.0 110.256 -162.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.0 m -120.63 156.97 30.57 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.298 161.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB1' ' NZ ' ' A' ' 4' ' ' LYS . . . -109.7 -0.44 18.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.698 -173.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -91.47 111.22 22.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.091 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.607 HD13 HG13 ' A' ' 34' ' ' ILE . 26.7 mt -120.12 173.62 6.99 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.464 174.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 16' ' ' LEU . 10.3 pt -151.71 127.78 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.416 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.557 ' OH ' HD13 ' A' ' 38' ' ' ILE . 10.0 t80 -98.11 137.15 37.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.361 -169.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -109.53 89.01 6.85 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.742 -173.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 7.3 Cg_exo -60.88 -14.59 33.31 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 122.553 2.168 . . . . 0.0 113.527 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -85.68 -34.97 21.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.053 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 24.3 mtt85 -101.0 -24.11 14.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.878 -1.055 . . . . 0.0 110.393 172.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.28 47.75 8.81 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -168.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -122.58 125.77 46.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.029 -0.585 . . . . 0.0 110.005 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.709 ' H ' HD12 ' A' ' 25' ' ' ILE . 1.9 mp -90.71 138.83 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.396 168.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 27' ' ' CYS . 6.0 t -132.67 177.26 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.981 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.591 ' H ' HG12 ' A' ' 26' ' ' VAL . 21.4 t -96.11 139.13 32.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.011 169.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.21 23.65 6.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.447 169.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 29' ' ' LYS . 0.5 OUTLIER -120.07 -66.53 1.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.531 171.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.28 -15.19 20.91 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.697 -168.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.5 -11.32 59.69 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.452 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -65.59 131.76 47.17 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 114.212 -0.994 . . . . 0.0 109.985 -169.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 34' ' ' ILE . 94.7 t -61.27 167.93 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.083 164.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.607 HG13 HD13 ' A' ' 16' ' ' LEU . 31.4 mm -116.71 -76.55 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 114.264 -1.334 . . . . 0.0 109.839 173.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.474 ' HB3' ' ND2' ' A' ' 37' ' ' ASN . 3.0 mp0 -138.95 -171.42 3.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.936 164.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -144.09 89.74 2.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.134 167.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.481 ' ND2' ' HA2' ' A' ' 42' ' ' GLY . 7.4 p30 -173.54 93.95 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.392 -174.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.65 ' C ' HD13 ' A' ' 39' ' ' ILE . 19.7 pt -105.29 123.99 59.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.189 166.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.65 HD13 ' C ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER 52.73 20.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.405 -169.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -117.11 -163.87 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.423 -168.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.76 -77.75 0.36 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.503 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.481 ' HA2' ' ND2' ' A' ' 37' ' ' ASN . . . 162.08 -151.14 21.06 Favored Glycine 0 CA--C 1.543 1.816 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.79 169.67 4.29 Favored 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.542 2.161 . . . . 0.0 113.514 -171.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -99.02 173.94 6.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.965 168.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 90.6 m95 66.71 154.93 0.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.42 -169.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mmt-85 61.52 79.47 0.25 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.429 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.65 161.02 3.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.289 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.52 -13.31 12.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.321 -170.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -96.19 79.34 3.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.368 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.575 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.24 169.791 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ttm . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.87 106.89 21.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.358 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -156.66 129.68 7.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.338 168.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.488 ' HD2' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER 58.3 -172.4 0.1 Allowed 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.603 175.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.34 136.94 25.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.471 177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.25 74.79 0.35 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.52 167.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' CG2' ' HD2' ' A' ' 4' ' ' LYS . 19.8 m -140.96 -164.09 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.819 169.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.4 t -105.73 116.23 60.27 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.42 165.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -68.39 -14.74 40.82 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.801 2.334 . . . . 0.0 113.856 168.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.585 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.51 -74.23 0.4 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.534 -175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -90.97 -9.46 45.96 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.675 -164.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 59.74 63.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.998 0.904 . . . . 0.0 110.257 -160.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.0 m -136.05 145.67 46.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.111 163.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -98.28 -16.59 19.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.646 -166.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 28' ' ' ALA . 3.7 mt-10 -72.12 129.45 38.53 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.055 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.677 HD13 HG13 ' A' ' 34' ' ' ILE . 8.1 mt -139.53 171.32 14.42 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.396 173.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.7 pt -157.62 146.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.475 -169.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.485 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 11.1 t80 -97.3 151.35 19.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.259 -175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.485 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 1.4 t0 -133.28 96.81 16.91 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.744 -172.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -62.29 -18.55 63.13 Favored 'Trans proline' 0 N--CA 1.485 1.005 0 C-N-CA 122.311 2.007 . . . . 0.0 113.506 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.09 -47.78 70.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.09 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -104.84 -19.28 13.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.489 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.587 ' HA3' HG22 ' A' ' 38' ' ' ILE . . . 81.78 26.69 49.11 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -167.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.563 ' HG3' HG13 ' A' ' 33' ' ' VAL . 2.2 tp10 -110.66 122.97 49.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.32 -0.44 . . . . 0.0 109.972 -166.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 25' ' ' ILE . 2.0 mp -89.46 131.4 36.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.927 164.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.7 t -125.23 172.89 12.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.091 -171.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.55 ' HA ' HD23 ' A' ' 16' ' ' LEU . 17.7 t -70.75 147.69 48.73 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.057 163.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 15' ' ' GLU . . . -94.59 14.69 20.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.353 170.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -123.01 -74.82 0.61 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.447 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.1 p -91.92 -15.68 27.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.645 -160.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.75 -11.99 42.02 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.365 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -63.15 125.35 23.78 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 113.965 -1.118 . . . . 0.0 109.647 -170.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.563 HG13 ' HG3' ' A' ' 24' ' ' GLU . 92.0 t -60.76 141.44 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.202 169.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.677 HG13 HD13 ' A' ' 16' ' ' LEU . 25.9 mm -90.17 -75.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.791 164.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.571 ' HB2' HD13 ' A' ' 25' ' ' ILE . 7.0 mt-10 -123.59 -169.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.908 -168.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.81 155.19 39.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.015 166.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.557 ' O ' HG22 ' A' ' 38' ' ' ILE . 8.0 p-10 -160.8 -174.42 4.41 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.387 -174.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.587 HG22 ' HA3' ' A' ' 23' ' ' GLY . 1.0 OUTLIER 59.74 172.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.709 -177.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.426 HG13 HG23 ' A' ' 38' ' ' ILE . 26.4 mt 66.7 88.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.098 -162.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 70.68 72.96 0.2 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.054 -162.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.6 ttt -60.59 -45.89 92.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.407 -165.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.11 -140.83 3.61 Favored Glycine 0 CA--C 1.543 1.813 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -172.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -54.3 -42.28 68.91 Favored 'Trans proline' 0 N--CA 1.484 0.927 0 C-N-CA 122.567 2.178 . . . . 0.0 113.64 -173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 58.5 176.38 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.558 -168.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 45.0 p90 -87.31 88.78 7.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.331 -169.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -173.39 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.407 169.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.26 94.05 6.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.235 169.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -100.98 -49.87 3.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.373 169.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.04 -44.13 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.338 169.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.589 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.246 -169.875 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ttp . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 121.139 0.495 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 p -171.21 91.12 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.371 172.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 63.38 -176.04 0.15 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.351 -178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.82 79.82 1.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.283 168.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 61.59 -165.56 0.22 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.451 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.506 ' NZ ' ' HB3' ' A' ' 6' ' ' LYS . 0.1 OUTLIER -169.12 43.35 0.03 OUTLIER 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.937 -172.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.3 m -157.67 177.52 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.143 -173.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 34.0 t -80.0 118.92 74.86 Favored Pre-proline 0 CA--C 1.55 0.967 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 153.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 6.0 Cg_endo -68.43 -12.69 35.57 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 122.68 2.253 . . . . 0.0 113.862 169.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.587 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -85.86 -75.32 0.38 Allowed 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.556 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.1 -11.39 41.43 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.65 -166.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.31 51.84 6.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.226 -164.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 60.8 m -103.61 148.33 26.13 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.208 158.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB3' ' OE1' ' A' ' 15' ' ' GLU . . . -94.46 -7.31 41.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.753 -169.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.463 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -108.7 144.81 35.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.995 -168.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.833 HD13 HG13 ' A' ' 34' ' ' ILE . 12.7 mt -140.13 171.03 14.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.487 175.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 28' ' ' ALA . 8.2 pt -159.7 145.66 6.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.406 -170.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.519 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.8 t80 -97.9 138.99 34.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.398 -167.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.89 95.71 25.52 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.879 176.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 14.3 Cg_exo -59.33 -15.03 27.32 Favored 'Trans proline' 0 N--CA 1.485 1.024 0 C-N-CA 122.14 1.893 . . . . 0.0 113.611 -174.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -81.74 -35.12 30.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.042 -168.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.93 -28.19 15.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.417 169.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.39 44.76 5.78 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -168.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' HG3' HG13 ' A' ' 33' ' ' VAL . 5.6 tp10 -119.31 160.26 22.59 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -168.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.67 HD13 ' HB3' ' A' ' 35' ' ' GLU . 2.3 mp -120.37 133.05 68.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 162.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 5.0 t -129.15 169.07 21.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.056 -167.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.461 ' HA ' HD23 ' A' ' 16' ' ' LEU . 20.1 t -63.64 149.17 47.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.926 163.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.605 ' HA ' HD11 ' A' ' 17' ' ' ILE . . . -94.34 13.61 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.283 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.78 -74.78 0.59 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.66 -177.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 27.2 p -87.11 -16.07 36.59 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.594 -164.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.96 -11.39 55.93 Favored Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.516 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -67.3 129.83 41.14 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 114.304 -0.948 . . . . 0.0 110.055 -170.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.527 HG13 ' HG3' ' A' ' 24' ' ' GLU . 84.5 t -61.52 167.56 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.268 176.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.833 HG13 HD13 ' A' ' 16' ' ' LEU . 15.5 mm -121.8 -79.69 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.604 170.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.67 ' HB3' HD13 ' A' ' 25' ' ' ILE . 29.2 tt0 -105.38 170.86 7.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.971 173.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -127.68 148.5 50.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.225 -166.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.12 176.78 0.11 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.593 170.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.8 tp -110.25 138.19 39.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.481 -172.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 40' ' ' ASP . 5.3 tp -130.44 -54.57 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.438 -168.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' N ' HG23 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -107.04 -64.05 1.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.368 -167.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.7 tpp -60.86 159.19 11.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.357 -167.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.57 -84.32 0.18 Allowed Glycine 0 CA--C 1.543 1.842 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 170.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -60.96 139.9 87.28 Favored 'Trans proline' 0 N--CA 1.485 0.979 0 C-N-CA 122.532 2.155 . . . . 0.0 113.559 -169.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -101.89 117.98 35.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.952 166.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.7 m0 -113.39 43.64 1.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.337 -165.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 47' ' ' ALA . 0.0 OUTLIER -156.99 -172.05 3.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.394 170.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 46' ' ' ARG . . . 62.03 75.2 0.41 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.204 -166.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -79.16 -51.34 9.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.399 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -105.27 150.59 25.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.337 169.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.611 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.295 178.594 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' HG22 ' A' ' 2' ' ' VAL . 15.2 ptp . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 1' ' ' MET . 10.2 m 59.52 34.44 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.211 172.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.475 ' HB3' ' HE3' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -101.99 -22.0 14.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.285 169.316 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 3' ' ' ASN . 0.3 OUTLIER -103.02 173.53 6.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.274 168.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -119.23 -58.73 1.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.347 -168.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.21 95.2 2.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.257 -169.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.662 ' O ' HD11 ' A' ' 16' ' ' LEU . 21.1 m -152.41 -169.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.192 -163.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 21.8 t -93.48 115.67 65.39 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.063 160.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 16.2 Cg_exo -62.29 -19.71 67.83 Favored 'Trans proline' 0 N--CA 1.483 0.862 0 C-N-CA 122.745 2.297 . . . . 0.0 113.751 167.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.58 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -84.15 -68.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.625 -171.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -93.51 -12.02 30.61 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.638 -169.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.44 54.61 4.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.213 -162.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.2 p -99.04 -172.04 2.21 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.048 159.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.78 -8.22 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.742 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -112.81 53.06 0.76 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.825 -163.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.662 HD11 ' O ' ' A' ' 7' ' ' VAL . 20.1 mt -60.72 171.43 1.16 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.518 -1.219 . . . . 0.0 110.562 175.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 16' ' ' LEU . 10.4 pt -160.07 179.19 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.4 -167.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.5 t80 -131.59 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.417 -169.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.473 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 5.8 t0 -143.73 89.8 7.24 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.725 -171.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -59.3 -14.72 25.81 Favored 'Trans proline' 0 N--CA 1.484 0.958 0 C-N-CA 122.54 2.16 . . . . 0.0 113.564 -171.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -88.24 -30.8 19.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.989 -168.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -96.92 -19.86 18.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.443 172.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' HA2' HG21 ' A' ' 38' ' ' ILE . . . 71.23 54.85 8.41 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -168.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.681 ' HG3' HG13 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -136.61 144.39 44.07 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -167.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -111.07 112.93 42.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.892 164.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 27' ' ' CYS . 5.1 t -112.39 169.33 4.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.165 -166.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.429 ' N ' HG12 ' A' ' 26' ' ' VAL . 21.9 t -69.73 154.65 41.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.887 164.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -104.12 15.9 27.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.302 172.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HA ' ' HE3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -127.3 -66.05 0.91 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.713 -173.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -94.45 -16.58 23.26 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.632 -172.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.91 -10.53 58.73 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.499 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -66.08 129.96 41.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 114.475 -0.863 . . . . 0.0 110.166 -167.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.681 HG13 ' HG3' ' A' ' 24' ' ' GLU . 87.5 t -61.12 167.97 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.301 170.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.526 ' N ' HG12 ' A' ' 33' ' ' VAL . 14.1 mm -118.99 -75.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 114.411 -1.268 . . . . 0.0 109.739 175.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' HD13 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -156.19 102.15 2.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.159 -170.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -66.94 140.01 57.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.947 -175.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -174.26 119.73 0.25 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.287 168.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.471 HG21 ' HA2' ' A' ' 23' ' ' GLY . 6.2 tt -175.15 48.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.381 170.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.9 mt -102.93 -51.67 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.435 169.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -173.41 151.39 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.387 169.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 32.2 mtp -67.66 92.7 0.34 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.328 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.55 141.3 8.39 Favored Glycine 0 CA--C 1.543 1.822 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -55.82 -28.56 68.0 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 122.519 2.146 . . . . 0.0 113.601 175.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 58.5 30.59 19.95 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.686 168.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.57 111.13 0.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.468 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -168.07 -64.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.419 168.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.89 17.7 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.456 -169.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 61.16 -169.9 0.16 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.359 167.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 t70 70.42 164.39 0.27 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.346 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.585 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.288 -169.465 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.6 mtm . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.14 178.74 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.385 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -61.07 173.44 0.81 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.333 169.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.582 ' O ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.38 -77.13 0.31 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.465 169.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.68 -74.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.428 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.8 108.96 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.341 172.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 4' ' ' LYS . 20.8 m -135.76 -177.34 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.129 -166.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 20.3 t -90.09 116.74 67.09 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.004 159.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 15.5 Cg_exo -61.19 -17.17 50.95 Favored 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 122.732 2.288 . . . . 0.0 113.721 167.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.582 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -91.84 -74.21 0.52 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.424 -168.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.8 p -86.17 -9.31 56.84 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.703 -165.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 59.59 61.74 1.91 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.774 0.797 . . . . 0.0 110.285 -160.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.401 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 65.5 p -103.8 -165.06 1.12 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.294 163.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.45 -7.46 1.31 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.816 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.698 ' O ' HD23 ' A' ' 16' ' ' LEU . 10.3 mm-40 -115.53 133.0 56.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.02 -167.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.698 HD23 ' O ' ' A' ' 15' ' ' GLU . 19.8 mt -137.67 178.32 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.432 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 16' ' ' LEU . 7.1 pt -160.32 139.36 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.413 -170.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 13.4 t80 -104.55 136.72 43.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.42 -171.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.21 80.07 71.46 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.822 -169.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -59.26 -18.62 45.92 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 122.46 2.107 . . . . 0.0 113.598 -171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -61.93 -37.4 84.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.008 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 61.1 mtt-85 -101.76 -25.95 13.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.407 170.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.14 51.64 4.62 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -168.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 1.5 tp10 -130.0 129.13 43.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -167.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.643 HD13 ' HB3' ' A' ' 35' ' ' GLU . 2.4 mp -103.31 114.59 43.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.113 168.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.79 HG22 HG22 ' A' ' 33' ' ' VAL . 5.2 t -118.15 168.79 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.275 -166.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.432 ' N ' HG12 ' A' ' 26' ' ' VAL . 24.0 t -78.06 144.76 36.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.856 167.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.46 20.64 9.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.363 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 -75.04 0.6 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.391 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.3 p -90.18 -14.85 32.66 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.648 -159.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.84 -9.82 34.5 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.401 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -72.48 126.18 29.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 114.539 -0.83 . . . . 0.0 110.126 -164.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.79 HG22 HG22 ' A' ' 26' ' ' VAL . 86.1 t -75.87 159.26 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.001 163.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 mt -114.88 -76.23 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.514 164.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 25' ' ' ILE . 38.8 tt0 -110.22 169.0 9.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.017 -165.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.89 146.78 36.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.163 -166.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.437 ' HB2' ' HG2' ' A' ' 43' ' ' PRO . 3.6 p-10 60.63 97.48 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.835 168.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.628 HD11 ' OE1' ' A' ' 35' ' ' GLU . 22.0 mt -147.19 63.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.372 166.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.0 mm -99.41 -79.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.554 -174.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.78 35.36 1.39 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.398 -175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 55.4 mtt 62.1 85.39 0.12 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.419 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' H ' ' HD3' ' A' ' 43' ' ' PRO . . . 88.06 51.95 3.05 Favored Glycine 0 CA--C 1.542 1.766 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.548 ' HD3' ' H ' ' A' ' 42' ' ' GLY . 2.0 Cg_endo -58.82 -154.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.201 0 C-N-CA 122.487 2.125 . . . . 0.0 113.499 167.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 58.79 -174.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.609 -170.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -99.23 42.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.321 -166.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -103.96 18.4 22.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.382 168.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.74 -165.59 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.187 -169.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -152.81 -75.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.346 169.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 63.36 -89.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.409 170.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.56 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.295 169.819 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 121.055 0.455 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.8 t 62.21 -83.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.394 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 p30 60.85 177.2 0.1 Allowed 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.648 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -130.65 -73.88 0.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.334 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 62.19 12.23 4.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.445 174.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.36 118.47 24.19 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.523 -177.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.6 m 59.52 -164.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.25 169.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.5 t -119.04 110.28 38.27 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 114.795 -1.093 . . . . 0.0 109.469 178.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -64.92 -4.59 9.07 Favored 'Trans proline' 0 N--CA 1.484 0.924 0 C-N-CA 122.605 2.203 . . . . 0.0 113.85 169.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -94.55 -67.63 0.84 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.493 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.9 p -97.56 -11.11 24.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.732 -165.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 59.59 57.7 3.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.305 -165.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.56 160.89 39.03 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.282 158.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -103.23 -10.97 18.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.791 -166.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.611 ' C ' HD23 ' A' ' 16' ' ' LEU . 14.7 mm-40 -75.71 106.55 7.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.157 -168.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.626 HD13 HG13 ' A' ' 34' ' ' ILE . 8.5 mt -129.98 171.65 12.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.356 -175.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 16' ' ' LEU . 8.7 pt -159.99 135.24 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.343 -169.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.509 ' CD1' HG13 ' A' ' 25' ' ' ILE . 27.7 t80 -98.82 149.7 22.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.331 -169.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 24' ' ' GLU . 30.1 t70 -127.79 95.83 33.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.727 -167.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -62.73 -18.39 63.98 Favored 'Trans proline' 0 N--CA 1.486 1.069 0 C-N-CA 122.121 1.881 . . . . 0.0 113.543 -172.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.98 -43.23 68.48 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.014 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.501 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -107.96 -19.31 13.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.487 -174.08 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.36 44.86 20.79 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -167.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.55 ' HG2' HG22 ' A' ' 26' ' ' VAL . 41.4 tt0 -120.01 124.51 46.09 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -168.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.667 ' H ' HD12 ' A' ' 25' ' ' ILE . 1.9 mp -93.9 128.12 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.86 167.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.752 HG12 ' H ' ' A' ' 27' ' ' CYS . 6.0 t -128.88 178.86 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.162 -169.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.752 ' H ' HG12 ' A' ' 26' ' ' VAL . 33.8 t -108.67 135.34 50.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.574 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.75 25.68 4.48 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.493 -1.231 . . . . 0.0 110.401 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 15' ' ' GLU . 0.7 OUTLIER -138.69 -36.54 0.56 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.549 -165.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -123.07 -15.65 7.24 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.845 166.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.2 -10.73 63.66 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.497 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.59 139.89 56.9 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 114.417 -0.891 . . . . 0.0 110.116 -168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 34' ' ' ILE . 92.4 t -61.03 168.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.278 167.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.626 HG13 HD13 ' A' ' 16' ' ' LEU . 16.5 mm -121.2 -75.82 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.416 -1.265 . . . . 0.0 109.462 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.79 -171.18 3.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.949 168.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.19 126.46 3.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.122 169.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' C ' HD12 ' A' ' 38' ' ' ILE . 1.6 m-80 -137.7 44.41 2.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.44 -171.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.477 HD12 ' C ' ' A' ' 37' ' ' ASN . 5.3 mp -143.08 104.9 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.227 168.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.409 HG22 ' C ' ' A' ' 38' ' ' ILE . 8.1 tp 55.83 83.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.011 -177.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -126.67 -24.73 3.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.294 -166.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 7.6 mtp -60.93 -87.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.427 -166.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.38 137.48 12.2 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -169.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -58.44 -154.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.139 0 C-N-CA 122.403 2.069 . . . . 0.0 113.499 169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.09 43.11 3.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.063 -170.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.59 -48.95 58.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.399 169.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.49 87.03 7.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.495 170.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.96 -82.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.297 -169.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -84.36 -80.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.331 -167.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -136.68 94.34 2.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.419 -169.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.54 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.287 -170.124 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.964 ' HG3' HG13 ' A' ' 2' ' ' VAL . 4.1 ptt? . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.964 HG13 ' HG3' ' A' ' 1' ' ' MET . 6.2 m 59.63 33.37 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.101 176.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 60.23 97.66 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.851 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.36 166.03 30.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.368 168.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 69.98 134.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.473 -170.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -74.63 94.98 2.75 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.389 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.9 m -154.78 -164.25 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.305 -168.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.5 t -111.79 111.53 54.01 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.415 171.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -67.94 -10.87 30.22 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 C-N-CA 122.739 2.293 . . . . 0.0 113.758 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.33 -73.93 0.37 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.456 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.1 p -92.45 -11.53 34.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.633 -164.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 59.48 57.81 3.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.254 -162.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.482 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 45.6 m -124.24 162.9 22.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.289 161.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.2 -7.84 15.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.779 -172.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.85 ' O ' HD23 ' A' ' 16' ' ' LEU . 27.2 mt-10 -90.62 119.61 31.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.066 -167.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.85 HD23 ' O ' ' A' ' 15' ' ' GLU . 10.6 mt -138.04 159.63 41.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.368 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 28' ' ' ALA . 7.0 pt -150.99 146.58 16.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.433 -169.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CD2' HG13 ' A' ' 25' ' ' ILE . 3.5 t80 -98.55 133.2 43.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.42 -168.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -110.1 90.14 9.22 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.882 172.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -59.42 -19.5 51.65 Favored 'Trans proline' 0 N--CA 1.485 1.0 0 C-N-CA 122.472 2.114 . . . . 0.0 113.497 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.82 -50.49 72.08 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.103 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 -29.83 22.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.401 171.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.55 27.65 14.45 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -167.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -92.06 165.31 13.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.341 -0.43 . . . . 0.0 110.0 -168.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 35' ' ' GLU . 1.9 mp -137.4 114.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.776 166.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.686 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.3 t -111.49 177.26 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.116 -167.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.686 ' H ' HG12 ' A' ' 26' ' ' VAL . 23.0 t -98.82 135.97 39.51 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.024 -1.443 . . . . 0.0 109.841 175.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.424 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -95.56 22.94 6.49 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.221 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' NZ ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -142.76 -25.08 0.63 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.197 -160.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -133.57 -17.33 2.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.846 163.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.59 58.35 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.476 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -70.86 138.75 50.51 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 114.558 -0.821 . . . . 0.0 110.156 -168.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.558 HG12 ' N ' ' A' ' 34' ' ' ILE . 64.9 t -61.17 168.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.277 171.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.663 HG13 HD13 ' A' ' 16' ' ' LEU . 16.8 mm -124.61 -74.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.243 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.609 ' O ' HD12 ' A' ' 25' ' ' ILE . 40.2 tt0 -143.64 168.26 20.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.85 166.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' HB3' ' OE2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -149.12 -169.77 3.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.094 -166.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 70.84 80.76 0.16 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.465 172.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.5 mt -149.7 65.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.334 167.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.3 pt -99.52 79.34 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.433 -176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.77 70.22 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.423 -177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.6 ttp 61.71 109.66 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.384 -177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.91 92.76 0.09 OUTLIER Glycine 0 CA--C 1.543 1.834 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -57.77 -66.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.485 0.992 0 C-N-CA 122.577 2.185 . . . . 0.0 113.504 -169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 58.58 20.75 7.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.559 -166.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -131.54 -37.75 1.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.371 -167.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -107.0 -167.85 1.33 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.439 -168.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -113.79 28.66 8.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.324 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 71.16 -74.58 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.336 -170.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -155.37 -178.58 7.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.351 170.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.516 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.234 169.825 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 mtt . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.107 0.48 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.3 m -111.22 127.76 68.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.314 -171.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -149.48 -78.98 0.14 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.414 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -129.11 -39.11 1.57 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.39 -168.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' HG2' ' H ' ' A' ' 6' ' ' LYS . 21.2 tt0 70.06 172.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.348 -169.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.698 ' HD3' HD12 ' A' ' 16' ' ' LEU . 0.0 OUTLIER 61.64 98.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.344 -168.088 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.45 -176.66 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.329 -166.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.5 t -110.68 113.25 55.71 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.42 -1.264 . . . . 0.0 109.507 172.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -65.49 -16.92 56.11 Favored 'Trans proline' 0 N--CA 1.483 0.895 0 C-N-CA 122.749 2.299 . . . . 0.0 113.76 169.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -78.55 -72.16 0.39 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.564 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -91.07 -9.15 46.81 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 118.46 -0.781 . . . . 0.0 111.981 -171.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 56.82 50.23 12.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.834 -167.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 77.4 p -97.03 -167.05 1.48 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.395 164.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.31 -10.12 3.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.844 171.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.68 116.42 25.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.056 -168.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.926 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -136.69 166.55 23.3 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.364 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 8.5 pt -151.28 133.16 5.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.476 -171.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 19' ' ' ASP . 49.2 t80 -80.34 163.01 24.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.322 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.498 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -146.41 100.2 4.13 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.742 -167.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -62.28 -18.38 62.19 Favored 'Trans proline' 0 N--CA 1.484 0.922 0 C-N-CA 122.564 2.176 . . . . 0.0 113.58 174.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.52 -47.09 77.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.008 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -109.29 -20.17 13.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.415 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.7 52.68 6.33 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -166.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.494 ' OE2' HG21 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -139.57 144.5 37.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 -166.156 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.469 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.4 mp -106.26 134.89 46.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.05 169.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.682 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.8 t -132.12 178.38 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.079 -167.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.682 ' H ' HG12 ' A' ' 26' ' ' VAL . 27.0 t -99.23 139.05 35.45 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.74 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.66 26.91 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.386 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.41 -34.66 0.33 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.585 -162.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.7 p -126.38 -16.71 5.33 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.9 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.57 -10.75 70.73 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.666 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -63.06 139.08 58.74 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.599 -0.801 . . . . 0.0 110.025 -174.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.528 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.2 t -61.09 167.24 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.265 170.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.926 HG13 HD13 ' A' ' 16' ' ' LEU . 15.8 mm -121.67 -76.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.567 173.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' HG2' ' N ' ' A' ' 36' ' ' GLU . 2.0 tt0 -125.2 151.41 45.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.055 177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' N ' ' HG2' ' A' ' 35' ' ' GLU . 9.6 mt-10 -111.99 165.75 11.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.953 -167.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 60.4 t30 69.64 121.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.258 167.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.554 ' O ' HG22 ' A' ' 39' ' ' ILE . 5.2 tt -64.77 111.0 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.133 166.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 38' ' ' ILE . 4.0 tp 58.19 166.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.576 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.007 -172.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.419 ' H ' HG13 ' A' ' 39' ' ' ILE . 28.7 t70 -129.79 128.88 43.27 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.383 -171.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.4 tpt -176.3 -73.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.246 168.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' H ' ' HD3' ' A' ' 43' ' ' PRO . . . 127.57 68.15 0.15 Allowed Glycine 0 CA--C 1.544 1.875 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 175.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.487 ' HD3' ' H ' ' A' ' 42' ' ' GLY . 3.0 Cg_exo -60.76 116.32 3.27 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.688 2.259 . . . . 0.0 113.448 -172.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 45' ' ' TRP . 0.0 OUTLIER 58.89 -82.0 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.662 172.177 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.413 ' H ' ' HB2' ' A' ' 44' ' ' GLU . 8.1 p-90 -154.18 144.71 22.31 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.521 -174.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' NH1' ' HA ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -75.38 159.22 31.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.342 169.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.63 134.5 37.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.325 -169.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -165.63 -80.55 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.38 169.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.07 144.47 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.35 169.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.58 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.292 169.522 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 121.142 0.496 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.1 m -122.53 144.71 30.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.329 -173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.5 m120 64.27 23.86 13.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.34 170.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.0 tptt -125.2 -169.01 1.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.408 170.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -80.04 -86.16 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.406 -167.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.591 ' HB3' HD12 ' A' ' 16' ' ' LEU . 4.1 tmtp? -178.75 127.87 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.197 -169.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.7 m -92.87 172.35 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.233 -162.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 28.7 t -113.64 115.26 46.73 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 114.248 -1.342 . . . . 0.0 109.004 175.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -62.67 -20.35 70.68 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 122.608 2.205 . . . . 0.0 113.717 169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -76.36 -70.54 0.44 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.49 179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.5 p -95.16 -9.7 32.7 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.022 -170.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 12' ' ' GLU . 7.3 pt-20 56.34 48.52 16.92 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 121.415 -0.803 . . . . 0.0 111.004 -168.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 80.2 p -85.46 -168.4 2.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.414 166.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.61 -13.07 5.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.741 167.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.534 ' O ' HD23 ' A' ' 16' ' ' LEU . 2.3 mp0 -91.49 109.56 20.85 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.12 -169.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.738 HD13 HG13 ' A' ' 34' ' ' ILE . 15.8 mt -127.9 -177.95 4.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.387 171.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 16' ' ' LEU . 3.7 pt -160.4 145.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.414 -169.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.58 ' OH ' HD13 ' A' ' 38' ' ' ILE . 5.9 t80 -108.81 119.15 38.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.416 -169.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.98 83.84 0.52 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.795 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 6.2 Cg_endo -59.93 -19.68 56.31 Favored 'Trans proline' 0 N--CA 1.485 1.001 0 C-N-CA 122.434 2.09 . . . . 0.0 113.596 -172.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -64.09 -51.99 61.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.999 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -79.12 -30.36 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.407 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.592 ' HA2' HD11 ' A' ' 38' ' ' ILE . . . 85.31 40.87 7.68 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -168.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -118.07 159.64 22.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -169.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.7 mp -129.47 133.13 65.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.037 163.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.8 t -131.93 178.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.114 -167.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.724 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.9 t -106.15 125.41 50.96 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.536 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.25 -2.44 31.41 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 114.568 -1.197 . . . . 0.0 111.868 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -77.59 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.447 171.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.5 p -83.2 -17.54 42.46 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.6 -162.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.95 -10.83 60.52 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.43 179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -68.93 139.93 55.09 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 114.547 -0.826 . . . . 0.0 110.265 -168.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 34' ' ' ILE . 95.7 t -62.17 167.68 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.038 165.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.738 HG13 HD13 ' A' ' 16' ' ' LEU . 16.9 mm -117.82 -74.88 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.1 -1.409 . . . . 0.0 109.725 171.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 36' ' ' GLU . 48.1 tp10 -142.2 168.14 20.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.984 166.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' N ' ' HG3' ' A' ' 35' ' ' GLU . 20.6 pm0 -154.22 -174.47 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.092 -168.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.6 t30 65.73 55.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.404 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.592 HD11 ' HA2' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -91.28 156.34 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.419 170.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.523 HG12 HD12 ' A' ' 38' ' ' ILE . 17.5 mm 66.19 115.42 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.409 -170.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.63 148.57 2.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.358 177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 35.6 mtm -128.43 128.97 45.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.408 -169.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' N ' ' HD3' ' A' ' 43' ' ' PRO . . . 63.72 50.45 61.38 Favored Glycine 0 CA--C 1.542 1.726 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 171.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 42' ' ' GLY . 1.0 OUTLIER -56.9 76.85 0.04 OUTLIER 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 122.391 2.06 . . . . 0.0 113.511 172.452 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -170.92 134.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.032 169.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 20.1 m95 61.3 86.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.266 -167.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -108.56 -80.73 0.57 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.366 -166.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -167.44 -161.42 0.41 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.122 -165.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 73.09 -71.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.407 -168.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.4 -171.58 3.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.446 173.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.602 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.368 -176.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtp . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 121.153 0.501 . . . . 0.0 109.785 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.0 p -118.59 110.92 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.349 -172.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.89 -152.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.399 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 mttt 65.2 175.2 0.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.299 -171.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -79.64 0.09 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.147 -163.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.547 ' CD ' HG21 ' A' ' 34' ' ' ILE . 0.1 OUTLIER 55.02 179.75 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.555 -168.078 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 16.9 m -135.78 -174.12 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.538 -166.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.7 t -111.57 112.61 53.92 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.175 174.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -63.25 -16.85 57.06 Favored 'Trans proline' 0 N--CA 1.484 0.938 0 C-N-CA 122.686 2.257 . . . . 0.0 113.735 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.52 -73.56 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.393 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.3 p -90.9 -11.01 40.44 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.645 -166.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 59.37 56.06 3.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.248 -163.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.45 ' HB3' ' HD3' ' A' ' 29' ' ' LYS . 52.6 p -109.57 -166.21 1.08 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.367 160.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . . . -142.36 -16.96 0.73 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 114.933 -1.031 . . . . 0.0 111.662 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.787 ' O ' HD23 ' A' ' 16' ' ' LEU . 1.9 mm-40 -81.39 122.59 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.05 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.933 HD13 HG13 ' A' ' 34' ' ' ILE . 13.5 mt -137.28 160.43 39.06 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.466 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.6 pt -136.37 132.01 48.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.369 -168.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.535 ' CD1' HG13 ' A' ' 25' ' ' ILE . 7.4 t80 -88.47 132.7 34.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.379 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.05 80.76 1.11 Allowed Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.653 168.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 5.6 Cg_endo -59.16 -20.23 53.48 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 C-N-CA 122.558 2.172 . . . . 0.0 113.512 -168.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.03 -53.22 57.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.178 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 39.5 mmm-85 -86.9 -19.13 29.31 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.397 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.738 ' HA3' HG22 ' A' ' 38' ' ' ILE . . . 77.26 30.55 54.33 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -168.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -89.46 162.31 15.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.929 -0.635 . . . . 0.0 109.993 178.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.535 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.1 mp -142.0 115.79 4.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.202 167.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.713 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -106.51 177.93 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.232 -170.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.713 ' H ' HG12 ' A' ' 26' ' ' VAL . 31.4 t -101.07 125.05 47.66 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.175 -1.375 . . . . 0.0 109.641 177.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.53 -4.61 43.64 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.882 176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 13' ' ' SER . 0.0 OUTLIER -92.97 -78.46 0.42 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.313 170.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.0 p -86.12 -16.6 37.43 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.612 -161.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.24 -10.38 54.56 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.455 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -72.61 133.97 44.94 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 114.592 -0.804 . . . . 0.0 110.172 -168.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 34' ' ' ILE . 88.3 t -61.27 167.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.133 165.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.933 HG13 HD13 ' A' ' 16' ' ' LEU . 33.4 mm -119.18 -76.53 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.251 -1.34 . . . . 0.0 109.644 173.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.87 -177.5 4.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.079 168.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 24' ' ' GLU . 2.3 pt-20 -146.47 -171.71 3.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.946 -168.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.6 t30 70.92 112.97 0.05 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.42 168.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.738 HG22 ' HA3' ' A' ' 23' ' ' GLY . 1.6 tt -151.06 164.55 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.26 167.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 38' ' ' ILE . 2.8 tt 59.74 171.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.826 -178.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -109.17 -99.0 0.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.318 -166.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 10.5 ptt? -144.48 -161.67 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.435 -164.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.19 -67.57 0.68 Allowed Glycine 0 CA--C 1.544 1.85 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -52.46 102.74 0.07 OUTLIER 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 122.529 2.153 . . . . 0.0 113.598 -172.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -98.28 -25.65 14.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.05 169.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.596 ' NE1' ' HB3' ' A' ' 47' ' ' ALA . 18.8 p90 60.54 177.46 0.1 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 114.792 -1.095 . . . . 0.0 110.67 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -66.45 -34.35 77.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.394 -162.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' NE1' ' A' ' 45' ' ' TRP . . . -64.92 -164.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.302 -166.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 71.71 -76.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.3 -168.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -132.82 149.39 52.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.347 -169.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.621 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.245 169.616 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttm . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.119 0.485 . . . . 0.0 109.757 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 p -74.61 135.89 26.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.342 171.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -61.11 100.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.396 -169.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -121.05 83.37 2.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.34 173.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 61.84 84.53 0.13 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.368 174.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.83 157.95 40.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.284 166.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 m -104.59 -176.78 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.247 -164.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 19.5 t -107.72 113.52 61.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 114.291 -1.322 . . . . 0.0 109.279 170.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -66.68 -13.72 41.03 Favored 'Trans proline' 0 N--CA 1.484 0.914 0 C-N-CA 122.71 2.273 . . . . 0.0 113.721 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.605 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.95 -74.58 0.31 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.456 178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -91.21 -11.02 39.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.691 -166.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 59.31 54.81 4.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.223 -163.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 32.5 p -88.85 176.55 7.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 114.779 -1.1 . . . . 0.0 110.038 162.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -117.33 -8.04 11.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.763 164.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.64 ' O ' HD23 ' A' ' 16' ' ' LEU . 19.0 mt-10 -99.04 116.18 30.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.988 -167.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.65 HD13 HG13 ' A' ' 34' ' ' ILE . 16.0 mt -132.62 166.59 21.78 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.379 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.478 HD13 ' HB2' ' A' ' 28' ' ' ALA . 10.2 pt -155.15 148.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.399 -167.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.476 ' CD1' HG13 ' A' ' 25' ' ' ILE . 12.9 t80 -107.73 123.17 48.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.312 -170.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -100.96 98.0 7.85 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.821 -171.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.1 Cg_endo -59.09 -14.18 22.41 Favored 'Trans proline' 0 N--CA 1.485 0.993 0 C-N-CA 122.306 2.004 . . . . 0.0 113.505 -178.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.55 -30.7 21.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.085 -169.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.31 -19.33 13.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.459 174.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.18 51.2 10.42 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -168.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 26' ' ' VAL . 31.9 tt0 -137.08 125.94 24.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.335 -0.432 . . . . 0.0 109.9 -167.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.664 ' H ' HD12 ' A' ' 25' ' ' ILE . 2.4 mp -88.83 128.11 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.128 169.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -130.76 177.12 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.968 -168.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.591 ' H ' HG12 ' A' ' 26' ' ' VAL . 19.7 t -93.33 124.01 37.01 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 114.207 -1.361 . . . . 0.0 109.916 169.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.478 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.73 7.31 4.78 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.753 176.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.406 ' HA ' ' HE2' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -112.95 -67.99 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.455 178.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.6 p -91.75 -19.14 22.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.512 -169.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.13 57.81 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.551 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 t80 -68.76 126.82 30.94 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 114.404 -0.898 . . . . 0.0 110.229 -170.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 34' ' ' ILE . 65.3 t -61.55 169.36 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.426 175.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.65 HG13 HD13 ' A' ' 16' ' ' LEU . 20.0 mm -124.75 -73.38 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 114.449 -1.25 . . . . 0.0 109.185 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.464 ' O ' HD12 ' A' ' 25' ' ' ILE . 5.0 tp10 -136.27 153.59 51.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.958 166.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 24' ' ' GLU . 1.4 tt0 -133.16 -179.23 5.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.965 -165.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 71.5 87.51 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.428 167.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 27.7 mt -150.75 141.34 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.309 166.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.478 ' O ' HD12 ' A' ' 39' ' ' ILE . 1.7 pp -153.55 22.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.38 169.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 68.98 -157.41 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.446 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 7.3 ttp -106.28 153.88 21.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.292 -169.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.07 -98.86 0.22 Allowed Glycine 0 CA--C 1.542 1.778 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 172.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.52 96.99 0.06 OUTLIER 'Trans proline' 0 N--CA 1.484 0.969 0 C-N-CA 122.413 2.076 . . . . 0.0 113.6 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -170.04 40.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.056 174.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 61.55 101.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.393 -173.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -56.88 10.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.369 -167.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.98 139.23 48.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.272 -167.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -98.12 -51.99 3.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.334 168.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.1 t0 66.62 -81.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.644 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.285 -169.607 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' O ' HG12 ' A' ' 2' ' ' VAL . 7.5 ptt? . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.675 HG22 ' H ' ' A' ' 3' ' ' ASN . 4.0 p 60.88 174.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.371 -0.832 . . . . 0.0 110.586 172.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.675 ' H ' HG22 ' A' ' 2' ' ' VAL . 23.9 m120 72.06 -68.09 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.458 -168.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -61.17 82.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.411 169.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.0 -54.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.224 175.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.49 ' O ' HG22 ' A' ' 7' ' ' VAL . 3.4 ttpp 64.1 -172.92 0.17 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.461 163.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 6' ' ' LYS . 9.7 m 59.55 -167.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.248 169.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 14.4 t -113.84 111.04 48.64 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.537 175.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -67.77 -10.57 29.21 Favored 'Trans proline' 0 N--CA 1.482 0.846 0 C-N-CA 122.751 2.301 . . . . 0.0 113.881 169.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.72 -71.81 0.47 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.549 178.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.1 p -93.98 -11.33 31.09 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.916 -0.583 . . . . 0.0 111.635 -165.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 59.48 58.11 3.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.228 -161.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.2 m -110.8 -171.35 1.81 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.231 159.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.76 -16.44 1.14 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.717 178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.852 ' O ' HD23 ' A' ' 16' ' ' LEU . 5.0 mm-40 -74.85 120.47 20.44 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.026 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.929 HD13 HG13 ' A' ' 34' ' ' ILE . 7.9 mt -135.77 165.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.411 175.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.456 HD13 ' HB2' ' A' ' 28' ' ' ALA . 8.9 pt -150.02 140.37 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.394 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.525 ' CD2' HG13 ' A' ' 25' ' ' ILE . 6.0 t80 -101.66 149.48 24.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.236 -168.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.494 ' N ' ' CD1' ' A' ' 18' ' ' TYR . 7.1 t70 -129.3 94.79 32.24 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.736 -167.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -59.89 -20.26 58.86 Favored 'Trans proline' 0 N--CA 1.485 0.975 0 C-N-CA 122.272 1.981 . . . . 0.0 113.571 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -66.92 -39.04 87.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.112 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.5 -22.62 11.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.44 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.52 30.29 30.48 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.41 164.65 12.54 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -170.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.999 HD11 HD11 ' A' ' 38' ' ' ILE . 2.6 mp -126.76 136.64 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.999 163.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.702 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -132.82 178.5 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.155 -167.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.702 ' H ' HG12 ' A' ' 26' ' ' VAL . 22.0 t -101.87 136.85 41.0 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.858 175.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -95.89 29.57 2.67 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.33 176.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.74 -35.41 0.34 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.613 -165.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.3 p -125.57 -16.49 5.78 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.823 169.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.43 -11.11 69.02 Favored Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.576 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -63.04 137.67 58.33 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 114.639 -0.78 . . . . 0.0 109.976 -173.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 34' ' ' ILE . 84.6 t -60.89 167.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.26 168.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.929 HG13 HD13 ' A' ' 16' ' ' LEU . 20.6 mm -120.78 -69.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 114.186 -1.37 . . . . 0.0 109.426 173.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.52 140.23 49.46 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.066 176.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -66.92 -161.24 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.171 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 52.7 p30 -61.53 141.61 57.62 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.418 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.999 HD11 HD11 ' A' ' 25' ' ' ILE . 26.7 mt -107.09 120.83 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.367 -167.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.554 HG13 HG22 ' A' ' 38' ' ' ILE . 11.3 mt 61.26 86.22 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.414 169.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -149.51 -97.49 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.186 -0.915 . . . . 0.0 110.325 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 76.4 mtp 65.23 -79.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.363 -169.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.76 142.68 4.26 Favored Glycine 0 CA--C 1.543 1.793 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 171.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 13.6 Cg_exo -57.58 -32.78 95.29 Favored 'Trans proline' 0 N--CA 1.484 0.943 0 C-N-CA 122.427 2.085 . . . . 0.0 113.613 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 43' ' ' PRO . 2.7 mt-10 58.87 -78.7 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.764 175.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 8.4 m95 68.33 -90.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.286 -165.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.3 -80.77 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.402 170.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -168.9 -162.76 0.39 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.188 168.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -86.2 111.17 20.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.311 168.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -110.85 -81.5 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.379 171.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.551 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.203 179.694 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttt . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.122 0.487 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 m -61.52 145.03 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.299 -173.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m120 70.18 -59.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.374 -169.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.34 99.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.368 -178.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.85 150.04 34.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.457 -170.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -143.69 46.82 1.47 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.9 171.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.9 m -145.79 -165.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.31 -172.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.912 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 28' ' ' ALA . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.604 ' CZ ' HG23 ' A' ' 38' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 35' ' ' GLU . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.718 ' H ' HG12 ' A' ' 26' ' ' VAL . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 34' ' ' ILE . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.912 HG13 HD13 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 25' ' ' ILE . 7.8 tp10 -160.33 170.19 21.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' N ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 tt0 -138.13 91.85 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.099 -166.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -173.94 105.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.399 -171.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.604 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -121.04 168.42 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.204 164.097 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -82.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.811 -168.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -68.81 77.45 0.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.298 -166.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -152.24 -172.87 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.397 169.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.22 -74.13 0.2 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.2 114.08 1.71 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.501 2.134 . . . . 0.0 113.576 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.86 -160.25 1.03 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.048 -168.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -31.7 51.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.368 -169.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -13.68 18.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.394 -170.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.5 106.31 5.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.321 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -112.0 -29.87 7.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.335 169.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.63 -162.14 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.414 169.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.542 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.267 -169.588 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttt . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 121.122 0.487 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 m -61.52 145.03 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.299 -173.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 m120 70.18 -59.02 0.53 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.374 -169.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.34 99.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.368 -178.639 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -146.85 150.04 34.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.457 -170.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -143.69 46.82 1.47 Allowed 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.9 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.9 m -145.79 -165.89 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.31 -172.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 17.1 t -104.65 112.14 65.3 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 114.435 -1.257 . . . . 0.0 109.353 168.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 9.9 Cg_exo -67.96 -12.11 34.23 Favored 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.83 169.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -80.61 -75.39 0.27 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.431 177.277 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.7 p -91.19 -10.98 39.7 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.677 -164.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.48 56.73 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.178 -162.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 73.9 m -114.0 -178.06 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.105 159.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.92 -16.04 2.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.623 -167.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.748 ' O ' HD23 ' A' ' 16' ' ' LEU . 3.1 mm-40 -90.6 129.07 36.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.194 -174.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.912 HD13 HG13 ' A' ' 34' ' ' ILE . 19.8 mt -137.27 153.59 50.3 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.37 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 28' ' ' ALA . 3.5 pt -137.64 128.72 39.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.348 -170.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.604 ' CZ ' HG23 ' A' ' 38' ' ' ILE . 2.6 t80 -86.96 139.04 31.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.374 -167.322 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.34 87.52 2.12 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.692 170.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 5.0 Cg_endo -59.72 -19.54 54.13 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 122.542 2.161 . . . . 0.0 113.474 -167.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -76.8 -46.49 24.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.125 -174.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -77.48 -33.12 54.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.361 175.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.42 34.38 9.51 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -169.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -113.71 160.56 18.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.385 -0.407 . . . . 0.0 110.021 -171.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 35' ' ' GLU . 2.6 mp -129.61 140.9 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.071 167.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.3 t -132.18 178.21 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.085 -170.282 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.718 ' H ' HG12 ' A' ' 26' ' ' VAL . 24.8 t -100.81 123.2 44.66 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.826 177.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' HD13 ' A' ' 17' ' ' ILE . . . -76.97 3.12 12.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.8 176.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -73.33 0.66 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.511 173.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.4 p -89.1 -18.37 27.38 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.585 -166.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.32 -11.81 56.93 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.417 179.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.59 138.76 51.12 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.196 -1.002 . . . . 0.0 110.065 -170.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG12 ' N ' ' A' ' 34' ' ' ILE . 73.4 t -61.12 168.25 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.233 170.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.912 HG13 HD13 ' A' ' 16' ' ' LEU . 11.0 mm -121.31 -70.74 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.509 172.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.694 ' O ' HD12 ' A' ' 25' ' ' ILE . 7.8 tp10 -160.33 170.19 21.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.916 -177.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' N ' ' HG3' ' A' ' 35' ' ' GLU . 10.8 tt0 -138.13 91.85 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.099 -166.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -173.94 105.56 0.12 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.399 -171.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.604 HG23 ' CZ ' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -121.04 168.42 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.204 164.097 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -82.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.811 -168.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -68.81 77.45 0.31 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.298 -166.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -152.24 -172.87 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.397 169.2 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 160.22 -74.13 0.2 Allowed Glycine 0 CA--C 1.543 1.825 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 -174.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.2 114.08 1.71 Allowed 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.501 2.134 . . . . 0.0 113.576 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -131.86 -160.25 1.03 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.048 -168.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -31.7 51.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.368 -169.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.1 -13.68 18.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.394 -170.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.5 106.31 5.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.043 -0.98 . . . . 0.0 110.321 -177.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -112.0 -29.87 7.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.335 169.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.63 -162.14 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.414 169.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.542 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.267 -169.588 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.632 HG12 ' HG3' ' A' ' 4' ' ' LYS . 20.6 t 66.55 -85.86 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.459 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 62.28 99.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.441 -170.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.632 ' HG3' HG12 ' A' ' 2' ' ' VAL . 1.8 mtmm -154.35 32.96 0.42 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.267 -168.314 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -95.64 33.62 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.541 173.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -82.84 106.41 14.65 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.282 -169.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 27.3 m -59.84 -161.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.293 166.119 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 15.9 t -95.63 111.22 54.9 Favored Pre-proline 0 CA--C 1.552 1.023 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.338 161.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 5.2 Cg_endo -69.99 -8.08 22.72 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.6 2.2 . . . . 0.0 113.968 169.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.32 -73.73 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.514 175.588 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -92.68 -11.45 34.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.663 -165.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.53 57.15 3.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.209 -162.645 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 72.0 m -114.02 172.94 6.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.209 160.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.15 -9.32 4.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.715 -172.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 65.8 mm-40 -96.83 52.64 1.19 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.977 -162.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.9 HD13 HG13 ' A' ' 34' ' ' ILE . 17.4 mt -69.71 175.97 3.89 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.449 -177.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 16' ' ' LEU . 9.5 pt -157.49 153.29 6.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.462 -168.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.529 ' CD2' HG13 ' A' ' 25' ' ' ILE . 2.3 t80 -106.8 132.36 52.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.434 -169.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.3 92.08 6.44 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.703 175.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 13.5 Cg_exo -59.07 -13.16 17.98 Favored 'Trans proline' 0 N--CA 1.487 1.093 0 C-N-CA 122.388 2.059 . . . . 0.0 113.602 -168.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.22 -47.68 14.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.016 -170.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.403 ' N ' ' HD3' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -90.05 -24.0 21.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.419 170.302 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.13 16.61 50.06 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -177.657 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HG2' HG22 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -79.59 164.2 24.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.085 -0.557 . . . . 0.0 110.027 -171.313 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 18' ' ' TYR . 2.0 mp -130.84 113.0 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.938 165.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.719 HG12 ' H ' ' A' ' 27' ' ' CYS . 5.1 t -114.04 177.61 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.147 -169.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.719 ' H ' HG12 ' A' ' 26' ' ' VAL . 15.4 t -90.5 126.17 35.83 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.157 -1.383 . . . . 0.0 110.076 178.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 15' ' ' GLU . . . -76.48 7.05 4.83 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.774 175.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.23 -67.66 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.514 178.244 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 29.8 p -93.03 -20.13 20.87 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.48 -167.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.98 60.23 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.639 -179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -69.52 131.94 45.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.659 -0.771 . . . . 0.0 110.333 -172.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.582 HG12 ' N ' ' A' ' 34' ' ' ILE . 61.3 t -61.79 170.98 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.368 175.012 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.9 HG13 HD13 ' A' ' 16' ' ' LEU . 14.0 mm -128.07 -73.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.013 -179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.07 174.35 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.022 167.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -130.32 107.89 9.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.113 -167.06 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.5 p30 61.43 176.24 0.11 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.498 171.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 79.2 mt -145.9 92.38 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.397 -170.57 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.4 mm 66.2 142.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.393 -168.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.55 -17.52 3.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.443 -167.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.3 ttm -95.3 38.72 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.371 -167.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.6 98.25 0.03 OUTLIER Glycine 0 CA--C 1.543 1.837 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 168.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -58.03 161.27 13.61 Favored 'Trans proline' 0 N--CA 1.486 1.034 0 C-N-CA 122.557 2.172 . . . . 0.0 113.494 170.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.59 106.03 2.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.992 167.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -100.4 98.42 9.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.422 -167.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.99 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.436 167.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -169.87 -162.0 0.3 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.28 -165.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 72.62 -60.68 0.52 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.475 171.537 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.5 t0 70.13 79.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.382 -170.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.582 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.243 169.528 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmm? . . . . . 0 N--CA 1.473 0.719 0 CA-C-O 121.075 0.464 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 p -120.59 81.09 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.327 -170.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.1 m120 64.37 -84.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.364 168.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.3 16.16 9.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.703 -178.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 60.73 105.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.51 166.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.25 177.36 4.71 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.339 -171.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.459 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 28.4 m -97.58 -160.57 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.19 -175.142 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.611 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.0 t -102.61 111.12 64.45 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.369 164.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 7.2 Cg_exo -68.45 -10.77 29.99 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.741 2.294 . . . . 0.0 113.751 169.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.611 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -81.14 -73.67 0.36 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.482 177.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.7 p -93.67 -11.86 30.64 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.596 -163.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.62 59.25 2.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.579 0.704 . . . . 0.0 110.193 -161.374 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.449 ' HB3' ' HG3' ' A' ' 29' ' ' LYS . 54.9 m -123.61 148.31 46.53 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.26 161.171 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -91.16 -16.31 27.93 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.602 -179.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.502 ' O ' HD23 ' A' ' 16' ' ' LEU . 15.3 mm-40 -75.89 118.05 18.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.158 -172.184 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.582 HD13 HG13 ' A' ' 34' ' ' ILE . 15.7 mt -141.95 158.04 44.24 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.315 178.038 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.9 pt -150.85 158.57 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.415 -167.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.768 ' OH ' HD13 ' A' ' 38' ' ' ILE . 2.8 t80 -108.68 121.79 45.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.375 -169.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -93.21 99.75 3.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.748 178.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.0 OUTLIER -59.61 -15.53 31.55 Favored 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 122.362 2.041 . . . . 0.0 113.469 179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -78.21 -30.86 49.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.039 -169.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -111.98 -20.22 12.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.398 173.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.8 44.79 7.56 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -169.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' OE1' ' HB3' ' A' ' 36' ' ' GLU . 0.4 OUTLIER -112.46 168.11 9.91 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -170.173 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -128.75 128.77 68.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.677 162.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.676 HG12 ' H ' ' A' ' 27' ' ' CYS . 3.7 t -130.88 176.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.93 -168.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.676 ' H ' HG12 ' A' ' 26' ' ' VAL . 17.8 t -94.54 136.78 34.45 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.01 176.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.8 20.91 8.1 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.237 178.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HA ' ' CE ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -143.41 -23.79 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.357 -158.361 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.3 p -135.99 -18.06 1.6 Allowed 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.838 164.726 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 102.15 -11.44 57.14 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 114.729 -1.123 . . . . 0.0 111.455 179.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -67.97 137.16 54.92 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 114.312 -0.944 . . . . 0.0 110.09 -170.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 34' ' ' ILE . 96.3 t -61.59 167.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.59 -1.187 . . . . 0.0 110.221 175.065 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.582 HG13 HD13 ' A' ' 16' ' ' LEU . 19.4 mm -124.21 -78.27 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.416 172.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.22 -164.05 1.28 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.978 174.019 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HB3' ' OE1' ' A' ' 24' ' ' GLU . 4.5 pt-20 -165.68 -170.83 1.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.14 171.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.687 ' C ' HD12 ' A' ' 38' ' ' ILE . 3.3 m120 70.84 103.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.428 169.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.768 HD13 ' OH ' ' A' ' 18' ' ' TYR . 3.6 mp -128.23 165.06 28.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.406 176.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.43 ' N ' HG22 ' A' ' 38' ' ' ILE . 1.1 pt -66.16 115.33 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.391 -168.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.1 -97.75 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.392 167.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.6 ttm 61.53 18.37 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.566 173.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 61.19 -157.81 31.6 Favored Glycine 0 CA--C 1.544 1.847 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 170.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.88 171.4 1.07 Allowed 'Trans proline' 0 N--CA 1.486 1.07 0 C-N-CA 122.509 2.14 . . . . 0.0 113.597 169.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.88 93.31 0.18 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.084 168.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 2.9 m0 -136.57 117.41 14.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.336 169.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -171.08 -74.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.331 170.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.72 104.36 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.277 -170.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -123.7 110.87 15.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.393 170.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -151.45 -41.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.408 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.617 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.234 169.599 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttm . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.152 0.501 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 m -145.31 108.48 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.369 172.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -156.5 58.53 0.56 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.368 179.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.97 149.83 35.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.344 169.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -99.15 33.05 2.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.365 -167.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -169.26 79.45 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.297 166.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.0 m -146.87 -174.15 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.29 -175.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 16.2 t -102.47 111.44 64.62 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 114.607 -1.178 . . . . 0.0 109.499 168.165 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.25 -11.76 33.41 Favored 'Trans proline' 0 N--CA 1.484 0.921 0 C-N-CA 122.706 2.271 . . . . 0.0 113.778 169.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -82.17 -69.78 0.59 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.619 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 31.2 p -96.53 -11.45 25.44 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.654 -166.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 59.62 58.32 2.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.242 -162.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 62.0 m -114.42 173.78 6.29 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.283 160.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.86 6.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.611 -169.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -88.22 126.97 35.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.043 -178.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.973 HD13 HG13 ' A' ' 34' ' ' ILE . 17.6 mt -135.52 161.54 35.19 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.446 174.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 4.4 pt -135.64 140.29 44.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.367 -167.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.422 ' HE2' HD13 ' A' ' 38' ' ' ILE . 4.5 t80 -104.29 135.85 44.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.256 -169.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.65 92.23 49.15 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.794 -168.14 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -59.47 -20.12 55.15 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 122.44 2.093 . . . . 0.0 113.61 -172.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -70.77 -46.99 61.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.076 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -91.76 -21.79 20.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.406 -178.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.99 41.79 60.62 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -167.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HG3' HG13 ' A' ' 33' ' ' VAL . 17.6 tt0 -128.3 141.34 51.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.404 . . . . 0.0 109.968 -166.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.72 HD11 HD11 ' A' ' 38' ' ' ILE . 2.5 mp -108.04 137.67 38.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.091 170.796 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG12 ' H ' ' A' ' 27' ' ' CYS . 4.6 t -134.06 176.95 7.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.908 -168.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.635 ' H ' HG12 ' A' ' 26' ' ' VAL . 18.1 t -92.6 131.09 38.01 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.841 174.138 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.15 43.24 1.14 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 113.956 -1.475 . . . . 0.0 110.379 170.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -53.05 0.16 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.464 -178.045 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 31.8 p -111.03 -18.23 13.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.717 -178.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.99 -10.61 68.01 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.671 179.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -62.17 132.59 53.27 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.74 -0.73 . . . . 0.0 109.999 -175.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 34' ' ' ILE . 88.8 t -61.06 167.76 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.279 170.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.973 HG13 HD13 ' A' ' 16' ' ' LEU . 21.1 mm -120.24 -77.84 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.331 -1.304 . . . . 0.0 109.698 173.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.687 ' HG3' HD13 ' A' ' 25' ' ' ILE . 0.0 OUTLIER -136.33 169.15 18.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.055 172.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -143.58 148.09 35.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.068 -168.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 60.7 94.54 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 114.772 -1.104 . . . . 0.0 110.764 176.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.72 HD11 HD11 ' A' ' 25' ' ' ILE . 3.0 mp -92.18 114.3 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.477 170.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -171.53 -35.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.473 171.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 p30 61.25 179.29 0.11 Allowed 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.584 172.286 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 61.44 -85.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.434 -169.519 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.17 153.18 25.02 Favored Glycine 0 CA--C 1.541 1.701 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 175.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.81 -156.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.484 0.94 0 C-N-CA 122.354 2.036 . . . . 0.0 113.627 177.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -91.93 137.07 32.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.1 179.394 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -60.89 -75.24 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.393 168.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 mtt180 65.57 -80.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.493 170.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -176.06 123.36 0.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.229 168.377 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 173.31 107.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.3 167.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -148.02 -72.5 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.343 168.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.559 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.241 -170.973 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 mtt . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.179 0.514 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.81 -44.63 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.377 -172.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -86.53 -179.37 6.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.322 167.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.11 139.17 13.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.298 -167.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 70.39 145.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.383 164.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.17 144.7 55.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.109 164.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 23.3 m -124.53 -176.03 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.333 -163.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.599 ' SG ' ' HB3' ' A' ' 10' ' ' ALA . 22.9 t -103.01 111.73 65.27 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.105 168.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' VAL . 8.0 Cg_exo -66.8 -4.26 10.89 Favored 'Trans proline' 0 N--CA 1.485 0.991 0 C-N-CA 122.678 2.252 . . . . 0.0 113.776 170.331 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.599 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . . . -93.45 -68.53 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.557 -178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 30.3 p -94.87 -11.29 29.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.555 -167.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 59.44 57.35 3.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.185 -162.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.9 p -101.82 -165.81 1.23 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.279 160.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -138.08 -16.91 1.23 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.681 175.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.843 ' O ' HD23 ' A' ' 16' ' ' LEU . 4.3 mm-40 -86.42 122.03 29.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.111 -175.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.843 HD23 ' O ' ' A' ' 15' ' ' GLU . 11.0 mt -137.81 -176.3 4.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 114.601 -1.182 . . . . 0.0 110.442 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 16' ' ' LEU . 4.3 pt -161.81 138.94 2.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.426 -169.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.755 ' OH ' HG22 ' A' ' 38' ' ' ILE . 13.7 t80 -105.92 121.08 43.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.401 -177.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.75 94.56 3.71 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.869 -175.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 18' ' ' TYR . 1.2 Cg_endo -58.92 -15.17 25.85 Favored 'Trans proline' 0 N--CA 1.486 1.067 0 C-N-CA 122.348 2.032 . . . . 0.0 113.449 -170.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.83 -31.69 23.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.988 -170.426 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.48 -27.15 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.371 171.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 72.87 62.01 3.32 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -163.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.507 ' OE2' HG21 ' A' ' 33' ' ' VAL . 9.3 tt0 -140.78 114.88 9.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.315 -0.443 . . . . 0.0 109.93 -166.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.521 HG13 ' CD1' ' A' ' 18' ' ' TYR . 2.8 mp -93.36 116.05 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.158 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.886 HG22 HG22 ' A' ' 33' ' ' VAL . 5.3 t -121.17 177.66 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.246 -164.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.721 ' H ' HG12 ' A' ' 26' ' ' VAL . 35.0 t -106.33 131.75 53.18 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 114.121 -1.4 . . . . 0.0 109.457 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.25 39.32 1.02 Allowed 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 113.661 -1.608 . . . . 0.0 110.455 173.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.94 -50.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.371 -175.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 30.0 p -113.12 -17.19 12.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.65 -177.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.13 -11.0 63.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -66.28 137.02 56.65 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 114.406 -0.897 . . . . 0.0 110.037 -170.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.886 HG22 HG22 ' A' ' 26' ' ' VAL . 90.1 t -79.89 159.85 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.031 161.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.442 HG22 ' HB2' ' A' ' 35' ' ' GLU . 5.3 mt -116.38 -75.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 113.527 -1.67 . . . . 0.0 109.5 166.093 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.442 ' HB2' HG22 ' A' ' 34' ' ' ILE . 4.6 tt0 -120.46 165.42 14.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.079 -162.842 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' H ' ' HG3' ' A' ' 35' ' ' GLU . 29.2 mt-10 -128.3 134.64 48.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.979 -169.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 60.31 170.41 0.09 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.73 -177.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.755 HG22 ' OH ' ' A' ' 18' ' ' TYR . 7.4 tt -170.11 46.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.349 -177.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 29.9 mt 60.86 -88.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.474 169.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -139.85 -156.6 0.69 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.445 170.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.6 ttt -130.11 113.18 14.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.344 169.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.36 102.58 0.16 Allowed Glycine 0 CA--C 1.542 1.764 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 178.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -60.65 -156.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.988 0 C-N-CA 122.552 2.168 . . . . 0.0 113.6 -175.118 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.37 43.18 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.935 -168.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -172.44 97.39 0.15 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.333 169.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.27 79.96 6.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.445 -170.289 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -174.46 106.31 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.272 177.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -148.94 -78.64 0.14 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.335 -177.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -99.87 -55.75 2.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.363 -169.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.629 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.215 177.416 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_